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SUMMARY
The tryptophan analogues, |3-(2-azaindol-3-yl)-, |3-(7-azaindol-3-yl)-
and |3-(l-benzothien-3-yl)-alanine, were synthesised and fed to PeniciIlium
cyclopium cultures. The three compounds caused inhibition of normal
fungal growth and metabolite production. 3“Acetyl-5-(indol-3-ylmethyl)-
tetramic acid, a known intermediate in cyclopiazonic acid biosynthesis,
14
labelled with C, was synthesised. After administration of this compound
to cultures of P. cyclopium. no radioactivity was detected in the
metabolites. It is presumed that cell-wall permeability problems were
responsible for this result. When grown on a replacement medium
containing no exogenous nitrogen source, P. cyclopium produced a- and
|3-cyclopiazonic acids only when small amounts of 3“a'Cetyl-5-(indol-3~yl-
2
methyl)tetramic acid were added. However, when 3“C H^]acetyl-5-(indol-3- 
2
ylmethyl)-£5- H]tetramic acid was administered, the a- and p-cyclopiazonic
acids isolated contained no deuterium. These results suggest that the
tetramic acid is first degraded to tryptophan, which can then lose the 
2
H-atom in a transamination reaction, prior to incorporation into the 
metabolites•
iZj,
cyclo-(L-Ihenylalanyl-D-seryl), labelled with G, was synthesised 
and administered to cultures of Hyalodendron sp. and found to be poorly 
incorporated into bisdethiobis(methylthio)hyalodendrin. This finding 
complemented previous results obtained in this group and indicated 
that of the four cyclo-(phenylalanyl-sexyl) stereoisomers, only the 
LL-isomer is an efficient precursor for hyalodendrin biosynthesis. 
Moreover, experiments involving the feeding of cyclo-(L-phenylalanyl- 
L-[3-1 C^T]seryl) indicated that the precursor is incorporated intact 
into the metabolite. Exploratory studies on the status of cyclo-
(L-N-Me-Ihe-L-Ser) as a precursor for bisdethiobis(methylthio)hyalodendrin
are also described.
The stereoisomers of cyclo-(phenylalanyl-phenylalanyl)t labelled 
l*fwith C, were synthesised and fed to cultures of Apergillus terreus.
Only the LL-isomer was incorporated efficiently into bisdethiobis(methyl-
1^thio)acetylaranotin. L-£U- G]Phenylalanine was fed to A. terreus and 
14C-labelled cyclo-(L-phenylalanyl-L-phenylalanyl) was isolated in an 
"intermediate-trapping" experiment. This indicated that the fungus 
was capable of producing cyclo-(L-phenylalanyl-L-phenylalanyl). 
Furthermore, feeding experiments using cyclo-(L-f~^N~]phenylalanyl-L- 
[l-1'^G]phenylalanyl) and cyclo-(L-T3,3-2H2]phenylalanyl-L-[3,3-2H2]phenyl- 
alanyl) indicated that, in its transformation into bisdethiobis(methyl- 
thio)acetylaranotin, cyclo-(L-phenylalanyl-L-phenylalany1) is 
incorporated intact but with partial, i.e. non-obligatory, exchange of 
methylene hydrogen.
1GENERAL INTRODUCTION
In its earliest days, organic chemistry was confined to the study
of those materials which are available from natural sources. Following
the isolation of these materials, chemists were then concerned with
the investigation of their structures, which eventually led to attempts
at their synthesis. The next logical question that chemists asked
themselves was how Nature went about making such a variety of structurally
different compounds. Wohler's synthesis of urea from ammonium cyanate
had already disproved the old theory of a "vital force" at work. The
study of the biosynthesis of natural products was thus originated and
it received its greatest push forward with the advent of nuclear
technology in the early forties, which led to the availability of
1^ 3radioactively labelled compounds, chiefly G and VH.
Living organisms synthesise and degrade chemical compounds by 
means of a series of enzyme-mediated chemical reactions, collectively 
known as metabolism. The products of these metabolic processes have 
been classified as primary and secondary metabolites. Primary 
metabolites are derived from metabolic pathways common to all organisms 
and are essential to their survival and well being. Examples of 
primary metabolites are amino acids, sugars, nucleic acids, common 
fatty acids and polymers derived from them. Secondary metabolites 
are products biosynthesised from primary metabolites by specialised 
pathways and are species, and often strain, specific. Secondary 
metabolism is well developed in plants and microorganisms and leads 
to compounds such as phenols, alkaloids and terpenes.
2The exact purpose of this wide range of secondary metabolites has 
been the subject of much speculation. It has been suggested that these 
metabolites may have the dual role of being a means of food storage and 
of influencing the growth, health, behaviour and population biology 
of other living organisms sharing the same environment. We will be 
concerned here with some secondary metabolites produced by fungi.
Together with the algae and bacteria, fungi have been traditionally 
classified as members of the Thallophyta, a division of the plant 
kingdom which comprises organisms with no true roots, stems or leaves.
The individual reproductive bodies of fungi are the spores and these 
are borne by sporophores, which are the visible fruiting bodies 
commonly known as mushrooms and toadstools. Under favourable conditions, 
spores become detached from the sporophores and, if they reach a suitable 
environment, they grow and produce the vegetative phase of the fungus. 
This is known as the mycelium and consists of a network of fine, branched 
filaments, individually known as hypha.
Fungi lack photosynthetic pigments and are therefore unable to 
manufacture organic compounds from carbon dioxide and water. They 
require oxidisable organic compounds as energy sources. In their 
natural habitat, these can be obtained from dead or living plants, 
animals or other microorganisms. In cultures, they are grown on 
artificial media containing a carbon source (usually a sugar), a 
nitrogen source (usually ammonia, nitrate or an amino acid) and a 
variety of other vital ions and trace elements.
Fungi can be induced to utilise most organic compounds and this 
enables the investigation of their secondary metabolism. Administration 
of isotopically labelled precursors, followed by the isolation and 
investigation of the metabolic products, has made possible the
3elucidation of the pathways leading to a variety of compounds of 
"biological interest. In establishing biosynthetic routes by use of
i
isotopically labelled precursors, the investigator must overcome several 
experimental difficulties. The first and most obvious one is that the 
organism under study must be producing the metabolites of interest in 
amounts sufficient to permit their isolation and purification. The 
added precursor must then be able to enter the system. Once inside, 
it must become metabolically equivalent to the endogenous substrate it 
is intended to label. The labelled metabolite obtained in the end will 
be diluted with endogenous metabolite and the extent of this dilution 
will affect the sensitivity of the detection system. Therefore, the 
experiment must be designed so as to allow a detectable amount of 
labelled precursor to be incorporated, without this amount causing 
perturbations to the normal state of the organism. The sensitivity 
of the detection system depends on the nature of the label used. 
Radioactive tracers offer the advantage of accurate and sensitive 
detection, but do not yield information as to the precise location 
of the label in the final metabolite. This has to be established by 
long and often complicated procedures involving the degradation of 
the metabolite to simple products, usually containing just one or two 
carbons, through which the exact position of the label can be ascertained. 
Frequently, the amounts of metabolite available, its impure condition 
or the lack of suitable chemical reactions, make complete degradation 
studies impossible. The use of stable isotopes, detectable by mass 
spectrometry and/or nuclear magnetic resonance spectroscopy has allowed 
the determination of the exact location of the introduced label(s) 
without having to resort to chemical degradations. However, stable 
isotopes also have their drawbacks, the main one being the need to
4introduce larger amounts of the precursor to permit reasonable detection.
Some of the techniques briefly outlined above have been used 
throughout this study. In the first part of this work, some aspects 
of the biosynthesis of a fungal toxin, cyclopiazonic acid, will be 
investigated. The second part deals with a variety of fungal metabolites 
with antibiotic properties which possess as a common feature an 
epidithiodioxopiperazine moiety.
5PART I
STUDIES RELATED TO THE BIOSYNTHESIS 
OF CYCLOPIAZONIC ACID
6CHAPTER 1
INTRODUCTION
Penicillium cyclopium Westling is a saprophytic fungus frequently
found growing on stored grain and cereal products. Outbreaks of
cattle*poisoning in the United States in 1964 were attributed by Albright
et al.^ ~ to the presence of P.cyclopium in com used as feedstuff. The
fungus has also been isolated on two other occasions from contaminated
2
feedstuffs which had caused diseases among farm animals. In 1968, 
Holzapfel investigated a strain (1082) of P. cyclopium. obtained from 
ground nuts and grown on maize meal. He isolated the main toxic 
principle, cyclopiazonic acid, and, on the basis of chemical and 
spectroscopic evidence, assigned to it the structure and relative 
stereochemistry shown in (l).^
NH
(1)
—  N r— n
o-...H
(2) (3) (4)
73
Holzapfel initially formulated cyclopiazonic acid as the enol
13
tautomer (2) of the acetyltetramic acid. Ten years later, C nuclear 
magnetic resonance (n.m.r.) studies by Steyn and Vessels indicated 
that cyclopiazonic acid exists, in deuteriochloroform, as a mixture 
of three tautomers (2), (3) and (^ ), of which (^ ) is the preferred 
tautomer.
In 1971» from analysis of its structure, Holzapfel and Wilkins^ 
suggested that cyclopiazonic acid is biosynthesised from tryptophan 
and either a unit derived from mevalonic acid and two acetic acid 
molecules, or two units derived from mevalonic acid. The first 
possibility is analogous to the formation of tenuazonic acid (5) in 
Altemaria tenuis Auct. from one molecule of L-isoleucine and two 
molecules of acetic acid^
HN
(5)
In order to establish the major precursors used by the fungus to make 
cyclopiazonic acid (l), Holzapfel and Wilkins-^  fed [l-^G]acetate,
l^j,
[2- C]mevalonic acid and DL-£U- C]tryptophan to cultures of P. cyclopium
7
grown on a synthetic medium. The cyclopiazonic acid isolated from 
the tryptophan-fed culture contained 2^,7% of the radioactivity, thus 
confirming that tryptophan is a direct precursor of cyclopiazonic acid. 
Acetic and mevalonic acids gave incorporations of 3*5 and 7-0% respectively.
8Degradation of the cyclopiazonic acid (l) derived from these two 
feeding experiments showed that, as with the biosynthesis of tenuazonic 
acid (5), the other atoms of (l) are derived from two molecules of 
acetic acid and an isoprene unit formed from mevalonic acid, as shown in 
Scheme 1.
CH3C02H
O:
Two other compounds were isolated from cyclopium (1082) by
Holzapfel and coworkers: cyclopiazonic acid imine and bissecodehydro-
piazonic acid, and their structures were shown to be (6) and (7)
0
respectively. The latter is usually referred to in the literature as 
p-cyclopiazonic acid (7), whilst cyclopiazonic acid itself is known as 
a-cyclopiazonic acid (l). Subsequently, a-cyclopiazonic acid,
Scheme I
NH,
NH
(6)
HN-
NH
OH
(7)
9cyclopiazonic acid imine and p-cyclopiazonic acid were also isolated
from cultures of Aspergillus versicolor (Vuill.) Tiraboschi.^
a-Cyclopiazonic acid is also present in Aspergillus flavus Link.^
After studies of the reaction of a-cyclopiazonic acid with aqueous
ammonia, Holzapfel et al. suggested that cyclopiazonic acid imine (6)
might not he the product of an enzymic reaction, hut rather that it
might result from the direct reaction of a-cyclopiazonic acid and
ammonia from the ammonium pool of the fungus. With regard to
p-cyclopiazonic acid (7), these workers found that its concentration
increased rapidly during the early stages of the fermentation and
then decreased rapidly as soon as a-cyclopiazonic acid production
accelerated. However, if the fungus was grown on a zinc- or iron-
deficient medium, f3-cyclopiazonic acid continued to accumulate.
Shortly after, five isoenzymes, collectively designated as (3-cyclopiazonate
oxidocyclase, were isolated from P. cyclopium (1082) and found to
he capable of quantitatively converting in vitro (3-cyclopiazonic acid
into a-cyclopiazonic acid in the presence of air.^
These observations suggested that (3-cyclopiazonic acid (7) might
he a precursor of a-cyclopiazonic acid (l). To test this hypothesis,
Holzapfel and Wilkins-'* prepared labelled p-cyclopiazonic acid by growing
P. cyclopium on a synthetic medium containing a low zinc concentration 
1^and sodium p.- C]acetate. The labelled p-cyclopiazonic acid thus 
obtained was then fed to cultures of the fungus grown on the full 
synthetic medium and the a-cyclopiazonic acid produced was found to 
contain 67% of the added label. This is compelling evidence that 
p-cyclopiazonic acid (7) is a direct precursor of (l).
Attention was then turned towards the order in which the simple
10
precursors of |3- and a-cyclopiazonic acids are assembled. It was
suggested, in keeping with the biosynthetic route to the clavine 
12alkaloids, that dimethylallyl tryptophan (8) is an early precursor.
NH
NH
(8)
However, this compound has never been isolated from P. cyclopium
cultures. McGrath and coworkers'*'^  fed ^-dimethylallyl[]G-^H]tryptophan,
mixed with L-^^CSytryptophan, to cultures of P. cyclopium and isolated
1^a-cyclopiazonic acid containing 8.^6 of the G label but no tritium,
thus excluding the possible intermediacy of (8).
A second possibility in the sequence of events would involve
incorporation of the acetoacetate portion of cyclopiazonic acid prior
to incorporation of dimethylallyl pyrophosphate. This possibility was
investigated by McGrath and c o w o r k e r s . ^  mixture of L-£G-^H]- 
l4tryptophan and [ 1 - C^dimethylallyl pyrophosphate was incubated for lh 
at 30°G with a cell-free extract prepared from P. cyclopium cultures.
The a-cyclopiazonic acid (l) isolated from the reaction mixture contained
r>
no H or G, while the p-cyclopiazonic acid (7) produced contained
3 l4no H but 19% of the added C. This indicated that the cell-free
extract contained both an enzyme and a substrate which, along with
dimethylallyl pyrophosphate, produces p-cyclopiazonic acid. This
cosubstrate was isolated and identified as 3-a.cetyl-5-(indol-3-ylmethyl)-
tetramic acid (9, cyclo-acetoacetyl-L-tryptophyl).
11
HN
NH
(9)
Incubation of cyclo-acetoacetyl-L-fG-^H~1 tryptoohyl .and. (^1-^Gjdimethyl- 
allyl pyrophosphate with a cell-free extract produced (3-cyclopiazonic 
acid (7) with a ^H:^C ratio which indicated a 1:1 reaction of the 
substrates. The enzyme responsible for this transformation, secondary 
dimethylallyl transferase, was isolated and found to be present only 
in the mycelium. These results lead to a more detailed picture of the 
pathway followed in a-cyclopiazonic acid biosynthesis, shown in Scheme II.
NH
AcSCoA
NH
^ g-Cyclopiazonate 
iNH oxidocyclase
HN
NH
OH
OPP
Secondary
dimethylallyl
transferase
HN
OH
NH
(i) (7)
Scheme II
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Having established the sequence of events in the biosynthesis
of a-cyclopiazonic acid, examination of individual steps was possible.
The first step, involving the formation of 3-acety1-5-(indol-3-ylmethyl)-
tetramic acid (9) , is analogous to the biosynthesis of tenuazonic acid
(vide supra). The isoprenylation of tryptophan or a tryptophan
derivative is not novel either. Apart from the already mentioned
12analogy with the biosynthesis of clavine alkaloids, dimethylallyl 
pyrophosphate has also been found to be transferred to the 2-position 
of the indole nucleus of cyclo(alanyltryptophyl) in Aspergillus 
amstelodami. ^  The conversion of (3-cyclopiazonic acid (7) into 
a-cyclopiazonic acid (l) may be regarded as a didehydrogenation . 
followed by cyclization. Schabort et al.^~ suggested that 4,5-didehydro- 
(3-cyclopiazonic acid (10) is an intermediate in this cyclization.
HN
,OH
NH
(10)
This possibility would require the loss of a hydrogen atom at C-5 of 
{3-cyclopiazonic acid and was tested by Holzapfel and Schabort."^
They synthesised DL-^5“^HD“P”cyc^°P^azlon^ c DL-£*J—
17cyclopiazonic acid following literature procedures. These two 
compounds were then incubated together with purified 3-cyclopiazonate 
oxidocyclase in the presence of 2,6-dichlorophenolindophenol, a 
teminal electron acceptor. The a-cyclopiazonic acid (l) formed in
13
3 JAthe reaction contained of the initial radioactivity and the H/ G 
ratio was essentially unchanged. This result demonstrates that retention 
of tritium at C-5 of p-cyclopiazonic acid (7) is essentially complete 
during its biochemical conversion into a-cyclopiazonic acid and thus 
excludes the possibility of a ^ ,5-didehydro-derivative such as (10).
This retention of the label at C-5 also indicates that a-cyclopiazonic
acid has the same configuration at that position as |3-cyclopiazonic
3 8acid. Circular dichroisjn studies ' of both a- and |3-cyclopiazonic 
acid suggest that they both have the (£[)-configuration at C-5. This 
conclusion was supported"^ by feeding suitable precursors to P. 
cyclopium cultures grown on a ferrous ion deficient medium, which 
results in the supression of a-cyclopiazonic acid production and 
accumulation of p-cyclopiazonic acid. In this way, separate feedings
lif 2/j,
of L-[[3- C ]tryptophan and D-£3- C]tryptophan produced (3 -cyclopiazonic 
acid (7) that contained 22.1$ of the activity of the labelled L-tryptophan 
and 5*6$ of fhe activity of the labelled D-tryptophan. This result 
suggests that 3-cyclopiazonic acid and thus a-cyclopiazonic acid have 
the (s)-configuration at C-5.
IQ
Steyn and coworkers suggested that a 1A-didehydro derivative 
of {3 -cyclopiazonic acid could be the precursor for the final oxidative 
cyclization reaction. Formation of this intermediate would involve 
loss of one of the C-^ methylene protons in p-cyclopiazonic acid. To 
test their hypothesis, the authors fed stereospecifically labelled 
(3R)- and (3S3)-[3-^H,3-^C] tryptophan separately to cultures of P. 
cyclopium. Both stereoisomers were incorporated into p-cyclopiazonic 
acid (7) with high retention of tritium. The a-cyclopiazonic acid 
isolated from cultures fed with (3£)“C3-^H»3-^*C]'tryptophan showed 
essentially complete retention of tritium. Conversely, in its
14
o T/j,
transformation to a-cyclopiazonic acid, (3S)-[3“ H,3- C]tryptophan 
lost almost all its tritium. These results showed that the methylene 
group of tryptophan remains intact during the early stages of the 
biosynthesis and that G-C bond formation at C-4 occurs from the side 
of the molecule opposite to proton removal. Furthermore, together 
with the previous findings that the proton at C-5 in f3-cyclopiazonic 
acid (7) is not involved in the oxidative cyclization step, these 
results are consistent with the cyclization proceeding via a 1,4- 
didehydroderivative of (7) as shown in Scheme III.
,OH
NH
HN
OH
Hydride
abstraction
NH
Cyclization
OH
NH
(i)
Scheme III
15
The biosynthesis of cyclopiazonic acid and related tetramic acids
19has been reviewed recently by Holzapfel.
The present study had two main objectives. Firstly, to establish, 
by the use of stable isotopic labels, that the C-5 proton of |3-cyclopiazonic 
acid (7) is not involved in the final oxidative cyclization step 
which leads to a-cyclopiazonic acid (l). This study was initiated 
before the work of Holzapfel and Schabort^ had appeared. Second, 
to determine if structurally modified versions of the natural 
precursors and intermediates can be converted by P. cyclopium into 
the corresponding analogues of a-cyclopiazonic acid.
16
CHAPTER 2 
DISCUSSION
The first objective in any biosynthetic investigation is to establish 
that the organism under study is growing well and producing the desired 
metabolite(s). The P. cyclopium culture used in this study was 
kindly supplied by Dr P. S. Steyn, of the National Chemical Research 
Laboratory, Pretoria, South Africa. It took some time, however, before 
it could be grown in a reproducible and satisfactory manner. Consequently, 
one of the feeding experiments was carried out by Dr. Steyn in his 
laboratories with material synthesised by us.
2.1 Synthesis of deuterium labelled precursors.- Our initial
efforts were directed towards the synthesis of a suitable precursor
with a deuterium label in what would become the C-5 position of
a-cyclopiazonic acid (l). The three possible deuterium labelled
precursors are shown in Scheme IV.
The precursor was chosen according to the following considerations.
Of the three possibilities, [a- H]tryptophan (11) is obviously the
2, 20
easiest compound to synthesise with a high n content. However,
because stable isotope experiments require the administration of the
precursor at concentrations higher than those normally required when
using radioisotopes, the effect of adding large amounts of tryptophan
7to the mould culture had to be considered. Neethling and McGrath 
have reported that tryptophan does not form a pool in P. cyclopium 
and that exogenous tryptophan depresses both mycelium weight and
17
NH
NH
V
HN
.OH
CR
NH (12) 
a: R=H
b: R = D
.OH
NH
A
HN
OH
NH
(13)
Scheme IV
a-cyclopiazonic acid yield, possibly by inhibition of tryptophan 
synthetase. This clearly excluded tryptophan (ll) as the precursor
of choice. The £5“ H]tetramic acid derivative (12a) was chosen instead, 
since the synthesis appeared relatively straightforward and it was 
a known precursor of the cyclopiazonic acids.
18
The discovery of the antiviral, and antitumor properties of
tenuazonic acid (2) led to the synthesis of a large number of 3-acetyl-
215-substituted tetramic acids by Yuki et al., Harris, Fisher and
22 28 Folkers, and Mulholland's group at I.G.I. among many others. All
oLl
these syntheses essentially follow Lacey*s original method, outlined 
in Scheme V, starting from the amino acid, which is esterified, aceto- 
acetylated, and finally cyclized with a sodium alkoxide.
NH NH.ROH
R— CH >  R — CH
NHCCHoCCH
R — CH
R'ONa
Scheme V
The initial plan was therefore to synthesise [a-^H]tryptophan (11) 
and submit it to the reaction conditions described above, using CD^ONa 
as the base for the cyclization. First, however, the cyclization of 
unlabelled N-acetoacetyltryptophan methyl ester using CD^ONa in 
refluxing deuteriated methanol and benzene was investigated. The ^H- 
n.m.r. spectrum of the tetramic acid produced in this reaction showed 
that the cyclization had proceeded with partial exchange of the C-5
2
and acetyl protons. Thus, if these conditions were to he used for [a- H]-
tryptophan (ll), the product would he only partially tetradeuteriated
tetramic acid. Milder conditions were then tried to effect the desired
cyclization of the N-acetoacetyltryptophan methyl ester, namely, heating
it under reflux in (a) mixtures of piperidine and methanol, (h) NN-dimethyl-
aniline and methanol, and (c) anhydrous potassium carbonate in acetone.
Uncyclized N-acetoacetyltryptophan methyl ester was recovered from all these
reactions. The behaviour of N-acetoacetyltryptophan methyl ester in sodium
deuteroxide in deuterium oxide was then followed by ^H-n.m.r. spectroscopy
at room temperature. It was observed that both a- and acetyl-protons
exchanged with deuterium at very much the same rate; partial hydrolysis of
the methyl ester was also evident. Unlabelled 3“acetyl-5-(indol-3-ylmethyl)-
tetramic acid (9) was synthesised in 77% yield by slight modifications of
21the literature procedure. Its behaviour in the presence of sodium 
deuteroxide in deuterium oxide was also followed by ^H-n.m.r. spectroscopy 
at 35°G. Almost immediately, integration of the spectrum showed that the 
C-5 and methyl protons were being exchanged, whilst the pattern corresponding 
to the methylene protons became simpler. After 1,5 h, approximately 50% 
of the methyl protons had exchanged and the ABX pattern due to the C-5 and 
methylene protons was no longer clear. The signals due to the C-5 and 
methyl protons had virtually disappeared after ^.5 h and the pattern due to 
the methylene protons had simplified to an AB quartet. After 21.5 h at 
35°C, the exchange was complete. It was therefore decided to settle for 
the tetradeuteriated tetramic acid (12b) as the precursor of choice. The 
3-acetyl-5-(indol-3-ylmethyl)tetramic acid (9) was heated overnight under 
reflux in sodium deuteroxide solution to yield 3“C^H^]a'Cetyl-5-(indol-3-yl- 
methyl)-£5-2H]tetramic acid, containing 82% species, in 92% yield. A
sample of this compound was sent to Dr. Steyn for feeding to P.cyclopium 
cultures. The results obtained will be discussed later.
20
2.2 Synthesis of tryptophan analogues. The synthesis of tryptophan 
analogues was then undertaken. Tryptophan analogues have "been synthesised 
to he used in pharmacological, biological and biosynthetic studies.
Three analogues were chosen as the most likely to mimic tryptophan 
behaviour: |3-(2-azaindol-3-yl)alanine (l^ ), |3-(7-azaindol-3-yl)alanine (15) 
and p-(l-benzothien-3-yl)alanine (16).
NH NH2
C02H c o 2h
H H
(i*0 (15)
NHIn
c o 2h
(16)
The synthesis of all three compounds have been reported in the
literature and those procedures were followed with only slight 
modifications.
The reaction sequence used to synthesise the 2-azaindole analogue (l^ )
25
starting from isatin, is shown in Scheme VI.
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c o 2h
NMe NMe,
NHCR
NMe
(17)
(b )  R = Me
H
(1*0
Reagents: (a) aq. NaOH; H^SO^NaNO^; HGl/SnGl^; A  ; (t>) SOGl^; Me^NH; 
(c) LiAlH^; (d) Mel; (e) Na0Et/RG0NHGH(G02Et)2; (f) conc. HG1
Scheme VI
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In the original literature procedure,^ the acetamido diester (17b) 
was saponified to the malonic acid derivative, which was then 
decarboxylated to the substituted propionic acid and transformed to 
the amino acid (1^ ) by hydrolysis of the acetyl group in barium, hydroxide 
solution. We found that the amino acid (l4) could be more easily 
obtained by heating the formamido diester (17a) in refluxing 
concentrated hydrochloric acid for 7h. The amino acid (l^ ) was also 
similarly prepared, albeit in lower yield, from the crude acetamido 
diester (17b).
(3-(7-Azaindol-3-yl)alanine (15) was prepared by the method
26described by Robison and Robison, as shown in Scheme VII.
NH
NMe.
V NHAc
(15)
Reagents: (a) (CH-O) /fae2NH/nBuOH; (t>) NaOEt/AcNHCH(C02Bt)2; (c) oono. HC1
Scheme VII
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The thiotryptophan analogue (16) was synthesised from benzothiophene
27according to the procedure described by Avakian et al. and depicted 
in Scheme VIII.
Cl
NHCHONH
(16)
Reagents: (a) 1,3,5-Trioxane/HCl/HOAcj (b) Na0Et/HC0NHGH(G02Et)2;
(c) conc. HG1
Scheme VIII
2.3 Feeding experiments.- Having synthesised the required 
tryptophan analogues, attention was turned to the evaluation of P. 
cyclopium cultures which were by then being grown in our laboratories. 
Once the correct growth conditions for metabolite production had been 
obtained, efforts were concentrated on the isolation of the two main 
metabolites, a- and p-cyclopiazonic acids. Ibis turned out to be 
quite a problem. A considerable number of time-consuming extractions 
and chromatographies were required to isolate the crude metabolites.
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In general, mycelial extracts were cleaner than broth extracts. The
weight of the mycelium obtained (ca. 14.3 g/l of culture) compared
favourably with the literature value (15 g/l of culture^). In several
instances, a third major compound was isolated from the cultures.
^H-N.m.r. spectroscopy and mixed melting point determination with an
authentic sample, obtained from Prof. G.J.W.Brooks in our Department,
showed this compound to be 6-methylsalicylic acid. Although not
previously reported for P. cyclopium. 6-methylsalicylic acid is a
28well known and widespread fungal metabolite. On one occasion,
another metabolite was isolated from the mycelial extract. Melting
point and optical rotation determinations, together with n.m.r.
spectroscopic evidence, indicated that this compound was ergosterol.
29Preparation of its Diels-Alder adduct with Cookson*s dienophile,
followed by determination of its mixed melting point with that of the
same adduct prepared from commercial ergosterol, confirmed their identity.
Ergosterol has been previously isolated from the mycelium, but not the
broth, of a strain of P. cyclopium (NRRL A-15-465) and qualitative
30assays have indicated its presence in several other strains.
In order to evaluate the efficiency of our cultures in producing 
a-cyclopiazonic acid (l), two separate feedings of DL-Q^G}^^tryptophan 
(25pCi) were carried out. On average, 208 mg of a-cyclopiazonic acid 
were obtained with a specific activity of 1.94 UCi/mmol, corresponding 
to am incorporation of 9.6% for the L-isomer. This value was considerably 
lower than the 24.7% reported by Holzapfel and Wilkins,-^  but was 
considered as sufficient evidence that our culture was producing 
a-cyclopiazonic acid at am acceptable level.
The tryptophan, analogues were now fed to our cultures of P. cyclopium. 
The results of these feeding experiments are summarized in Table 1.
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TABLE 1
FEEDING OF TRYPTOPHAN ANALOGUES TO I\ cyclopium
Experiment Amino acid fed
None
DL-Tryptophan
DL-|3-(2-Azaindol- 
3-yl)alanine (l*+)
DL-p-(7-Azaindol- 
3-yl)alanine (15)
Concentration
of amino acid 
(mmol/l of 
culture)
(a
(*
(a
(t
(a
(*
(a
(*
DL-p-(l-Benzothien- (a 
3-yl)alanine (16) (b
O.98
2.00
1.06
1.96
1.0**
1.96
0.8**
1.92
Mycelial
Weight 
(g/100 ml 
of culture)
1.032
O.968
0.8**9
0.316
0.260
0.055
< 0.001
0.003 
0.013 
0.003
Figures in parentheses refer to pH values for the broth 
two days after addition of the amino acid.
pH of broth 
at
harvesting*
7.0 (5.1) 
7.3
6.2 (3.0) 
6.6
5.5 (3.6)
3.0
3.0 (3.0) 
2.**
3.0 (3.0)
2.6
26
The first observation that can be made from the table above is that,
7
as already noted by Neethling and McGrath, doubling the concentration
of tryptophan causes a very significant decrease in the mycelial
weight. This, however, does not seem to be accompanied by any significant
decrease in the final pH of the broth. Of the three analogues fed,
only |3-(2-azaindol-3-yl)alanine (Experiment 3) shows the same
dependence of mycelial weight on amount of amino acid administered.
Yet, this decrease is, in this case, accompanied by a significant
lowering of the final pH value. The other two analogues, at both
concentration levels, show a large suppression on mycelial weight.
Attention must be turned now to the pH values obtained. On the fourth
day after inoculation, the non-fed control (Experiment la) has a broth
pH of 5.1. This increases with time, until it reaches a neutral pH on
the seventh day, when harvesting is done. Administration of tryptophan
(Experiment 2) decreases the pH of the broth more than in the control,
but once again, towards the end of growth the pH approaches neutrality.
(3-(2-Azaindol-3-yl)alanine (l^), when fed at the lower concentration
(Experiment 3a) , causes roughly the same effect as observed on addition
of tryptophan. However, at the higher concentration (Experiment 3b),
there is no increase of pH with age. This same effect is observed
with the two other analogues (Experiments ^ and 5)* It i-s worth
31noting that McGrath et al. have determined that the optimum pH value 
for the various enzymes involved in a-cyclopiazonic acid (l) biosynthesis 
lies in the 6.5 - 8.0 range. Thence, it seems that the initial low 
pH in the early stages of growth must increase before the metabolites 
can be produced. In other words, if the organism is unable to 
overcome that initial low pH, there can be no production of a-cyclo­
piazonic acid. However, one must keep in mind that, because of their
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poor solubility in water, the amino acids were fed in fairly acidic 
solutions (see Experimental Section) and this fact, coupled with the 
presence of an unnatural amino acid, could be responsible for the 
results obtained.
The cultures from Experiments 1, 2 and 3a were extracted as usual. 
Analytical thin layer chromatography (t.l.c.) showed that a- and (3- 
cyclopiazonic acids had only been produced in Experiments 1 and 2 (the 
control and tryptophan-fed experiments). It seems, therefore, that 
although ( I k ) does not have as drastic an effect as the other analogues 
on the growth of the organism, it does affect its normal behaviour.
At this point, it was decided to investigate the use of analogues
of the tetramic acid (9). These could be synthesised from the
previously prepared tryptophan analogues by following the route
described in Scheme V. Prior to undertaking these syntheses, however,
it was necessary to investigate the response of P. cyclopium to the
administration of 3-a-cetyl-5-(indol-3-ylraethy1)tetramic acid (9).
As described in the introduction, earlier studies involving this
intermediate were restricted to cell-free extracts of the organism.
It was therefore necessary to synthesise the radioactively labelled
20tetramic acid (9). This was obtained by the usual procedure, 
starting from DL-^^CH^]tryptophan, in 62% yield and with a specific 
. activity of, 391.7 y Ci/mmol.
In the first feeding experiment involving this precursor, an 
ethanolic solution (1.5 ml) of the labelled tetramic acid (0.086 mmol., 
33.7 yCi) was distributed between 22 flasks of P. cyolopium culture 
(each containing 100 ml of medium), on the seventh day after 
inoculation, when growth was well established. After 2k h, the
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culture was harvested and extracted as described in the Experimental 
Section. The mycelium extract contained only 2% of the added 
radioactivity, whilst the broth contained Analytical t.l.c.
plates of both extracts and of the labelled precursor, as a reference, 
were scanned for radioactivity and autoradiographed. The scans and 
autoradiograms showed that the radioactivity in the broth extract 
was concentrated mainly in the band corresponding to the fed precursor, 
whilst that of the mycelium extract, barely detectable, was concentrated 
in the baseline. Preparative layer chromatography of both extracts 
yielded unlabelled a- and {3-cyclopiazonic acids. No efforts were 
made to recover the labelled precursor, although there were indications 
that it had undergone some degradation, since the baselines of the
preparative t.l.c. plates showed considerable activity.
7
Neethlmg and McGrath have reported that the highest rate of 
0-cyclopiazonic acid biosynthesis occurs on the third day after 
inoculation. It seemed appropriate, therefore, to introduce the 
tetramic acid (9) at an earlier time. In the second feeding experiment, 
the labelled precursor (0.060 mmol., 23.5 yCi) in ethanolic solution 
(1.3 nil) was distributed between 2.5 1 of culture, on the second day 
after inoculation. Cultures were harvested 120 h later. The mycelium 
extract contained approximately J% of the added radioactivity; the 
broth extract contained 77%°* Once again, scans and autoradiograms 
showed no detectable radioactivity in the mycelial extract, whilst 
most of the radioactivity of the broth extract was accounted for 
in the band corresponding to the precursor administered, with a smaller 
amount present in the baseline. Unlabelled tetramic acid was aided 
to the crude broth extract. Great difficulties were experienced 
in recovering any tetramic acid from this complex mixture. Eventually,
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some material, highly contaminated with assorted impurities, was
isolated and found to he radioactive. No reliable figure for its
specific activity could he obtained. The only conclusions that could
he drawn from these experiments were: i) there is no tetramic acid
present in the mycelial extracts; ii) most of the radioactivity present
in the broth extracts is due to the tetramic acid, which also seems
to suffer a certain amount of degradation to highly polar material.
It seems, therefore, that 3-acetyl-5-(indol-3-ylmethyl)tetramic ac^  (9)
is not incorporated, under the conditions used, by whole cultures of
P. cyclopium. These results could be rationalized by an inability of
the precursor (9) to penetrate the cell wall of the organism. McGrath 
13et al. have reported that secondary dime thy lallyl transferase, the
enzyme mediating the conversion of (9) into {3-cyclopiazonic acid (7),
is found only in the mycelium. Hence, if the tetramic acid cannot pass
through the cell membrane, it cannot be transformed into 3- and
eventually, a-cyclopiazonic acid. The idea of feeding analogues of
(9) was therefore abandoned, partly because it was probable that the
same membrane permeability problems would be encountered, partly
because no suitable control experiment would be available.
It was about this time that Dr. Steyn's results on the conversion
of 3-acety1-5-(indol-3-ylmethy1)tetramic acid (9) into a-cyclopiazonic
32acid (l) were obtained. A system was developed to study this 
conversion by means of a replacement culture technique in which the 
replacement medium contained no NaNO^, thus depriving the organism 
of any exogenous nitrogen source. Under these conditions, no
3a-cyclopiazonic acid was produced.. Addition of small levels of H- 
labelled tetramic acid (9), led to a highly efficient conversion of
30
p
(9) into a-cyclopiazonic acid. When higher levels of 3~C H^]acetyl-
p
5-(indol-3-ylmethyl)-[5- H]tetramic acid (12b) were fed to the
replacement cultures, a- and {3-cyclopiazonic acids, together with
some recovered acid (9), were isolated. N.m.r. spectroscopic
analysis of the acid (9) revealed that, although the deuterium atoms
at the acetyl methyl group had exchanged completely, the deuterium
atom at the C-5 position was retained. Both a- and {3-cyclopiazonic
2
acids produced contained no deuterium. If 3~C H^]acetyl-5-(indol-3-yl- 
2
methyl)-[[5“ H]tetramic acid had been a direct substrate for the 
isoprenylation reaction, a-cyclopiazonic acid should have retained 
the deuterium atom at the C-5 position. Therefore, it seems that 
the tetramic acid (9) is not incorporated under these conditions, 
but rather that it is first degraded to the amino acid and then 
subjected to a transamination reaction, which would account for the 
observed loss of deuterium.
h i  Conclusions. - The results that had been obtained to this 
date were by no means encouraging. The objectives that had been set 
at the beginning of the project could not be realised. Moreover, 
considerable difficulties were being experienced in keeping the cultures 
at an appropriate production level. Work with this organism was 
therefore brought to an end.
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CHAPTER 3 
EXPERIMENTAL-
i i  General Procedures
Melting points were measured on a Reichert hot-stage melting point 
apparatus and are uncorrected. Microanalyses were carried out by Mrs.
W. Harkness and her staff. Infrared spectra were obtained from 
Perkin-Elmer 257 or 580 infrared spectrometers by Mrs. F. Lawrie and 
her staff and only significant absorptions are quoted. Ultraviolet 
spectra were obtained on a Pye-Unicam SP 800 spectrometer. Mass spectra 
were recorded on a GEC-AEI MS12 spectrometer by Mr. A. Ritchie and 
his staff.
Proton nuclear magnetic resonance spectra were recorded on Varian 
T-60A (60 MHz), Perkin-Elmer R32 (90 MHz) and Varian XL-100 (100 MHz) 
spectrometers, using tetramethylsilane as the internal standard. The 
following abbreviations are used: s - singlet, d - doublet, t - triplet, 
q - quartet, m - multipiet, dd - double doublet, ddd - doublet of 
double doublets, and b - broad. Spectral parameters are derived 
from first order analyses unless otherwise stated.
Analytical thin layer chromatography (t.l.c.) was carried out on 
commercially prepared plates coated with Kieselgel GF^^ (Merck)
0.25 mm thick. For preparative t.l.c., plates (20 x 20 cm) coated 
with Kieselgel GF^^, (Fluka) 1 mm thick were used. Plates precoated 
with oxalic acid were prepared by either dipping Kieselgel GF^^
(Merck) precoated plates in 8% methanolic solution of oxalic acid 
and air-drying for 2^ h, or by coating glass plates with a slurry 
prepared with Kieselgel GF^^, (Fluka) with 0.2 M aqueous oxalic acid 
in a 1:2 ratio to a 1 mm thickness.
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2sS. Radioactive Methods
Radioactive tryptophan was obtained from The Radiochemical Centre, 
Amersham. Radioactive samples were counted on a Philips liquid 
scintillation counter, model PV&510 D6^9» Liquid samples were 
measured using an Oxford micropipette. Solid samples were weighed 
on metal foil boats in a Mettler UM-6 microbalance. Samples were 
placed in Packard scintillation vials and dissolved in scintillation 
solution (10. ml). The scintillation solution contained 2,5-diphenyl- 
oxazole (4 g) and 1,^-cis-2-(4-methyl-5-phenyloxalyl)benzene (0.1 g) 
per litre of Analar grade toluene. Solid samples were crystallised 
to constant activity. The radioactivity measurements are subject 
to a statistical error of 2%, A Panax Thin Layer Scanner, model 
RTLS-1A, was used for radioscanning of t.l.c. plates. Autoradiography 
was carried out using Ilford Red Seal 100FW and Kodak XR-P1 X-ray 
films.
Fermentation Conditions
Penicillium cyclopium Westling strain 1082 from the culture
collection of the Microbiological Research Group, C.S.I.R., Pretoria,
was used in this investigation. The fungus was grown at 25°C in
shake culture (200 rpm) in a synthetic medium (100 ml) contained
in 500 ml Erlenmeyer flasks. The synthetic medium had the following 
7
compositions
Glucose 60 g
.NaNO^ 4.5 g
^gS0^.7H20 0.5 g
KC1 0 .5  g
lyffo* 1 g
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Ka2B^O„.10H20 0.7 mg
(KH^)6Mo702itAH20 0.5 mg
GuS0^.5H20 0.3 mg
MnSO^HgO 0.11 mg
ZnS0^.7H20 17.6 mg
FeS0^.7H20 10 mg
Deionised water 1 litre
The pH of the medium was adjusted to 5«5 with hydrochloric acid and 
the solution was sterilized "by autoclaving at 120°G and 15 psi for 
15 min. The flasks were inoculated with 5 ml of inoculum from a 
two-day-old culture of P. cyclopium grown on the above synthetic 
medium. The mould was grown on slants of 2% malt agar for 7 - 1 0  
days. These were shaken with a sterile 0.1$ w/v solution of Tween-80 
and the spore suspension thus obtained was used for setting up the 
seed flasks.
3.^ Feeding Experiments
DL-03-^C]Tryptophan (25yCi, 0.5 ml of aqueous solution 
containing 2% ethanol) was fed to cultures (ca. 2.7 l) six to seven 
days after inoculation and cultures were harvested 2k h later.
Tryptophan analogues were fed in parallel with unlabelled 
tryptophan to cultures (0.5 l) on the second day after inoculation, 
in aqueous solutions (ca. 15 ml) containing 10$ ethanol and k - 5 
drops of concentrated hydrochloric acid. The solutions were 
sterilized by passage through a millipore filter. Two different 
feeding concentrations were used (l and 2 mM) and in both cases 
harvesting was done seven days after inoculation.
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The labelled tetramic acid derivative was fed under two different 
conditions. Firstly, an ethanolic solution (1.5 ml) of the compound 
was fed to cultures (ca. 2.2 l) on the seventh day after inoculation, 
in 0.04 mM concentration, and harvesting was done 24 h later. In 
the second experiment, the compound was fed in ethanolic solution 
(1.5 ml) at a concentration of 0.024 mM to two-day-old cultures (ca.
2.5 l), which were harvested seven days after inoculation.
13Metabolite Isolation 
The cultures were subjected to suction filtration. The mycelium 
was washed with methanol, dried in a desiccator over ^2^5 re(^ uce(i 
pressure for 48 h, and then was continuously extracted with chloroform 
in a Soxhlet extractor for 96 h. The broth was acidified to pH 2 
with hydrochloric acid, mixed with the mycelial methanolic washings 
and continuously extracted with chloroform for 96 h. The chloroform 
extract was concentrated under reduced pressure. The residue was 
dissolved in chloroform (ca. 100 ml) and extracted with saturated 
sodium bicarbonate solution (5 x 20 ml). The aqueous solution was 
acidified to pH 2 with hydrochloric acid and then re-extracted with 
chloroform (6 x 20 ml). The extracts were washed with water, dried 
over MgSO^ and concentrated to dryness under vacuum and weighed.
Each extract was purified by successive preparative t.l.c. In the 
first, the crude extract was chromatographed on silica gel plates 
developed with ethyl acetate: methanol: conc. aqueous ammonia (85:15*10)* 
The ultraviolet active bands, corresponding to a-cyclopiazonic (R^ ^0.5) 
and p-cyclopiazonic (R^ ^0.4) acids, were scraped off and eluted 
with methanol. The methanolic solutions of a- and 3-cyclopiazonic 
acid were concentrated and separately applied to plates precoated
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with oxalic acid and developed using chloroforms methylisobutylketone 
(^:1). The a-cyclopiazonic acid (R^ ^0.7) and p-cyclopiazonic acid 
(R^ ^0.5) "bands were eluted with chloroform. The chloroform extracts 
were concentrated under reduced pressure and afforded the crude 
metabolites.. Typical total crude yields were ca. 120 mg/l for 
a-cyclopiazonic acid and ca. 100 mg/l for p-cyclopiazonic acid.
3.6 Synthetic Procedures
N-Acetyl-DL-tryptophan.- Treatment of a solution of DL-tryptophan 
in 1M sodium hydroxide with acetic anhydride, according to the method 
of du Vigneaud and Sealock^ gave plates (82% yield) after crystallisation 
from water, m.p. 2C& - 207°G ( l i t . 205 - 206°C) (Found: C, 63.2;
H, 5.6; N, 11.0. Calc, for C-^H^O^s C, 63.^ ; H, 5.7; N, 11.^);
6 (d6-Me2C0) (90 MHz) 7.25 (6H, m, ArH and NH), 4.77 (1H, mf a-CH),
3,25 (2H, m, p-CHp)t and 1.88 (3H, s, COMe); m/e 246 (M+), 18? (M - 
NHGOMe - H) and 130 (G^HgN).
N-Acetyl-L-[a-^Hj tryptophan.-*^ N-Acetyl-DL-tryptophan (1.75 g»
7 mmoles) was heated for ten min in refluxing anhydrous 1,4-dioxan 
(35 ml) containing acetic anhydride (1.5 ml). Pyridine (0.5 ml) was
added to the cooled solution, which was stirred for five min, and 
then deuterium oxide (8 ml) was added. The mixture was evaporated to 
dryness under reduced pressure. The brown oil obtained was resubmitted
to the reaction conditions and was then dissolved in hot water (ca.
10 ml), treated twice with charcoal and, on cooling, gave white
crystals (0.84 g, *+8% yield, O.9O atom deuterium), m.p. 204 -'206°C
(lit.,^ 205 - 206°C for non-deuteriated compound); 6(dg-Me2C0/D20)
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(90 MHz) 7.44 (5H, m, ArH), 3.44 (2H, AB q, 15 Hz, p-CH2),
and 2.15 (3H, s, COMe); m/e 247 (M+) and 130 (C^HgN)•
DL-fa-2HlTryptophan (11).- N-Acetyl-DL-[a-2H]tryptophan (0.79 g,
3 mmoles) was heated in refluxing 2M hydrochloric acid (20 ml) for 
three h. The pink solution was cooled, taken to pH 5*9 with dilute 
ammonia solution, treated twice with charcoal and kept at 0°G 
overnight. This afforded white crystals (O.52 g, 85% yield, 0.90 
atom deuterium), m.p. 258 - 260°C (dec.) [lit.,3** 265°C (dec.) for 
nondeuteriated compound]; v (KBr) 3 400, 3 040, 1 660, 1 610, and
IH5LX
1 580 cm’1; 6(d6-Me2G0/D20) (90 MHz) 7.70 (5H, m, ArH) and 3.44 (2H,
AB q, 15 Hz, p-GH2); m/e 205 (M+), 160 (M - C02H), 130 (C HqN), 
and 117 (CgiyO.
DL-Tryptophan methyl ester hydrochloride.- This compound was
prepared hy the method of Brenner and Huber33 in 80% yield, m.p.
225 - 226°C (dec.) lit.,36 225°G (dec.,) ; S(CDClj) (90 MHz) For
the free base, 8.90 (1H, bs, NH, exchangeable with DgO), 7.16 (5H,
m, ArH), 3.76 (1H, X part of ABX system, 8, J_BX 5 Hz, a-CH), 3.62
(3H, s, G02Me), 3«H and 3*04 (2H, AB part of ABX system, J_ 8,
J 5* JAT3 15 Hz, p-CH0), and 1.57 (2H, bs, NH^ exchangeable with BX “AB &
D20); m/e 218 (M r- HGl), 159 (M - HC1 - GO^e) and 130 (C HgN),
21DL-3-Acety1-5-(indol-3-ylmethy1)tetramic acid (9).- DL-Tryptophan
methyl ester hydrochloride (0.90 g, 3*5 mmoles) was dissolved in 
water (10 ml) and an equivalent amount of triethylamine was added.
The free amino acid methyl ester was extracted into diethyl ether.
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The ether extracts were dried and evaporated to give a yellow oil 
(98^ recovery) which was dissolved in anhydrous methanol (6 ml) and 
cooled to 0°G. Redistilled diketene (0.5 nil* 6.3 mmoles) was added 
dropwise, with stirring, and the solution was stirred at 0°G for 10 
min and then at room temperature for 2 h. The solvent was 
evaporated leaving a viscous yellow oil, the crude N-acetoacetyl- 
tryptophan methyl ester. This ester gave only one spot on t.l.c.
(R^ = 0.33# EtOAc) which turned purple on spraying with methanolic 
FeCl^ solution; 6(GDC1^) (90 MHz) 8.55 (1H, bs, NH, exchangeable 
with D20), 7.22 (5H, m, ArH), 4.89 (1H, m, gc-CH), 3.60 (3H, s, C02Me),
3.25 (2H, m, P-Ciy, 3.19 (2H, s, C0CH2C0), 2.16 (1H, s, NH), and
2.00 (3H, s, COMe).
The crude oil from above was dissolved in anhydrous benzene (2 ml) 
and to this was added a solution of sodium methoxide (4.4 mmoles) 
in methanol and the mixture was refluxed for 3h. The mixture was 
left at room temperature overnight, and then extracted with water 
(5 x 30 ml). The water extracts were acidified to pH 2 with dilute 
hydrochloric acid and extracted with ether (5 x 20 ml). The 
combined ether extracts were dried and concentrated. The residue 
was recrystallised from ethanol to give pale yellow crystals (0.73 St 
77% yield) and gave one spot on t!.I.e. (R^ = 0.6l, CHCly MeOH: HOAc - 
80:20:2), which turned brownish orange when sprayed with methanolic 
FeCl^ solution; m.p. 173 - 174°C (lit.,21 171 - 173°C) (Found: G, 66.6; 
H, 5.0; N, 10.2. Calc, for G, 66.7; H, 5.2, and N, 10.*$);
Xma fCHClJ 226 ( 112 x 103) and 280 ( 57 x 103) nm; vm (CHC1,.)
PlcLX  J) UlclX
3 480, 3 440, 1 715, 1 660, and 1 620 cm*1; 6(CDG1^) (90 MHz) 10.70 
(1H, bs, OH, exchangeable with DgO), 8.15 (1H, bs,. NH, exchangeable
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with 7*35 (5H, m, ArH), 6.05 (1H, s, NH exchangeable with D^O),
4.10 (1H, X part of ABX system, J 10, JBX 4 Hz, 5-H), 3.^5 and 
2.83 (2H, AB part of ABX system, J 10, J_BX 4, 15 Hz, 3-CH2),
and 2.45 (3H, s, COMe); m/e 270 (M+) and 130 (C HgN).
DL-3-[2H^Il-Acetyl-5-(indol-3-ylmethy1)-5-C2H]-* t etramic acid (12b).- 
DL-3-Acetyl-5~(indol-3-ylmethyl)tetramic acid (0.50 g, 109 mmoles) was 
heated overnight in a refluxing 0.4 M sodium deuteroxide solution 
(40 ml). The cold solution was acidified to pH 2 with dilute DC1 
solution and was extracted with chloroform (10 x 5 ml)# The combined 
chloroform extracts were dried, concentrated and the residue was 
recrystallised from ethanol to give pale yellow crystals (0.47 g,
92^ yield, 82^ [2H^>pecies) m.p. 171 - 173°C (lit.,21 171 - 173°C 
for non-deuteriated compound); 6 (CDCl^) (90 MHz) 11.20 (1H, bs, OH, 
exchangeable with 0^0), 8.15 (1H, bs, NH, exchangeable with 0^0),
7.33 (5H, m, ArH), 6.05 (1H, bs, NH, exchangeable with D^O), 3*42 
(1H, d, 15 Hz, p-CH), and 2.80 (1H, d, 15 Hz, p-CH); m/e
274 (M+) and 130 (C^HgN).
DL-3-Acetyl- 5-( indol-3-yl-r1 '^G~lme thyl) te trami c acid.- DL-CP-^cG- 
Tryptophan (250 U Ci) diluted with unlabelled DL-tryptophan(126 mg,
0.62 mmoles) was suspended in anhydrous methanol (l ml), cooled to 
0°C and thionyl chloride (100 Ul) was added to give a clear yellow 
solution which was kept at 0°C for 45 h, followed by 1 h at room 
temperature. The solvent was removed,.under dry nitrogen and anhydrous 
methanol (1.5 ml) was added to the residue, followed by 3*67 M sodium 
methoxide solution (200 yl, 0.73 mmole), which liberated the amino 
ester. The reaction mixture was cooled to -4o°C and redistilled
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diketene (100 pi, 1.27 mmoles) was added dropwise with stirring.
The reaction was stirred for Zh h at room temperature. The solvent 
was removed under dry nitrogen and the residue was purified by 
preparative t.l.c. developing with ethyl acetate. The radioactive 
hand (R^ ^0.3 - 0.^) was eluted with 20% methanol in ethyl acetate.
The N-acetoacetyl methyl ester was heated for 1 h in a refluxing 
solution of benzene (l ml) and 3*67 M sodium methoxide solution
(170 y 1, 0.62 mmole), and then left at room temperature for ^ 8 h.
The product was isolated as described previously for the unlabelled 
analogue (9) and. was crystallised from ethanol to give pale yellow 
crystals (103 mg, 62%, 391*7 yCi/mmol), m.p. 173°C (lit.,20 171 - 
173°C).
2-Azaindole-3-carboxylic acid.- 2-Azaindole-3-carboxylic acid
25was prepared from isatin by the method described by Snyder et al.
The crude product was crystallised from water, giving pale yellow 
needles (33^ yield.), m.p. 268 - 268.5°C (block preheated to 220°C) 
(lit.,2-5 268 - 268.5°C) (Found: G, 59*2; H, 3*9; N, 1 ? A . Calc, for
G8H6N2°2s G' 59#3; H' 3*7j N| 6 (90 MHz) 8.08 (lH,
d, J 8 Hz, H-7) and 7.30 (3H, m, ArH); m/e 162 (M+), 1^5 (M - OH),
and 118 (tt - C02H + H).
NN-Dimethyl-2-azaindole-3-carboxylic acid amide.- This was prepared
from 2-azaindole-3-carboxylic acid, dimethylamine and thionyl chloride
25according to the procedure of Snyder et al. J The crude product gave 
pale beige crystals (7&% yield) from nitromethane, m.p. 191 - 192°G 
(lit.,25 187 - 188.5°C) (Found: G, 63.^ ; H, 6.1; N, 22.1. Gale, for
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giohiiN30: G, 63.5; H, 5.9; 22.2^); ^ (KBr) 3 ^0, 3 160, and 1 600 
cm”1; 6(G®G13) (90 MHz) 8.08 (1H, d, J 8 Hz, H-7), 7.31 (3H, m, ArH),
and 3.30 (6H, s , 2 x  Me); m/e I89 (M+), 1^5 (M - NMe^), and 118 
(M - C0NMe2 + H).
3-Dimethylaminomethyl-2-azaindole.- NN-Dimethyl-2-azaindole-3- 
carboxylic acid amide was reduced with lithium aluminium hydride 
in refluxing anhydrous tetrahydrofuran, as described by Snyder et al.2-5 
Crystallisation from diethyl ether afforded white crystals (77% yield), 
m.p. 126 - 127°C (lit.,2-5 125 - 126°C) (Found: C, 68.6; H, 7.7; N,
24.0. Calc, for C ^ H ^ N  : C, 68.5; H, 7.5; N, 24.1#); v max(KBr)
3 120, 3 080, 3 040, 2 990, 2 960, 2 870, 2 830, 2 810, and 1 620 cm”1 
6 (CDCl,p (90 MHz) 7.82 (1H, d, J 8 Hz, H-7), 7.20 (3H, m, ArH), 3.88 
(2H, s, CH2), and 2.32 (6H, s , 2 x Me); m/e 175 (M+), 160 (M - Me),
1^5 (M - 2 x Me), and 132 (M - NMe2 + H).
Methiodide of 3-dimethylaminomethyl-2-azaindole.- A mixture of 
3-dimethylaminomethyl-2-azaindole and methyl iodide in ethanol was 
heated to give a clear solution, which was then left at 0°C overnight.
The crude solid formed was filtered, dried (84# yield) and recrystallised 
(9^  recovery) from ethanol, m.p. 192 - 194°C (lit.,2-5 192 - 193°C).
No attempts were made to further .characterise this, compound due to 
its instability.
Ethyl q-formamido-q-ethoxycarbonyl-B-(2-azaindol-3-yl)propionate 
(17a).- Treatment of diethyl formamidomalonate with sodium ethoxide 
and the methiodide of 3-dimethylaminomethyl-2-azaindole, according
2*5
to the published procedure, gave white crystals ( 53% yield) from 
ethanol, m.p. 140 - l42°C (lit.,2-5 140 - l4o.5°C) (Found: G, 57-9;
H, 5.8; N, 12.6. Calc* for C-^H-^Oy G, 57.7; H, 5.7; N, 12.6%); 
W KBr) 3 390, 3 260, 2 990, 1 760, 1 735, and 1 645 cm-1; 6 (CDC13) 
(60 MHz) 8.10 (1H, s, GHO), 7.33 (6H, m, ArH and 2.x NH, which 
exchange with D20), 4.43 (4H, q, GH^e) and 4.10 (2H, s, CH2-C), and
I.26 (6H, t, 2 x GHpMe); m/e 333 (M+), 289 (M - NHGHO), 288 (M - OEt), 
260 (M - C02Et), 243 (M - 2 x OEt), 232 (M - NHCHO - 2  xEt+H),
214, 198, 186 (M - 2 x G02Et - H), and 131 (CgH^).
8-(2-Azaindol-3-yl)alanine (14).- Ethyl a-formamido-a-ethoxy- 
carbonyl-p-(2-azaindol-3-yl)propionate (1.6l g, 5 mmoles) was heated 
in refluxing concentrated hydrochloric acid for 7 h. The resulting
1
clear solution was evaporated under reduced pressure to give a white 
foam, which was dissolved in water (ca. 5 ml) and neutralized with 
dilute ammonia solution. The solid obtained on cooling was filtered 
and crystallised from water to give a white crystalline solid (85$ 
yield) which gave a positive ninhydrin test, m.p. 248 - 251°C (dec.) 
[lit.,2-5 249 - 250°C (dec.)]; V (KBr) 3 ^20, 3.200 -.2 900, 1 620,
IilclX
1 500, 1 400, and 1 350 cm"1; 6(d£-DMS0/D20) <100 MHz)37 7.82 (1H, 
d, 7.9 Hz, H-4), 7 .5 k (1H, d, J?6 8.3 Hz, H-7), 7-38 (1H, ddd,
0.9, 6.5, J^7 8.4 Hz, H-6), 7.13 (1H, ddd, 8.0, 6.5,
1.4 Hz, H-5), 3.79 (1H, X part of ABX system, 2.8, 9.4 Hz,
a-GH), 3.55 and 3.29 (2H, AB part of ABX system, 8.0, 2.8,
JBX 9 A  Hz, e-GH2); m/e 205 (M+), 187 (M - 1^0), 160 (M - C02H),
132 (CgHgN2), and 118 (CJig^).
The amino acid was also obtained by reacting the methiodide of 
3-dimethylaminomethyl-2-azaindole with dimethyl acetamidomalonate 
and sodium ethoxide in ethanol, followed by hydrolysis in
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refluxing concentrated hydrochloric acid, without prior purification 
of the acetamido diester (17b)• Evaporation of the hydrolysis mixture 
to dryness, followed by neutralization to pH 7 with dilute ammonia 
solution and cooling, gave a solid which was treated with charcoal 
and twice recrystallised from water, giving white crystals (l6% yield 
from the methiodide) with the same characteristics described before.
3-Dime thylamin ome thy1-7-az aindole.- This compound was prepared
26as described by Robison and Robison from 7-azaindole» dimethylamine 
hydrochloride and paraformaldehyde (75^ crude yield), m.p. 147 - 152°C
p
(lit., 144 - 152°C); 6(GDC13) (90 MHz) 8.24- (1H, d, ArH), 8.00 (1H, 
d, ArH), 7.22 (1H, bs, ArH), 7.03 (1H, m, ArH), 3.56 (2H, s, CHg),
2.21 (6H, s , NMe2), and 1.82 (1H, bs, NH, exchangeable with D^O); 
m/e 175 (M+) and 131 (M - NMe^).
Ethyl q-acetamido-a-ethoxycarbonyl-6-(7-azaindol-3-yl)propionate. -
The unrecrystallised 3“dimethylaminomethyl-7-azaindole was heated in
refluxing xylene with powdered sodium hydroxide and diethyl acetamido-
28malonate as described in the literature, giving the crude title 
compound in 59% yield. A sample recrystallised from benzene had m.p.
172 - 173.5°G (lit., 170 - 170.5°c) (Found: C, 58.9s H, 5.8: N, 12.3. 
Calc, for C17H21N,0,: C, 58.8: H, 6.1: N, 12.1$;v max(KBr) 3 420,
3 300, 1 740, and 1 645 cm-1: 6(CDC13) (90 MHz) 8.37 (1H, bs, HH, 
exchangeable with D^O), 7.97 (1H, d, ArH), 7.22 (2H, m, ArH), 6.80 
(1H, s, ArH), 4.37 (4H, q, GH^Me), 3-97 (2H, s, GHg-C), 2.07 (3H, s, 
COMe), 1.35 (6H, t, GHpMe). and 1.05 (1H, s, NH, exchangeable with D20); 
m/e 347 (M+), 302 (M - OEt), 289 (M - NHAc), 216 [C(C02Et)2NHAc],
and 131 (GqH7N2).
^3
ft-(7-Azaindol-3-yl)alanine (15).- Ethyl oc-acetamido-oc- ethoxy-
carbonyl-3-(7-azaindol-3-yl) propionate was hydrolysed in' concentrated
26hydrochloric acid "by the method described. The crude amino acid was
treated with charcoal and re crystallised from water to give white
crystals yield) which gave a positive ninhydrin test, m.p. 254 -
256°C (dec.) [lit.,26 257 - 259°G (dec.)]; v (KBr) 3 420, 3 240 -msix
2 900, 1 630, 1 585, 1 500, 1 ^50, 1 350, and 1 330 cm"1; 6 (d6-DMS0/D20) 
(100 MHz)38 8.19 (1H, dd, 1.5, 4.6 Hz, H-6), 8.11 (1H, dd,
1.2, J^5 8.0 Hz, H-4), 7.32 (1H, s, H-2), 7.08 (1H, dd, 7-9,
“56 3*59 (!H» X part of ABX system, 3.9, JBX 8.7 Hz,
a-CH), 3*31 and 3»08 (2H, AB part- of ABX system, 3.9# J^x 8.7,
8A  Hz, g-CH2); m/e 205 (M+), 160 (M - CO^), 131 (CgH N2), and 118
(c7h6n2).
3~Ghoromethylhenzothiophene.- 3-Ghloromethylbenzothiophene was
prepared from benzothiophene and trioxymethylene in acid solution
30
as described by King and Nord. 7 The crude product was purified by 
bulb-to-bulb distillation (95 - 100°C/0.05 Torr) to give a colourless 
oil that solidified on standing. The solid was recrystallised from 
petroleum ether (40 - 60°C) to give white plates (56$), which decomposed 
on standing, m.p. 37 - 39°G (lit.,^ 39 “ *K)0C) (Founds G, 59*0; H, 3 .6 ;  
S, 17.7. Calc, for G^GIS: G, 59-2; H, 3.8; S, T?.5%)i 5 (CCl^)
(60 MHz) 7.9 - 7.7 (2H, m, ArH), 7.4 - 7.3 (3H, m, ArH), and 4.8 
(2H, s, CHj; m/e 184- (M+ with 37Cl), 182 (M+ with 35Cl), 1 ^  [M^S) - 
Cl], 14-7 [M^S) - Cl], 134- (CgHgS), and 108 (CgH^S).
Ethyl g-formamido-g-ethoxycarbonyl-8-(l-benzothien-3-vl)propionate.- 
3-Ghloromethylbenzothiophene was reacted with diethyl formajnidomalonate
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in the presence of sodium ethoxide in ethanol, according to the 
procedure described by Avakian et al.,27 to give white crystals from 
benzene - petroleum ether (60 - 80°C), m.p. 103 - 105°C (lit.,27 106 - 
107°G); 6(CDC13) (90 MHz) 7.93 (1H, s, GHO), 7.53 (4H, m, ArH), 7.08 
(1H, s, H-2), 4.26 (4H, q, GH^Me), 3*97 (2H, s, CH2-C), 1.52 (1H, bs, 
NH, exchangeable with D20), and 1.23 (6H, t, GH2Me); m/e 349 (M+),
304 (M - OEt), 276' (M - G02Et), 259 (M - 2 x OEt), 248 (M - NHCHO -
2 x Et), 230 (M - OEt - C02Et + H), and 202 (M - 2 x C02Et - H).
3-(l-Benzothien-3-yl)alanine (16).- Ethyl a-formamido-a-ethoxy-
s
carbonyl-3-(l-benzothien-3-yl)propionate ([1.94 mmoles) was heated 
in refluxing concentrated hydrochloric acid (10 ml) for six hours.
The solution was evaporated to dryness and the residue was dissolved 
in aqueous ethanol (1:1, 8 ml) and neutralized to pH 7 with dilute 
ammonia. On cooling, a solid.was obtained which was recrystallised 
from aqueous ethanol (1:1) to give white crystals {7^% yield) which 
gave a positive ninhydrin test, m.p. 230 - 232°C (dec.)^lit.
242 - 244°G (dec.)] (Found: G, 59-9; H, 4.8; N, 6.2; S, 14.5. Gale, 
for G11H11N02S: G, 59-7; H, 5.0; N, 6.3? S, 14.3*)s vmax(KBr) 3 430,
3 060, 3 030, 1 630, 1 500, and 1 400 cm-1; 6(d£-DMS0/D20) (100 MHz)^1
7.97 (2H, m, H-4 and H-7), 7.52 (1H, s, H-2), 7.43 (2H, m, H-5 and H 
H-6), 3.70 (1H, X part of ABX system, 3»9* 9*3 Hz, a-GH),
3.50 and 3.16 (2H, AB part of ABX system, 3«9» J.BX 9»3» 9*3
Hz, p-CH,); m/e 221 (M+), 176 (M - C02H), 160 (M - COgH - NHg), W? 
( C ^ S ) , and V>h (CgHgS).
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PART II
BIOSYNTHETIC STUDIES ON SOME METABOLITES 
CONTAINING THE DITHIODIOXOPIPERAZINE MOIETY.
^9
CHAPTER 1
The role of cyclic dipeptides in epipolythiodioxopiperazine biosynthesis
1.1 General
and the subsequent discovery and isolation of other fungal metabolites 
with related structural features has established the epipolythiodioxo­
piperazine family of metabolites. The forty-odd metabolites in this 
family possess as their common feature either the sulphur-bridged 
dioxopiperazine moiety indicated in (2) or its closely related 
bisdethiobis(methylthio) variant (3) •
The isolation of gliotoxin (l) in 1936 by Weindling and Emerson,^
c h 2o h
(1)
(2) (3)
50
Structural analysis of the compounds belonging to this family
1 2indicated that one or both of the residues R and R are derived 
from the aromatic amino acids phenylalanine (4, R = H), tryptophan (5) 
or tyrosine (*+, R = OH). The other residue may be derived from alanine 
(6, R = H), serine (6, R = OH) or glycine. In a number of cases, 
feeding experiments with the appropriate amino acids have supported 
this theory.
h 2n  c o 2h
W  (5)
H C 02H
RCH2 X
' n h 2
(6)
Several reviews on the structure, chemistry, biosynthesis, and
biological activity of these metabolites have appeared in the
2-5
literature during the last ten years. Recently, Kirby and Robins 
have provided a comprehensive review on the biosynthesis of gliotoxin 
and related epipolythiodioxopiperazines.^
Simple cyclic dipeptides have been shown to be precursors to more 
complex dioxopiperazines.^ Two examples are echinulin (7), shown 
to be derived from cyclo-(L-alanyl-L-tryptophyl) [8, cyclo-(L-Ala-L-Trp)] 
and brevianamide A (9), which is biosynthesised from cyclo-(L-prolyl-
51
L-tryptophyl) £10, cyclo-(L-Pro-L-Trp).]. The purpose of this chapter 
is to survey briefly the role of cyclic dipeptides (dioxopiperazines) 
as intermediates in the biosynthesis of epipolythiodioxopiperazines.
NH NH
HN
(7) (8)
(9) (10)
1.2 Gliotoxin
7
MacDonald and Slater were the first to suggest that cyclp-
(L-phenylalanyl-L-seryl) Qll, cyclo-(L-Phe-L-Ser)~| might be an
intermediate in the biosynthesis of gliotoxin (l). However, when
1^these authors fed cyclo-(L-fl- C]Phe-L-Ser) to cultures of PeniciIlium 
terlikowskii, a known gliotoxin producer, they observed only a low
52
incorporation of the cyclic dipeptide into gliotoxin, despite its 
efficient uptake into the mycelium. They concluded that the cyclic 
dipeptide (11) could not he a fTBe intermediate. Shortly after,
HN
NH
OH
(11)
Bu'Lock and Leigh^ fed a mixture of cyclo-(L-[Ar-^H]Rie-D-[]l-'^C]Ser)
and cyclo- (L-£ Ar-^H]Phe-L-£l-^c]3er) to Trichoderma viride (probably
a Gliocladium sp.) and observed a high incorporation (21$) of the
1^+ 3
radioactivity into gliotoxin (l). Moreover, the Gj H isotope 
ratios of the precursor mixture and the isolated gliotoxin were
effectively unchanged, indicating that the cyclic dipeptide was
g
incorporated intact into gliotoxin. Bu’Lock and Leigh suggested
7
that the misleading results obtained by MacDonald and Slater' were
due to the administration of precursor in such high levels that
equilibration of exogenous material with biosynthetic intermediates
had been blocked.
The observations of Bu'Lock and Leigh were later confirmed and
q t/j,
extended by Kirby et al. C-Labelled samples of all four possible 
stereoisomers of cyclo-(phenylalanylseryl) were separately fed to 
cultures of T. viride (Gliocladium deliquescens). The LL-isomer was 
efficiently incorporated (up to 50$) into gliotoxin, whereas none of
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the other stereoisomers was incorporated to any significant extent.
Administration of cyclo-fL-f^H~lPhe-L-[V'^ClSer') to the fungus
gave gliotoxin (l) with essentially the same isotope ratio as the
precursor, and hydrolysis of the isolated metabolite produced
inactive methylamine. These results^ supported the hypothesis that
(ll) is incorporated intact into gliotoxin. Breakdown of the cyclic 
l^-idipeptide to [_3- CJserine, and equilibration with the metabolite
1l±
pool would have resulted in C-activity appearing in the methylamine.
The status of the cyclic dipeptide (ll) as a free intermediate
m  T. viride was also investigated by the same group^ by means of
an "intermediate-trapping" experiment. Non-radioactive (ll) was fed
1^to the mould culture and, 2 hours later, L-Qj- CJPhe was added to
the medium. After a further 2 hours, the organism was harvested
and the culture filtrate was extracted with chloroform to remove
gliotoxin and was then extracted with ethyl acetate to remove the
cyclodipeptide (ll). This was diluted with unlabelled (ll) and
the mixture was crystallised to constant activity. The residual
activity corresponded to 1.3$ of that administered as L-^U-^CjPhe.
The presence of cyclo-(phenylalanylseryl) as a free biosynthetic
intermediate has also been demonstrated recently in G. virens.
another gliotoxin producing fungus . Behling and Fischer^ 
iZx
incubated DL-^3- CJserine with protoplasts of G. virens and isolated 
from this mixture radioactive cyclo-(phenylalanylseryl). The 
experimental conditions used by these authors did not lead to 
gliotoxin biosynthesis. Nevertheless, this observation supports the 
status of (ll) as an intermediate in gliotoxin biosynthesis.
5^
1.3 Sporidesmins
Sporidesmin A (12) and related metabolites are thought to he 
derived from cyclo-(L-Ala-L-Trp) (8). The metabolism of (8) in 
Pithomyces chartarum was studied by Varley."^ Administration of 
cyclo-(L-f3~^ H~lAla-L-r3-'^ C~]Trp') resulted in a 2.05% incorporation
into sporidesmin A, but the ratio, of the product was only 51%
OH OH
MeO
MeMeO
Me
(12)
that of the precursor. The author proposed that this result could 
have arisen.-by either: (a) partial or complete cleavage of (8) into 
its constituent amino-acids,. followed by their separate incorporation 
or (b) loss of *^H from the methyl group of the alanine unit via 
reversible formation of a dehydroalanyl derivative at some point 
in the biosynthetic pathway. Further studies are needed to settle 
the role of the cyclodipeptide (8) in sporidesmin biosynthesis.
l.^ > Sirodesmins
12Curtis et al. were the first to suggest that a cyclo-(seryl- 
tyrosyl) derivative might be a precursor to the sirodesmins.
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Recently, Ferezou et al.1  ^fed cyclo-(L-Ser-L-fU-^ClTyr) (1*0 to 
Phoma lingam cultures at two different concentration levels. The 
isolated metabolite, sirodesmin A (l^ ) contained 12.5^ and ^*35% o f  
the precursor radioactivity from the low- and high-level feedings
OHAcO
NMe
OH
(13) (I/O
respectively. These results are in agreement with Bu'Lock.and Leigh's
8previous observations regarding levels of administered precursors 
in biosynthetic experiments.
h i  Other epipolythicdicxopiperazines
MeN
NMe
OH
OAc
AcO
(15) (16)
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Hyalodendrin (15) and acetylaxanotin (16) are two members of the 
epipolythiodioxcpiperacine family that show an interesting resemblance 
to gliotoxin (l). The study of their biosynthesis, and the role 
played in it by cyclic dipeptides, is the object of this work and 
is discussed in the following chapters.
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CHAPTER 2 
Hyalodendrin
2.1 Isolation, biological activity and structural determination
14In 1973» Strunz et al. found potent antifungal properties 
associated with a species of Hyalodendron. an imperfect fungus. The 
search for the active principle responsible for this activity led to the 
isolation of a new metabolite, designated hyalodendrin and assigned 
the structure (15) on spectroscopic and chemical evidence. Comparison
^ O H
(15)
of the circular dichroism curve of hyalodendrin with those obtained
14for other epidithiodioxopiperazines showed that the disulphide bridge
in hyalodendrin is antipodal to that of gliotoxin (l), the sporidesmins
and the aranotins.
The biological activity of hyalodendrin (15) has been studied by 
15Stillwell's group. They found that the antimicrobial activity of 
hyalodendrin against fungi associated with decay and deterioration in
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trees and wood products was, with few exceptions, considerably
greater than that of nystatin, cryptosporiopsin or scytalidin.
Hyalodendrin also compared favourably with nystatin and benomyl in
its ability to inhibit the growth of Ceratocystis ulmi. the causal
organism of Dutch elm disease. Its potential use as a control agent
15of this devastating tree disease was suggested by the authors. 
Hyalodendrin also showed antibacterial and antifungal activity against 
several human pathogens. However, hyalodendrin is also acutely toxic 
to mice, the having been established at 75 mg/kg.
A second metabolite was isolated from Hyalodendron sp. by Strunz 
et al."^ Comparison of its spectroscopic properties with those 
of hyalodendrin (15) , showed that this new metabolite was bisdethio- 
bis(methylthio)hyalodendrin (17)» in which the disulphide bridge has
SMe
MeN
NMe
MeS ?
OH
(17)
been replaced by two methylthio groups. Isolation of bisdethiobis(methyl- 
thio) modifications of epidithicdioxopiperazine metabolites are well 
precedented in the literature.^ In all these cases, (17) included, the 
absence of a sulphur bridge results in a total lack of biological 
activity.
Strunz et al. treated hyalodendrin (15) with sodium borohydride
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in the presence of methyl iodide and pyridine at 0°C.^ Comparison 
of the chromatographic behaviour and spectra of the product of this 
reaction, together with a mixed melting point determination, established 
its identity with the natural metabolite (17)• Regrettably, the optical 
rotations of the synthetic product and of natural bisdethicbis(methylthio)- 
hyalodendrin were not compared.
17Also in 1973» De Vault and Rosenbrook ' reported the isolation of 
three metabolites from an unidentified fungus, NRRL 3888. On the 
basis of n.m.r. and mass spectroscopic evidence, they assigned ta> two 
of these metabolites the same structures, (15) and (17)» independently 
given to hyalodendrin and its congener, but no efforts were made 
to determine the absolute configuration of the sulphur substituents 
in either metabolite. The third metabolite was found to possess a 
bridge containing three sulphur atoms, as shown in (18).
(18)
Two other groups have isolated another metabolite closely
related to bisdethiobis(methylthio)hyalodendrin (17). Helminthosporium
18victoriae was found by Dorn and Arigoni to produce gliovictin (19),
a metabolite with the same gross structure as (17), but with the
(R)-configuration at positions 3 and 6. Independently, Michel at al.1^
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(19)
isolated from Penicillium turbatum a compound, antibiotic A26771E, to
which they assigned the structure (19)» Thus antibiotic A26771E and
gliovictin (19) are identical. P. turbatum was also found to produce
two more metabolites with the (R)-configuration at positions 3 6:
the hyalodendrin antipode (20), whose structure, excluding absolute
configuration, was established by X-ray diffraction studies, and
the epitetrathiodioxopiperazine (21). Both compounds possess antiviral
19and antibacterial activity. 7
(20) (21)
20Strunz et al.. have also isolated an epitetrathiodioxopiperazine 
from cultures of Hyalodendrcn sp. Its gross structure was found, by 
spectroscopic methods, to be identical to that of (21), isolated from
6l
P. turbatum. However, comparison of the circular dichroism curve of
the Hyalodendron tetrasulphide with that of (21), established that
20these compounds are enantiomers. The structure and relative, but
not absolute, configuration of the (S)-tetrasulphide was confirmed by 
21X-ray studies.
Summarizing, P. turbatum and Hyalodendron are each able to produce - 
a family of polythiodioxopiperazine metabolites enantiomeric with each 
other. The reasons for this enantiomeric selectivity in nature are 
not yet understood.
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2.2 Synthesis
22Hyalodendrin was first synthesised by Strunz and Kakushima, 
using a slight modification of the method developed by Kishi et al. 
for the total synthesis of dehydrogliotoxin^ and1 sporidesmin A.^
In this method, the thioacetal (22), prepared from the cis-dithiol 
and ]D-anisaldehyde, serves as a protected precursor of the epidithio- 
moiety and can be metalated and alkylated selectively stepwise at the 
bridgehead position as shown in Scheme I. Treatment of (22) with one 
equivalent of n-butyl lithium, followed by alkylation with chloromethyl 
methyl ether afforded the methyl ether (23). This was again metalated 
and alkylated with benzyl bromide to give the protected hyalodendrin 
precursor (24). Oxidation of (24) with m-chloroperbenzoic acid, 
followed by treatment with perchloric acid in tetrahydrofuran
23 24according to Kishi's procedure, gave, after chromatography, the
racemic hyalodendrin methyl ether (25). The methyl ether was cleaved 
using boron trichloride and, after chromatography of the reaction 
mixture, racemic hyalodendrin (15) was obtained in 3% overall yield 
from (22).
25A couple of years later Kishi and coworkers reported another, 
shorter, synthesis of hyalodendrin starting from 1,4-dimethy1-3,6- 
di(methoxymethylthio)piperazine-2,5“dicne (26) (Scheme II; all compounds 
were racemic). The dianion generated from treatment of (26) with
2.3 equivalents of lithium di-isopropylamide was alkylated first with 
benzyl bromide and then with bromomethyl methyl ether to give, in a 
one-pot reaction, the unsymmetrically disubstituted, protected 
dithiopiperazinedione (27). Removal of the sulphur protecting groups
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was achieved using boron trichloride. Iodine oxidation of the
resulting dithiol, to give the desired disulphide bridge, was followed
by further treatment with boron trichloride to liberate the primary
alcohol group of hyalodendrin (15)• The overall yield of (15) from
(26) was 16%. The authors^ report a melting point of 101 - 102°G for
1^
their product. This is close to that obtained by Strunz at al.
for natural hyalodendrin (100.5 - 101.5°G) but not to that reported
22by Strunz and Kakushima for their synthetic racemic hyalodendrin 
(131 - 13^°G). Whether this discrepancy is due to a printing error 
or to the omission of reporting a resolution step is not clear.
M eO M eO
Ph
MeM eN
•NMeN M e
M eO
O M eOM e
(27)(26)
/
MeN
NMe
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(±M15)
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26Williams and Rastetter have recently synthesised racemic 
bisdethiohis(methylthio)hyalodendrin (17) (Scheme III) and hyalodendrin 
(15) (Scheme IV). Their method is based on the stereoselective 
alkylation and sulphenylation of enolates derived from dioxopiperazines. 
The authors found that reactions of enolates of dioxopiperazines 
already containing a sulphur substituent, with a carbon or sulphur 
electrophile, occur preferentially, although to varying degrees, 
on the face opposite to the existing sulphur substituent (vide infra).
Addition of a slight excess of methanesulphenyl chloride, in the 
presence of one equivalent of triethylamine, to the enol (28) (Scheme 
III), obtained from monoformyiation of sarcosine anhydride (l,4-dimethyl- 
piperazine-2,5-dione), gave the product (29). Its aldehyde group was 
reduced with tri-t-butoxyaluminium hydride to give a primary alcohol, 
which was protected with t-butyldimethylsilyl chloride to give (30)•
The enolate derived from treatment of this compound with lithium 
di-isopropylamide was sulphenylated with dimethyl disulphide to give 
a mixture of diastereomers (31), which was not separated. Benzylation 
of the enolate of (31), followed by removal of the silyl protecting 
group, afforded racemic bisdethiobis(methylthio)hyalodendrin (17) 
in JQ% overall yield from sarcosine anhydride ..
Hyalodendrin was synthesised along similar lines (Scheme IV), 
albeit in lower yield. Benzylation of the enolate of (32.), 
prepared from the potassium salt of (28) and t-butyldiphenylsilyl 
chloride, afforded the silyl ether (33). Sulphenylation of the 
enolate of this compound, using monoclinic sulphur, followed by 
reductive work up, gave the thiol (3^ ). This was converted into the 
enolic methyl disulphide (35) reaction with methanesulphenyl
66
MeN
NMe
(28)
(29)
Me S.
MeN
NMe
MeS
(31)
M eN
NMe
MeS'
OSiMe *Bu
(30)
SMe
Me
.NMe
MeS
OH
Scheme III
NMe
(32)
(35)
♦
Ph
MeN
NMe
t BuSiPh
(33)
•SMePh
MeN
NMe
SHPh
MeN
NMe
BuSi Ph
(3*0
s— SMePh
MeNMeN
NMeNMe
S — SCPhOHC
(±)-(l5)
Scheme IV
68
chloride in the presence of triethylamine, followed by acid hydrolysis 
of the silyl protecting group. The enolate of (35) was generated 
with triethylamine and sulphenylated with triphenylmethyl chloro- 
disulphide to give (36) as a mixture of diastereomers, favouring the 
undesired anti-isomer. Reduction of (36) with sodium borohydride, 
followed by oxidation with potassium tri-iodide in pyridine and 
chromatography of the product, gave racemic hyalodendrin (15) in 12% 
overall yield from sarcosine anhydride.
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2.3 Biosynthesis
As mentioned in Chapter 1, hyalodendrin (15) ancL other
metabolites of the same group (vide supra), although structurally
simpler, bear a close resemblance to gliotoxin (l). They too appear
to be derived from phenylalanine and serine. Both nitrogen atoms
in the dioxopiperazine nucleus are methylated and ring closure to
the dihydroaromatic system has not occurred. Whether the absence
of this late-stage oxidation is due to the lack of the necessary
enzymes or whether oxidation cannot take place after the nitrogen
atoms are methylated, is yet to be established. Moreover, in the
‘group of metabolites produced by Hyalodendron sp., the sulphur-
bridged system is of a configuration opposite to that of gliotoxin.
g
In the light of the results obtained by Kirby et al. on the 
biosynthesis of gliotoxin, it seemed likely that cyclo-(pheny1- 
alanylseryl) might be an intermediate in the biosynthetic route 
leading to the Hyalodendron metabolites. The antipodal character 
of the disulphide bridge of hyalodendrin as compared to that of 
gliotoxin, further suggested comparative experiments- with the LL- 
and DD-forms of cyclo-(phenylalanylseryl).
27
These investigations were started by Patrick in our laboratories.
o 1^The temperature (21 C) used by Strunz at al. for growing
Hyalodendron sp. was not available in our growth room; instead, the
cultures were grown at 25°C. As a result, bisdethiobis(methylthio)-
hyalodendrin (17), and not hyalodendrin (15), was found to be the
major metabolite produced. Since (17) and (15) have the same configuration
of interest at the sulphur bridge and, moreover, since the former
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is easier to crystallise than the latter, our studies were all ^ carried 
out with this compound. Results obtained with bisdethiobis(methylthio)- 
hyalodendrin (17) should also hold true for hyalodendrin (15)»
Patrick synthesised ^»27 Cyclo-(L-TU-^ClPhe-L-Ser) and cyclo- 
(D-Phe-DL-£3“ G^ jSer) from the appropriate enantiomers of phenylalanine 
methyl ester hydrochloride and N-benzyloxycarbonylserine by standard 
methods. ''Administration of cyclo-(L-TU-^ClPhe-L-Ser) to cultures 
of Hyalodendron sp. resulted in. a total incorporation of 10$ of the 
precursor radioactivity into bisdethiobis(methylthio)hyalodendrin (17)• 
The radiolabelled mixture of DD- and DL~diastereomers was fed in 
parallel with cyclo-(L-fU-^C~lPhe-L-Ser). Whereas the latter was 
efficiently (28$) incorporated into the metabolite (17), no significant 
incorporation was obtained from the former mixture. The specific 
activity of the pure bisdethiobis(methylthio)hyalodendrin isolated 
from the administration of the diastereomeric mixture was only 0.6$ 
of the value obtained for the pure compound (17) isolated from the 
parallel' reference feeding.
Doubly labelled cyclo-(L-TV -^ H~|Phe-L-f 3-^C~|Ser) was also
27synthesised and administered to Hyalodendron sp. cultures by Patrick. 
Incorporation into the metabolite (17) was high (42$) and the % / ^ C  
ratio of the pure crystalline metabolite (11.l) was essentially unchanged 
from that of the precursor (10.9), thus indicating, as discussed in 
Chapter 1 for gliotoxin, that the precursor is incorporated intact into 
the metabolite.
Having demonstrated the involvement of cyclo-(L-Phe-L-Ser) in 
hyalodendrin biosynthesis, attention was turned to possible later 
intermediates. Several further stages are required to convert cyclo-
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(L-Phe-L-Ser) into hyalodendrin: N-methylation'of both nitrogen atoms 
and incorporation of the disulphide bridge. The order of these 
steps is unknown, but several intermediates can be postulated. The 
most accessible in terms of synthesis are cyclo-(L-Phe-L-N-Me-Ser) 
(37) and cyclo-(L-.iV-Me-Phe-L-Ser) (38) i which might be formed in the 
biosynthetic pathway by selective N-methylation at either nitrogen
dioxopiperazine (37) by dicyclohexylcarbodiimide coupling of the methyl
ester of N-methyl-L-serine t-butyl ether and N-benzyloxycarbonyl-L-
phenylalanine, followed by hydrogenolysis of the benzyloxycarbonyl
group to give spontaneously the t-butyl protected cyclized dipeptide,
which was finally deprotected with 45% hydrobromic acid in glacial
27acetic acid. The cyclic dipeptide (37) was fed in parallel with 
cyclo-(L-TU-lZfC~lPhe-L-Ser) to cultures of Hyalodendron sp. Only 
0.003% of the total radioactivity administered as (37) was found in 
the isolated bisdethiobis(methylthio)hyal-odendrin, whereas the 
reference feeding proceeded with 33% total incorporation.
(37) (38)
27 .of cyclo-(L-Phe-L-Ser). Patrick synthesised the previously unreported
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27
Patrick's results ( indicated that cyclo-(L-Phe-L-Ser), but
not the related DD- or DL-stereoisomer is a precursor to hyalodendrin.
Furthermore, there was some indication that the LL-stereoisomer is
incorporated intact. Finally, there was no support to the hypothesis
that cyclo-(L-Phe-L-N-flle-Ser) (37) could be an intermediate in hyalodendrin
biosynthesis. Several points, however, remained to be clarified.
Firstly*, cyclo-(L-Phe-D-Ser) remained to be investigated as a possible
biosynthetic precursor. Second, since no degradation studies had
been carried out on the metabolite isolated from any feeding experiment,
13it was desirable to feed a C-labelled precursor to show that 
incorporation had occurred without "scrambling" of the label. Finally, 
the possibility that the other N-methylated cyclodipeptide (38) 
might be incorporated also had to be investigated. These experiments 
were carried out by the author and are described below.
As discussed before, Hyalodendron sp. was grown at 25°C, thus 
producing bisdethiobis(methylthio)hyalodendrin (17) as the major 
metabolite. In a typical run, 20 - 25 mg of pure crystalline (17) were 
obtained from a litre of mould culture. The melting point, optical 
rotation,: mass aind ^H-n.m.r. spectra of the isolated metabolite (17) 
agreed with the data reported in the literature.1^ It was found that 
there was some solvent effect on the chemical shift of one of the 
N-methyl signals. Thus, in GDCl^, the two N-methyl signals appear 
at 6 3.03 and 3.3O ppm, whilst in CCl^ they are observed at 2.97 and 
3.13 ppm. For further "Si-n.m.r. comparison, the acetate (39) of 
bisdethiobis(methylthio)hyalodendrin was synthesised by treatment 
of (17) with pyridine and acetic anhydride. The previously unreported 
acetate (39) gave ‘'"H-n.m.r. spectral signals for the N-methyl protons
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at 5 3*28 and 3*05 ppm, approximately the same chemical shifts as 
those of (17) in CDGl^. However, the S^ -methyl signals shifted closer 
to each other, appearing at 2.33 and. 2.23 PPm» as opposed to 2.30 
and 2.13 ppm for bisdethiobis(methylthio)hyalodendrin. The acetyl 
protons of (39) appeared at 1.66 ppm, at considerably higher field 
than usual for simple acetyl protons.
All.the feeding experiments to be described were carried out by 
administering the precursor of choice in dimethyl sulphoxide to 
5-day old cultures of the fungus. Extraction of the fed cultures 
afforded, besides the natural metabolites, crystallisable amounts of 
a white solid, soluble in most organic solvents and in water.
Mixed melting point determination and comparison of the ^H-n.m.r. 
spectra showed this material to be dimethyl sulphone. Since this 
compound was- only isolated from cultures that had been fed, it 
seems that Hyalodendron sp. is capable of oxidising the administered 
dimethyl sulphoxide to the corresponding sulphone. Because dimethyl 
sulphone and bisdethiobis(methylthio)hyalodendrin have the same 
in the chromatographic system used to purify the desired metabolite, 
it was necessary to find some method to separate these two compounds. 
Washing a methylene chloride solution of the mixture with several
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portions of water afforded pure metabolite (17), devoid of any sulphone 
impurities, which could then be crystallised from methylene chloride - 
cyclohexane.
14cyclo-(L-(~U- C]Phe-D-Ser) was synthesised by dicyclohexylcarbodi- 
imide coupling of N-benzyloxycarbonyl-D-serine and L-QU-^C]phenyl- 
alanine methyl ester hydrochloride in the presence of trie thy lamine, 
followed by hydrogenolysis of the N-protecting group and cyclisation 
to the dioxopiperazine with saturated ammoniacal methanol. The 
product was obtained in 38% yield from the protected amino acids, 
with a specific aotivity of 31 • 5 yCi/mmol._ A solution of this compound 
(12.1 mg, 1.63 yCi) in dimethyl sulphoxide (1 ml) was distributed 
among 9 flasks of Hyalodendron culture (total volume, 900 ml)« ln 
a parallel feeding, cyclo-(L-T~|Phe-L-S er ) (12.3 mg, 2.99 MCi), in 
dimethyl sulphoxide (l ml), was administered to 8 flasks (total volume, 
800 ml) of the culture growing under the same conditions. Both 
cultures were cropped off and extracted as described in the Experimental 
section. Radioscanning and autoradiography of analytical t.l.c. plates 
of both crude extracts showed that the radioactivity was only detectable 
in the extract derived from feeding the LL-isomer. Moreover, in 
this extract most of the radioactivity was present in bisdethiobis- 
(methylthio)hyalodendrin (17), whilst a smaller quantity was present 
in hyalodendrin (15). The bisdethiobis (methylthio)hyalodendrin from 
both experiments was isolated, purified and crystallised to constant 
activity. It was found that whilst the metabolite (17) isolated 
from the culture fed the LL-isomer contained 15# of the administered 
radioactivity, that isolated from the culture fed the LD-isomer 
contained only 0 M %  of the radioactivity of the precursor. These
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results indicate that cyclo-(L-Phe-D-Ser) is not a precursor in 
hyalodendrin "biosynthesis.
As an alternative to carrying out chemical degradation studies
on doubly labelled bisdethiobis(methylthio)hyalodendrin derived from
3 i£l
cyclo-(L-P+1- HlPhe-L-f3- C^Ser), it was decided to synthesise and
feed cyclo-(L-Phe-DL-f3-^C~lSer^. The metabolite isolated from
such an'-experiment could then be studied by "^C-n.m.r. spectroscopy
which should show whether the label was in the expected position or
27whether it had been Hscrambled" throughout the molecule. Patrick
had synthesised cyclo-(L-Phe-DL-f3-1 C^~1Ser) from DL-^3-1 '^G]serine by
the method described above for the LD-isomer. However, t.l.c. and
^H-n.m.r. spectroscopy of the product showed the presence of two
13compoundss the desired cyclo-(L-Phe-DL-f3- C]Ser) and the unexpected
cyclo-(glycyl-L-phenylalanyl) f~cyclo-(Gly-L-Phe)~1. A sample of the 
13commercial DL-£3~ C]serine, supplied by Prochem, was checked for purity
by "Hi-n.m.r. spectroscopy and found to contain .glycine, Patrick did
27not pursue this line of work any further.
Initially, our attempts were directed to separating unlabelled 
mixtures of cyclo-(L-Phe-L-Ser) and cyclo-(Gly-L-Phe) by preparative 
chromatography on silica gel. Analytical t.l.c. showed that a mixture 
of chloroform, methanol and acetic acid (90:5*5) separated the two 
dioxopiperazines, cyclo-(L-Phe-L-Ser) and cyclo-(Gly-L-Phe) having 
Rf values of 0.22 and O.^ VO respectively. Preparative chromatography 
using the same solvent mixture was then attempted. Again, separation 
was good but recovery of either dioxopiperazine from the silica gel 
required several elutions with methanol. This in turn resulted in 
the extraction of undesirable organic and inorganic impurities off the 
silica gel. Nevertheless, successive crystallisations gave the
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desired dioxopiperazine reasonably pure, albeit with a very low 
recovery. This chromatographic separation was then attempted on the 
mixture of cyclic dipeptides synthesised by Patrick27 from DL-[3-1^G]- 
serine contaminated with glycine. Recovery was again difficult and 
low yielding. More important, however, was the fact that ^C-n.m.r. 
spectroscopy of the mixture of diastereomers of cyclo-(phenylalanylseryl) 
showed that the LD- to LL-isomer ratio had changed from 1:1.5 to 
6.5:1.1 after the chromatographic separation. It seemed that the 
cyclodipeptide was epimerising to the more stable trans-LD-isomer 
during preparative chromatography on silica gel. Since we had already 
established that only the LL-isomer is a precursor in hyalodendrin 
biosynthesis and, since we could not afford to lose 86% of our labelled 
precursor, it was apparent that this separation method would not be 
very fruitful.
It was therefore decided to effect the purification at an earlier
stage. Thus, efforts were directed towards the separation of the two
13amino acids, glycine and DL-[3“ C]serine. After several attempts
using various different conditions on mixtures of the unlabelled
amino acids, it was found that the best method was chromatography
using an acidic ion-exchange resin of very small bead size eluted at
a very slow flow rate with hydrochloric acid. Very good resolution
was obtained under these conditions and the recovered separated amino
acids were crystallised after neutralisation and evaporation of the
appropriate fractions, from aqueous ethanol. The recovered glycine
13accounted for 23^ of the total weight of the commercial DL-^3- C]-
serine sample.
The pure DL-[|3-1^G]serine was converted to its benzyloxycarbonyl
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derivative and then into cyclo-(L-Phe-DL-f3-1-^ ClSer>) "by the procedure 
previously described for the synthesis of cyclo-(L-fU-^ClPhe-D-Ser). 
Crystallisation of the product from methanol afforded three crops. The 
first crop of crystals was found, by "^C-n.m.r. spectroscopy, to have 
an LL:LD-isomer ratio of 1:3* In the second and third crops the
LL:LD-isomer ratio was 3.8:1 and 4.1:1, respectively.
x 1?We were now ready to feed our Hyalodendron culture with the Re­
labelled dioxopiperazine. However, our culture was starting to show 
signs of deterioration. Metabolite production was low and great 
differences in pH and physical appearance (colour, amount of growth,
etc.) were evident among flasks of the same culture batch. However, the
13feeding experiment with the -^-labelled precursor was carried out 
by administering a mixture of the LL- and LD-isomers "spiked” with 
cyclo-(L-fU-^C~]Phe-L-Ser) to the mould culture. The crude extract 
of the culture broth showed great amounts of impurities and dimethyl
sulphone, and very little bisdethiobis(methylthio)hyalodendrin. Indeed, 
after three preparative t.l.c. separations only 4.3 mg of the desired 
metabolite were obtained, far too little to crystallise to constant 
activity, but just enough for "^C-n.m.r. spectroscopy. Inspection 
of the ^C-n.m.r. spectrum (2.6 x 10^ scans at 90.6 MHz - Edinburgh 
n.m.r. service) of the metabolite showed a three-fold enhancement 
of the signal corresponding to the hydroxyl-bearing carbon, with no 
significant enhancement of any of the other signals. The corresponding 
■^C-enrichment, together with the 1^G-enrichment for the administered 
cyclo-(L-Phe-DL-f3-1 C^~]Ser), was used to calculate the dilution of 
the precursor in the biosynthetic transformation (see Appendix).
The calculations showed that in its transformation into bisdethiobis—
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(methylthio)hyalodendrin, cyclo-(L-Phe-L-Ser) suffered a dilution of ^1.
Although these results were very encouraging, the small quantity 
of pure metabolite isolated did not permit a comparison between the 
incorporation and dilution values observed from radioactivity 
measurements with those calculated from the "^C-n.m.r. spectrum. 
Therefore, when a new Hyalodendron culture was available, this 
experiment was repeated. Larger quantities of pure crystalline 
bisdethiobis(methylthio)hyalodendrin were obtained this second time,
thus enabling crystallisation to constant radioactivity and obtention
1? • 13
of a better -"C-n.m.r. spectrum. The C-n.m.r. spectra of natural
13abundance and C-enriched metabolite are shown in Figures la and lb,
respectively. Again, only the signal corresponding to the hydroxyl-
bearing carbon showed an enhancement. The measured enhancement was
3.0 and the dilution calculated therefrom was U o A . The bisdethio-
bis (methyTthio)hyalodendrin isolated from this experiment was
recrystallised to constant radioactivity and found to have a specific
activity of 0.59 pCi/mmol, whereas the precursor had a specific
activity of 21.82 yCi/mmol. Based on these values and on the amount
of pure material isolated, the total incorporation of the labelled
precursor was calculated to be 9 ,7% (minimum value). Moreover, the
dilution of the radioactive precursor was found to be 37» in close
1^
agreement with that measured from the ^C-enrichment. These results 
showed that cyclo-(L-Phe-L-Ser) is incorporated intact into hyalodendrin.
The next objective in our work was to synthesise cyclo-(L-N-Me—Fhe- 
L-Ser) (38), a compound previously unreported in the literature.
Specific monomethylation of cyclo-(L-Phe-L-Ser) did not seem feasible. 
Even when less than one equivalent of methylating agent was used
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FIGURE 1.- "^C-n.m.r. spectra of bisdethiobis(methylthio)hyalodendrin
(a) Natural abundance
(b) From feeding of cyclo-(L-Fne-DL-fj-^CjSer) to Hyalodenaron sp.
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on cyclo-(L-Phe-L-Ala), the NN-dimethylated cyclic dipeptide was
28obtained with no evidence of the mcnomethylated product. Racemisation,
Q-methylation and elimination might also occur on the seryl portion
of cyclo-(L-Phe-L-Ser). Therefore, it was decided to synthesise
the N-methyl dioxopiperazine (38) by the coupling of benzyloxycarbonyl-
L-serine with N-methyl-L-phenylalanine methyl ester hydrobromide,
so that hydrogenolysis of the N-protecting group would release a
primary amino group, necessary for the subsequent cyclization.. It
was believed at the time that cyclization of a secondary amine to
29the desired dioxopiperazine would not proceed readily. 7
N-Methyl-L-phenylalanine methyl ester hydrobromide was synthesised 
by methylation of benzyloxycarbonyl-L-phenylalanine with an excess 
of sodium hydride and methyl iodide in a tetrahydrofuran - dimethyl- 
formamide solvent mixture, followed by acid hydrolysis of the 
benzyloxycarbonyl protecting group, according to the method of 
Coggins and Benoiton.-^ The dicyclohexylcarbodiimide coupling of 
this N-methyl methyl ester with benzyloxycarbonyl-L-serine in the 
presence of triethylamine was attempted twice. In both instances, 
t.l.c. of the crude reaction mixture, after 4 and 24 h, showed 
very little dipeptide formation, but several other unidentified 
side products were observed along with the. unreacted amino acid 
derivatives. Since it was apparent that this route would not easily 
lead to the desired product, a different route was attempted.
The new route involved coupling of N-benzyloxycarbonyl-N-methyl- 
L-phenylalanine with L-serine methyl ester hydrochloride, followed 
by hydrogenolysis of the N-protecting group to give a secondary 
amine which then had to be cyclized to the desired dioxopiperazine (38).
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N-Benzyloxycarbonyl-N-methyl-L-phenylalanine was synthesised by the 
method of McDermott and Benoiton*^ using an excess of sodium hydride 
and methyl iodide on the N-protected amino-acid in tetrahydrofuran. 
Dicyclohexylcarbodiimide coupling of this compound with the L-serine 
derivative proceeded cleanly to give the desired N-benzyloxycarbonyl- 
N-methyl-L-phenylalanyl-L-serine methyl ester. The N-protecting 
group of this dipeptide was removed by palladium on charcoal 
hydrogenolysis in a methanol-acetic acid (85:15) solvent mixture.
Upon complete removal of the acetic acid, the unprotected dipeptide 
cyclized spontaneously to give the desired cyclo-(L-N-Me-Fhe-L-Ser) (38).
This synthetic route was repeated using L-[]3-^C]serine methyl 
ester hydrochloride. Again, coupling proceeded smoothly. Analytical 
t.l.c. of the crude protected dipeptide in two different solvent 
systems, followed by radioscanning of the plates, showed only one 
radioactive band. Removal of the N-protecting group was achieved 
by hydrogenolysis in the same conditions used for the unlabelled 
compound. However, upon removal of the solvent, there was no evidence 
of dioxopiperazine formation. Inspection of the crude hydrogenolysis 
reaction mixture by analytical t.l.c. showed the presence of three 
spots, one of them corresponding to the desired N-methyl dioxopiperazine 
(38). A methanol solution of this mixture was treated with ammoniacal 
methanol to induce cyclization. T.l.c. of the. product of this 
treatment, together with radioscanning of the chromatogram, once 
again revealed the presence of two compounds, one corresponding to 
the desired product (38)* the other being the same as one of those 
observed previous to treatment with ammonia. This unknown compound 
gave a colour reaction to o-tolidine spray (see Experimental) typical 
of dioxopiperazines. However, the ratio of the total radioactivity
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present in this compound to that present in the N-methyl dioxopiperazine 
(38) had nearly doubled upon treatment with ammonia, as shown by radio­
scanning. The two dioxopiperazines were separated by preparative 
t.l.c. on silica gel and both were recovered, but no attempts were 
made to identify the undesired one. -Attempts to crystallise the 
crude recovered cyclo-(L-N-Me-Phe-L-f3- CQSer) were unsuccessful.
This compound can only be recrystallised from methanol - diethyl ether 
mixtures and, in this instance, the presence of traces of silica 
gel carried through from the chromatography,, resulted in gelling and 
inhibition of crystallisation. The crude N-methyl compound (38) 
was dissolved in a known amount of methanol. An aliquot of this 
solution was taken for counting; another aliquot, after evaporation 
of the solvent and redissolution in dimethyl sulphoxide was fed 
to Hyalodendron cultures. A third aliquot was diluted with a known 
amount of unlabelled (38) and crystallised to constant specific 
radioactivity • This permitted calculation of the radiochenrucal purity 
of the precursor fed which was found to be 59»7%» The fact that the 
N-Me dioxopiperazine fed to the mould culture contained a 
high level of other unidentified radioactive impurities must be borne 
in mind for the discussion that follows.
The bisdethiobis(methylthio)hyalodendrin (17) isolated from
14
cultures that had been administered impure cyclo-(L-N-Me-Hie-L-[]3~
Ser) was crystallised to a constant specific activity of 1.00 yCi/mmol. 
The metabolite contained Z.Jfo of the total radioactivity administered 
and the cyclo-(L-N-Me-Phe-L-[3-lZfG]Ser) present in the feeding mixture 
had suffered a dilution of 5.5 in its transformation into (17).
However, these results are highly questionable on account of the
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TABLE 1
Results of incorporations of dioxopiperazines 
into bi sd e t hi obi s(methy1thi o)hyalodendrin (17) 
by cultures of Hyalodendron sp.
Experiment
No.
Precursor
Incorporation
S.A. of (17)
(SO of
(yCi/mmol)
into (17)
1. cyclo-(L-f U-1^ GlPhe-L-Ser>) 3.00 28
2.
3 •]
5.
6.
7.
8.
9.
10.
11. b
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
cyclo-
L-[U-lZfC]Phe-L-Ser)
D-Phe-DL-[3-1^ G]Ser)
L-[U-lZfG]Phe-L-Ser)
L-[U-lZ*C]Phe-D-Ser)
7.95
0.05
1.97
0.06
L-£U-l/fC]Phe-L-Ser) 3.30
L-^U-^CQPhe-L-N-Me-Ser) 0.0006
L-^U-^ClPhe-L-Ser) 
1^ ,
1.97
L-N-Me-Phe-L-[3“ C]Ser) 1.00
L-CU-^GjPhe-L-Ser)
L-Phe-DL-[3-15G]Ser)
0.59
28
0.36
15
0M
L-[4' -3H]Phe-L-[3-l/fC]Ser) 7.60 42
33
0.003
15
2.5
9.7
Precursors administered separately but in parallel
Precursors administered as a mixture
Dilution
27.7
8.3
12.5
28.9
53.5
12.1
26.3
1,5* IQ5
28.9
5.5
37.0
40.4
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uncertainties regarding the real composition of the administered
precursor. Clearly, the synthetic route to cyclo-(L-N-Me-Phe-L-S er)
must "be studied closer and maybe modified for the radiolabelled
synthesis. In retrospect, it also seems that it would be better to 
14
have the C-label at a different position. If the precursor 
were to be dissociated to its constituent amino-acids in the course 
of the biosynthetic experiment, the hydroxyl ^-bearing carbon (C-3) 
of serine would enter the pool and might still be incorporated 
into the metabolite, giving what would be very misleading results.
As it stands, the information obtained from this feeding experiment 
does not allow any conclusions to be drawn on the possible intermediacy 
of cyclo-(L-N-Me-Phe-L-Ser) (38) in hyalodendrin biosynthesis.
27The results of the feeding experiments carried out by Patrick 
and the author on Hyalodendron are summarized in Table 1. It is 
clear that cyclo-(L-Phe-L-Ser) is an efficient precursor for both 
gliotoxin and bisdethiobis(methylthio)hyalodendrin despite the 
antipodal configuration of the sulphur in these two metabolites.
It is possible that biosynthetic introduction of sulphur is preceded 
by a step which destroys the chiral centre correspondingto the cx-carbon 
of the amino acid, perhaps by the formation of an imino-group. 
Nucleophilic addition of a thiol (e.g. cysteine) could then occur 
from either face of the imino-group depending upon the organism.
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CHAPTER 3 
Acetylaranotin
lii Isolation, biological activity and initial biosynthetic studies
Whilst investigating fungi as a possible source of antiviral
compounds, workers at Lilly Research Laboratories isolated five
different metabolites from cultures of Arachniotus aureus (Eidam)
32 33Schroeter. These metabolites comprise what is now known as the
aranotin family of the epithiodioxopiperazines, Three of these possess 
the familiar disulphide bridge: aranotin (^0), acetylaranotin (l6) and
OAc
HO
OAc
RO
(^ 0 )  R = H
’ (1 6 )  R= Ac
.SMe
OAc
AcO
Me S'
SMe
OAc
AcO
MeS
{HZ) (**3)
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a p o a ra n o t in  ( ^ l ) .  The o th e r  two m e ta b o lite s  a re  th e  r e la t e d  b is (m e t h y l -  
t h i o ) - v a r i a n t s : b is d e t h io b is ( m e t h y l th io ) a c e t y la r a n o t in  (BDA) (^ 2) and  
b i  sde t h i  o b i s ( me th y  l t h i  o ) ace t y  la p o a ra n o  t i n  (BDAA) (^ 3).
At about the same time, workers at Lederle Laboratories, A 
Division of American Cyanamid, reported the isolation, from culture 
filtrates of Aspergillus terreus, of two compounds which they designated 
as LL-S§8a and LL-S88(3. Comparison of the chemical and physical 
properties, including X-ray analysis,^ of LL-S88a and acetylaranotin 
(l6) proved these two substances to be identical. Similarly, LL-S88f3 
was found to be. identical with BDA (^ 2).
As already noted briefly for other members of the polythiodioxo- 
piperazine family of metabolites, the presence of the disulphide bridge 
is essential for biological activity. Indeed, neither BDA (^ 2) nor 
BDAA (^ 3) display any antibiotic properties. The other three members 
of the aranotin family [X^O), (16) and (^l)] were effective in 
controlling Coxsackie virus infections in mice when administered 
intraperitoneally at levels of 5 - 8 mg/kg. The LD^q for mice was
36
determined to lie at 35 ~ 50 mg/kg. The three epidisulphide
aranotins were also active, to varying degrees, against several types
36-38
o f  p o l io ,  R h in o - ,  m e a s le s , in f lu e n z a  and p a r a in f lu e n z a  v i r u s .  ^
These th r e e  m e ta b o lite s  a re  d e v o id  o f  any a n t ib a c t e r i a l  o r  a n t i f u n g a l  
a c t i v i t y .  I t  i s  b e l i e v e d ^ ' ^  t h a t  th e  a n t i v i r a l  p r o p e r t ie s  o f  th e s e  
compounds r e s u l t  fro m  t h e i r  a b i l i t y  to  b lo c k  c o m p le te ly  v i r a l  RNA 
s y n th e s is  a t  le v e ls  w h ich  do n o t  a f f e c t  c e l l u l a r  RNA s y n th e s is .
The gross structures of the five aranotin metabolites were assigned 
on the basis of chemical and spectroscopic evidence. The structure 
and relative configuration of acetylaranotin (l6) was also confirmed
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35by X-ray studies. Comparison of the circular dichroism curves of 
acetylaranotin (16) and apoaranotin (4l) with that of gliotoxin (l), 
showed that the configurations of the corresponding, asymmetric centres 
of the three compounds are identical.^ These results were confirmed
4ofrom the X-ray studies done on BDA (42), which revealed that the
absolute configuration of the sulphur-bearing centres, and thus those
of aranotin (40) and acetylaranotin (16), were identical with those
of gliotoxin. Moreover, in apoaranotin (4l), both the oxepin moiety
characteristic of the aranotin family and the cyclohexadienol
characteristic of gliotoxin are present in the same molecule. This
suggests a close biosynthetic relationship between the aranotins and
33 38gliotoxin which has been explained by the intervention of an
arene oxide capable of rapid valence tautomerism to an oxepin ring 
(Scheme V).
Initial biosynthetic studies on the production of BDA (42) by
38Arachniotus aureus were carried out by Neuss and coworkers. They 
found that L-f^CH^^methionine, DL-[]3-^C]serine and DL-p-^C]- 
tryptophan were incorporated quite efficiently into BDA. Zeisel 
degradation of the metabolite (42) isolated from each experiment 
produced radioactive methyl iodide, derived from the S-methyl groups, 
accounting for most of the recovered radioactivity. Moreover, the 
most efficient (6A6% incorporation) and specific (96% in the S-methyl 
group) source of the S_-methyl carbon was found to be methionine.
The effectiveness of methionine as a sulphur donor was demonstrated 
by the authors^ by feeding a mixture of L-^^S^methionine and 
L-Qle-^H]methionine to cultures of A. aureus. The BDA derived from 
this experiment contained higher amounts of H (11.3% incorporation)
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OH
V
OH
Scheme V
35than of S (2.77%)» thus indicating that an intact S-methyl group was
probably not transferred to the dioxopiperazine ring system. Both 
l^fL- and D-[jL- C]phenylalanines were incorporated into BDA with 
similar efficiency (3.15 and 2AZ% respectively), but no attempts 
were made to locate the position of the label.
^1
Investigations carried out later by another group, showed that 
1£l
DL-[3- G]phenylalanine is a more efficient precursor for BDA in 
A. aureus than DL-^-^Gj-m-tyrosine and DL-3'^ ’-dihydroxy-p-^G]-
89
phenylalanine. These results agree with the findings of Bu'Lock and 
if2
Ryles that phenylalanine, hut not o^ or m-tyrosine or 2' ,3'“dihydroxy- 
phenylalanine, is incorporated into gliotoxin (l) by T. viride.
Feeding a mixture of DL-[3-lifG]phenylalanine and DL-[2'-3H]phenyl- 
alanine to A. aureus gave BDA (^ 2) which contained 7.0^ and 3 . 67% 
of the radioactivity administered as and -^H, respectively.^1 
This demonstrated that the tritium in the ortho position of the
phenyl ring is largely retained in BDA. These results were confirmed
^1 2 and expanded by feeding fully C-deuteriated ( Hg) DL-phenylalanine
to Aspergillus terreus, which is a good source of acetylaranotin (l6).
The deuterium content of the isolated acetylaranotin was determined 
by mass spectrometric comparison of the proportions of the dominant 
(M+- 2S) ions in natural abundance and deuterium-labelled acetylaranotin. 
The latter was found to contain large amounts of and
species. It was, therefore, concluded that [] Hg]phenylalanine had 
contributed to both halves of the symmetrical acetylaranotin molecule, 
with loss of only one deuterium atom, presumably from the a-position.
The (7 Hrjacetylaranotin formed could be accounted for by concurrent 
incorporation of endogenous, undeuteriated, phenylalanine and 
deuteriated precursor. In connection with similar work being carried 
out in gliotoxin biosynthesis, Johns et_ al. pointed out that the 
mass spectrum of the acetylaranotin isolated from the DL-£^Hg^phenyl­
alanine feeding also showed conspicuous fragment ions attributable 
to the loss of one deuterium in each half of the molecule. These 
authors^ confirmed their observations by administering DL-Q3'»3'“ H^ ,
1* -1^ C ] p h e n y l a l a n i n e  to cultures of A. terreus and isolating acetyl­
aranotin that showed, by mass spectrometry, substantial loss of one
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methylene deuteron. It seems, therefore, that the biosynthesis of 
acetylaranotin proceeds without obligatory loss of hydrogen from 
either the methylene or the phenyl group of phenylalanine.
The results obtained to date on the biosynthesis of the aranotins, 
when taken together with results obtained in studies of gliotoxin 
biosynthesis, strongly suggest that cyclo-(L-Phe-L-Phe) is a 
precursor for all the members of the aranotin group. This hypothesis 
has been tested by the author and is discussed in Section 3*3.
3.2 Synthetic attempts
Although the syntheses of several complex sulphur-containing 
dioxopiperazines have been reported in the literature, none of the 
members of the aranotin family have been -synthesised, probably owing
to the added difficulty introduced by the presence of the oxepin
L\L\.
ring. Goffen and coworkers, at Hoffman-La Roche, synthesised 
the aromatic analogues (44) and (45) in the hope that the dihydro- 
oxepin ring might not be crucial to the biological activity of the . 
aranotin series* However, when tested in mice, both compounds 
failed to show any antiviral activity.
(44) n s 2
(45) n s 3
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3*3 Biosynthesis
Our studies on the biosynthesis of acetylaranotin were carried
out on Aspergillus terreus. The growth conditions used led to the
production of BDA (42) as the major metabolite. BDAA (43) was the
next most abundant metabolite isolated. As discussed previously for
hyalodehdrin, results obtained with EDA (42) should also hold true for
acetylaranotin (16). BDA and BDAA were isolated from culture broth
extracts and separated by means of two successive preparative thin
layer chromatographies (see Experimental section). Generally, BDA
was obtained in a highly pure crystalline state, but the BDAA isolated
always contained some BDA, since the two could not be well resolved
in any chromatographic system tested. In a typical run, ca. 10 mg of pure
crystalline BDA were obtained per litre of mould culture. The melting
point, mass and ^H-n.m.r. spectra of the isolated BDA agreed with
32 34the data reported in the literature. '
The various cyclo-(Phe-The) stereoisomers used in our work were 
synthesised by dicyclohexylcarbodiimide coupling of the relevant benzyloxy- 
carbonyl and methyl ester hydrochloride derivatives of phenylalanine, 
followed by hydrogenolysis of the N-protecting group and cyclisation 
of the resultant dipeptide with saturated ammoniacal methanol. Since 
the methyl ester hydrochloride derivative of phenylalanine can be 
obtained in higher chemical yields than the benzyloxycarbonyl derivative, 
the labelled phenylalanine or the more expensive of the two labelled 
phenylalanines, was converted into its methyl ester hydrochloride 
derivative•
Feeding experiments were carried out by administering the cyclic
dipeptid.es dissolved in dimethyl sulphoxide to three-day old cultures 
of the mould. Due to the low solubility of the cyclic dipeptides 
administered, relatively large volumes of dimethyl sulphoxide (up to 
1 ml/100 ml culture) had to be used. Nevertheless, the organism did 
not seem to be affected by the amounts of solvent administered. The 
final pH value of the culture broth and the yield of metabolite isolated 
from cultures that had been fed dimethyl sulphoxide (l ml/lOO ml 
culture) were comparable to those obtained from unfed cultures. Moreover, 
in contrast to what was observed in Hyalodendron sp., A. terreus seems -to 
reduce most of the administered dimethyl sulphoxide to dimethyl sulphide. 
Since the mould is grown at 28 - 30°C, most of this compound evaporated 
as it formed. Nevertheless, the organic extract of the culture broth 
was washed with water to remove residual dimethyl sulphoxide.
After the feeding experiments involving radioactive precursors 
had been concluded, the A. terreus cultures started to show signs of 
deterioration, as demonstrated by a decrease in the yield of 
metabolite and the appearance of a yellow pigment in the culture broth. 
Upon thorough investigation, we discovered that there were two major 
factors leading to this deterioration. Firstly, following suggestions 
of the suppliers of our mould culture, tomato paste-oatmeal agar slants 
were being used for the continuous propagation of the mould culture.
Since the production of the yellow pigment was already observable at 
this stage, other agar systems routinely used for mycological 
purposes were investigated, namely malt, potato dextrose and Czapek-Dox 
agar. Of these, Czapek-Dox agar slants gave the best growth and the 
minimum production of the undesired yellow pigment. Successive 
subculturing of the fungus on these slants resulted in the total 
disappearance of the pigment. The second factor was that, for
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s e v e r a l  m onths, th e  fe rm e n ta t io n  s ta g e  o f  th e  fu n g a l g ro w th  was 
c a r r ie d  o u t u n d e r 2h h o f  a r t i f i c i a l  i l lu m in a t io n ,  because c u ltu r e s  
o f  o th e r  f u n g i  b e in g  grown c o n c u rre n t ly  had th e s e  l i g h t  re q u ire m e n ts • 
S ince  th e  t im in g  o f  t h i s  a d d i t io n a l  i l lu m in a t io n  seemed to  c o in c id e  
w ith  th e  d e t e r io r a t io n  o f  A. t e r r e u s ,  th e  amount and k in d  o f  i l l u m in a t io n  
was r e s t r i c t e d  to  n o rm a l d a y l ig h t  h o u rs . We had a lr e a d y  o bserved  t h a t  
t o t a l  e x c lu s io n  o f  l i g h t ,  by w rap p in g  th e  c u l tu r e  f la s k s  i n  b la c k  
p l a s t i c , l e d  t o  a  d e c re a s e  in  m y c e l ia l  g ro w th . Thus, th e  use o f  C zap e k -  
Dox agar  s la n t s  and o f  norm al d a y l ig h t  hours i l lu m in a t io n  d u r in g  th e  
fe r m e n ta t io n  s ta g e , re tu rn e d  th e  c u l tu r e  to  i t s  p re v io u s  n o rm a l, c le a n ,  
p ro d u c t iv e  b e h a v io u r .
I n  th e  in t e r v e n in g  t im e , i n  case our A. te r r e u s  c u l tu r e s  d id  n o t  
r e c o v e r ,  we t r i e d  to  g e t  c u ltu r e s  o f  Amauroascus aureus  (p r e v io u s ly  
known as A ra c h n io tu s  a u re u s ) in t o  p ro d u c tio n . The g ro w th  c o n d it io n s  
f i r s t  used w ere th o s e  d e s c r ib e d  i n  th e  l i t e r a t u r e  f o r  A ra c h n io tu s  
a u re u s , i n  w h ich  th e  m ain carbon source i n  th e  fe r m e n ta t io n  medium is  
m o la s s e s . I n  s p i t e  o f  two s u c c e s s iv e  s t e r i l i z a t i o n s  o f  th e  c u l tu r e  
medium a t  2 ^  h i n t e r v a l s ,  th e  fu n g a l c u ltu r e  was c o n ta m in a te d  w ith  
la r g e  am ounts o f  b a c t e r ia ,  m o s tly  c o c c i, and m y c e lia l  g ro w th  was v e ry  
p o o r. No s u lp h u r -c o n ta in in g  m e ta b o lite s  co u ld  be d e te c te d  w ith  s i l v e r  
n i t r a t e  s p ra y  r e a g e n t  (se e  E x p e r im e n ta l s e c t io n )  on chrom atogram s o f  
c u l tu r e  b r o th  e x t r a c t s .  N e x t, th e  g row th  c o n d it io n s  used f o r  A. t e r r e u s  
w ere t r i e d  w ith  Amauroascus a u re u s . No b a c t e r i a l  c o n ta m in a tio n  was 
o bserved  t h i s  t im e , b u t  m y c e lia l  g ro w th  was s t i l l  poor and no s u lp h u r -  
c o n ta in in g  m e ta b o lite s  w ere p ro d u ced . T h is  g ro w th  medium i s  a  much 
" p o o re r” medium th a n  th e  one suggested  f o r  A ra c h n io tu s  a u re u s , b u t  
s in c e  th e  l a t t e r  i s  so " r ic h "  t h a t  b a c t e r ia l  c o n ta m in a tio n  is  a lm o s t  
i n e v i t a b l e ,  we s e t t l e d  on a  compromise betw een th e  tw o . Growth was
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initiated on the A. terreus medium and on the fifth day, when mycelial 
growth was well on its way, each culture flask.was supplemented with 
some "rich medium and grown for a further three days • This resulted 
in some production of BDA (42) and BDAA (43), as shown hy "hi-n.m.r. 
spectra of the crude hroth extract. The first feeding experiments 
involving stable isotopes (vide infra) were carried out in a culture 
of Amauroascus aureus grown in this manner.. Unfortunately and for 
reasons unknown, although mycelial growth was good, there was no 
metabolite production. It was at around this time that the A. terreus 
cultures started to show signs of recovery and, therefore, all work 
on Amauroascus aureus was abandoned. Thus, in the end, all feeding 
experiments were carried out using A. terreus cultures.
The efficiency of A. terreus in producing BDA (42) was evaluated
by feeding L-Qj-^C]phenylalanine to the mould culture. Figure 2 shows
an autoradiogram obtained from a t.l.c. plate of the crude culture
broth extract from this feeding; most of the radioactivity is
distributed between the major metabolites, BDA and BDAA. The isolated
pure BDA (42) accounted for 10.1% of the radioactivity administered.
14Since no feeding of [ C]phenylalanine to A. terreus has been reported, 
this result cannot be compared to any literature value. However, 
feedings of L-[l-lZfC]phenylalanine^ and DL-[3-1^ C]phenylanine^1 to the 
closely related organism Arachniotus aureus gave comparable, albeit 
lower, incorporation values.
We were now ready to test whether cyclo- (L-Phe-L-Phe), rather 
than cyclo-(D-Phe-D-Phe) or cyclo-(L-Phe-D-Phe), served as a precursor 
for BDA in A. terreus. A solution of cyclo-(L-CU- CQPhe-L-Phe) (32.9 
mg, 4.87 yCi) in dimethyl sulphoxide (19 ml) was distributed among 24 
flasks of A. terreus culture (total volume, 2.4 l). After three days
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FIGURE 2.- Feeding of L-£U- CJphenylalanine to Aspergillus terreus. 
Autoradiogram of t.l.c. plate (silica gel; isopropyl ether - chloroform ■ 
acetic acid, 6:3:1): (a) Total crude extract of culture broth at end 
pH (7.2); (b) Total crude extract of culture broth after acidification
to pH 3.
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growth, analytical t.l.c. plates of the crude broth culture extracts
in several solvent systems, were scanned for radioactivity and submitted
to autoradiography. Only the bands corresponding to BDA, BDAA and
cyclo-(L-Phe-L-Phe) were found to be radioactive. The crude extracts
were chromatographed and the BDA isolated was re crystallised to constant
radioactivity. Attempts to recover the cyclic dipeptide from the crude
culture broth extracts were unsuccessful due partly to the strong
adsorption of the compound on to the silica gel used for chromatography
and partly to its low solubility in most organic solvents. Attempts
to recrystallise the isolated BDAA were also unsuccessful, owing to
the small quantities of compound available and to its contamination
with BDA. The pure BDA was found to have a specific activity of 9.5^
yCi/mmol, whereas the precursor had had a specific activity of ^3*5 yCi/mmol.
Based on these values and on the amounts of material isolated, the
1^minimum value for the total incorporation of C- labelled precursor 
was calculated to be 19.9% and the dilution of cyclo-(L-fU- C]Fhe-L- 
Phe) in its transformation into BDA was ^.6.
I kOwing to the commercial unavailability of C-labelled D-phenyl- 
alanine, the two other diastereomers of cyclo-(Phe-Phe) were synthesised 
together from D-phenylalanine and DL-£l-^C]phenylalanine as a k :6  
mixture (determined by "Si-n.m.r. spectroscopy) of cyclo-(D-Fhe-D- 
[l-^CjPhe) and cyclo-(D-Phe-L-Cl-^GjPhe). A solution of this mixture 
in dimethyl sulphoxide was administered to A. terreus cultures.
Measurement of the radioactivity of the culture broth extract and of 
the aqueous residue accounted for 61% of the administered radioactivity, 
thus indicating that the remainder must be in the mycelium and hence, 
that there had been no ce 11-wall permeability problems. Radioactive 
scanning of t.l.c. plates of the total culture broth extract showed
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that most of the radioactivity was associated with the bands 
corresponding to the two diastereomeric cyclic dipeptides. The BDA 
isolated from this extract was crystallised to a constant specific 
activity of 0,22 yCi/mmol. Using the total weight of pure metabolite 
isolated and the specific activity of the precursor (20.73 PCi/mmol), 
the minimum incorporation of the cyclo-(Phe-Phe) diastereomers into 
BDA was"calculated to be 0 .%  and the dilution value was 9^ .
From the results discussed above (Table 2, Experiments 2 and 3)» 
the incorporation of activity into BDA (^ 2) is strikingly dependent 
upon the stereochemistry of the precursor. Of the three possible 
stereomers of cyclo-(Phe-Phe) only the LL-isomer is incorporated 
efficiently. This finding closely resembles those obtained for 
gliotoxin^ and hyalodendrin (Chapter 2)* The small incorporation 
of radioactivity from the (DD + DL)-mixture might have arisen from 
cleavage of the cyclodipeptide followed by incorporation of 
phenylalanine.
The next point to be tested was the possibility that cyclo-(L-Phe- 
L-Phe) might not be a normal biosynthetic intermediate, but rather 
that it underwent some structural modification in the organism prior 
to entry into the normal pathway. Therefore, the status of cyclo-(L- 
Phe-L-Phe) as a natural intermediate was tested by means of an 
'‘intermediate-trapping” experiment. Non-radioactive cyclo-(L-Phe-L-Phe)
1^ -1was incubated with A. terreus and, 2 h later, L-^U- CJphenylalanine 
was added to the medium. After a further 2 h, the organism was 
harvested and the culture extracted with chloroform. The extract was 
concentrated and cooled to 0°C, and the solid that separated was 
found to be cyclo-(L-Phe—L-Phe) by comparison with an authentic 
sample (melting point, ^H-n.m.r. spectroscopy). The cyclic dipeptide 
was re crystallised to constant radioactivity and found to contain 10o^ &
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TABLE 2
Results of incorporations of radioactive precursors 
into bisdethiobis(methylthio)acetylaranotin (BDA) 
(^2) by cultures of Aspergillus terreus
Incorporation
Experiment S.A. of (^ 2)
Precursor (%) of G
No. (yCi/mmol)
into (^ 2)
"1^
1. L-[]U- C] phenylalanine 62.99 10.1
2. cyclo- (L-T U-l/f GlPhe-L-Phe) 9.5^ 19*9
3. cyclo-(D-Phe-DL-[l-lZfG]Phe) 0.22 0.5
4. cyclo-(L-T^1 -3HlPhe-L-C3-llfG]Ser) - l . f
Dilution
a  1 * to3
^.6
9^
a Refers to the mixture of BDA (42) and BDAA (43).
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of the total radioactivity administered as L-Qj—^C[]phenylalanine. 
cyclo-(L-Phe-L-Phe) had, therefore, been formed from phenylalanine 
and was presumably present in the organism under normal conditions 
of growth.
Our attention was v then directed to investigating the c l a i m ^  
that A. terreus is also a gliotoxin (l) producer. Although we had 
never detected any gliotoxin in our culture broth extracts, it 
was possible that the compound was there, but in amounts too low 
to permit chromatographic detection. Therefore, cyclo-(L-TV-^HlPhe- 
L-£3“^C]Ser) (^H/^C, 13.1), a known gliotoxin precursor,^ was 
administered to our cultures of A. terreus to increase the sensitivity 
of detection of any gliotoxin present. However, radioactive scanning 
of chromatograms of the total crude extract obtained from this 
experiment did not show any radioactivity corresponding to gliotoxin.
In fact, the only radioactivity detected was present in the bands 
corresponding to BDA and BDAA, and in the baseline of the chromatogram. 
After chromatographic purification, the mixture of BDA and. BDAA was 
recrystallised to constant radioactivity. Attempts to obtain gliotoxin 
from the extract by chromatography were fruitless. The baseline 
of the chromatograms was found to contain a complex mixture of polar 
material and was not investigated further. The pure crystalline 
material, corresponding to a mixture of BDA and BDAA was found to 
have a ^H:^C ratio of 50.8, corresponding to total incorporation 
values for and lZfC of 5.5 and 1.5%, respectively. This seemed 
to indicate that the cyclo-(L-f~V -3H]Phe-L-[3-1^G]Ser) ha/i been 
cleaved by the organism into L-[V -Vjphenylalanine and L-[3-lZfG]serine. 
The phenylalanine, after dilution with endogenous material, was then
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in c o r p o r a te d ,  w i t h  an i n t a c t  carhon s k e le to n , in t o  BDA i n  th e  u s u a l  
way* The s e r in e ,  how ever, h a v in g  no d i r e c t  r o le  i n  BDA " b io s y n th e s is , 
passed in t o  th e  m e ta b o lic  C ^ -p o o l, l a t e r  to  ap p e ar i n  th e  S -m e th y l 
groups and a c e ta te  p o r t io n s  o f  BDA and BDAA. No a tte m p ts  w ere made 
to  c h e m ic a l ly  d eg rad e  th e  is o la t e d  m e ta b o lite s  to  c o n firm  t h i s  h y p o th e s is ,  
b u t no o th e r  p la u s ib le  e x p la n a t io n  co u ld  be found  to  a cc o u n t f o r  th e  
r e s u l t s  O b ta in e d . The purpose o f  t h is  e x p e rim e n t was to  in v e s t ig a t e  
th e  a l le g e d  p ro d u c t io n  o f  g l io t o x in  by A. te r r e u s  and th e  o n ly  
c o n c lu s io n  t h a t  may be drawn i s  t h a t  o u r c u ltu r e s  o f  A. t e r r e u s  a re  
n o t  g l i o t o x i n  p ro d u c e rs .
A more im p o r ta n t  outcome o f  t h i s  e x p e rim e n t i s  t h a t  i t  poses  
th e  q u e s t io n :  i s  c y c lo - (L -P h e -L -P h e )  a ls o  b e in g  c le a v e d  by A. t e r r e u s  
in t o  tw o p h e n y la la n in e  u n i t s  w hich  a re  th e n  r e in c o r p o r a te d  in t o  th e  
m e ta b o lite ?  I n  o th e r  w ords, i s  c y c lo - ( L -P h e -L -P h e ) in c o r p o ra te d  in t a c t  
i n  i t s  b io s y n th e t ic  t r a n s fo rm a t io n  in t o  BDA? Because o f  th e  sym m etry  
o f  th e  p r e c u r s o r ,  th e  u s u a l means o f  t e s t in g  f o r  t h i s  p o s s i b i l i t y ,  
n am ely , u s in g  a  , ^ C - l a b e l l e d  p re c u rs o r , i s  n o t  f e a s i b l e .  C leavag e  
o f  th e  c y c l ic  d ip e p t id e  w ould le a d  to  ^H - and ^ C - l a b e l l e d  p h e n y la la n in e ,  
in d is t in g u is h a b le  to  th e  o rg an ism , w hich  co u ld  th e n  m ix  w ith  
endogenous u n la b e l le d  p h e n y la la n in e , to  g iv e  u l t im a t e ly  a  m ix tu r e  o f  
and ^ C - l a b e l l e d  BDA in  a  r a t i o  i d e n t i c a l  to  th e  i n i t i a l  ^ H s ^ C  
r a t i o  o f  th e  p r e c u r s o r . T h e r e fo r e , i t  was n e c e s s a ry  to  f in d  a  way o f  
l a b e l l i n g  th e  p re c u rs o r  t h a t  would r e v e a l  any b reakdow n. C y c lo -C L - T ^ l f l -  
p h e - £ l - 1 *^C]Phe) was d e c id e d  upon s in c e  i t  was hoped t h a t  c le a v a g e  o f  
1 ^ C -1^N bond w ould  be e v id e n t, fro m -lo s s , o f  1^C1 ^ N -c o u p lin g  i n  th e  
^ C -  n .m . r .  spectrum  o f  th e  d e r iv e d  m e ta b o li te .
13
Once a g a in ,  th e  com m erc ia l u n a v a i l a b i l i t y  o f  L - £ l — C []p h e n y la la n in e
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meant, that the pure LL-isomer could not he made. However, since it 
had already "been established (vide supra) that the LD-isomer is not 
incorporated significantly into BDA, its presence should not present 
any problems. Thus, a 53:^7 mixture of cyclo-(L-f1 VlPhe-L-Tl-1 VlPhe) 
and cyclo-(L-f^NlPhe-D-TI-^ClFhe) was synthesised and fed, mixed 
with cyclo-(L-£U-^C]Phe-L-Phe) in an amount equivalent to the ^^C,^N- 
labelled LL-isomer, to A. terreus cultures. The BDA isolated from 
this experiment was recrystallised to constant specific activity.
The amount of total radioactivity incorporated into the pure crystalline 
BDA was calculated to be and the total cyclo-(L-Phe-L-Phe)
administered had undergone a dilution of 6.0 in its transformation 
into BDA.
Figure 3 shows the ^C- n.m.r. carbonyl signals of natural 
abundance and ^ G , 1^N -enriched BDA. The lower fiEld signal corresponds 
to the acetate carbonyl, whilst that at 6 16^.^ ppm corresponds to 
the amide carbonyl in the dioxopiperazine moiety. The amide carbonyl 
signal of ^C^^N-enriched BDA shows two satellites due to a 
one-bond coupling, J ™  13 Hz. No other differences were discernible
NMe
OHMeN
NMe
(46)
102
BDA
*'N
AcO 13] OAc
M c£
NATURAL ABUNDANCE ENRICHED
v u
& 164-4
FIGURE 3.- C-n.m.r. spectra (carbonyl region) of 
bisdethiobis(methyltnio)acetylaranotin.
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tetween the spectra of natural abundance and enriched BDA. Brewer
et al. determined the structure of chetomin (^ 6), another epidithio-
13 1*5
dioxopiperazine, by C- and N-spectroscopy. They reported one- 
bond coupling constants of 1^.6 and 13.7 Hz for and 2,
respectively, and a two-bond ^N— "^G coupling constant of 3 Hz for 
y  Thus, the value obtained for BDA is in good agreement 
with the only close enough example that could be found in the literature. 
No efforts were made to pick out two-bond couplings in our spectrum, 
since they would probably be very small and would not give any new 
additional information.
In the discussion that follows, we shall; refer to the intensity 
of only the central peak of the triplet of Figure 3* No quantitative 
comparison involving the two outer satellite peaks can be made, since
the nuclear Overhauser effects and spin-lattice relaxation times
13 15 1^for C are different when bonded to N and N. All that may be
said about them is that they arise from a BDA molecule that has a
13 15C-labelled carbonyl group directly bonded to a N atom. The central
13peak, in turn, arises from a C-labelled carbonyl group directly
14 13bonded to a N atom. Whether the -'C-content in this carbonyl group
is derived partly from [l-1^C]phenylalanine resulting from cleavage
of the administered cyclodipeptide is the crux of the experiment.
In the natural abundance spectrum of BDA the ratio of the heights
of the acetate and amide peaks was found to be 1.37 • This value was
13
corroborated with similar measurements on other C-n.m.r. spectra 
of natural abundance BDA, recorded at different times, but using the 
same experimental conditions. Inspection of the relative heights of 
the acetate and amide peaks in the spectrum of the enriched BDA, 
reveals that the situation here is very different, the central amide
10^
peak "being larger "than the acetate peak. Using "the height of the
acetate peak in this spectrum (6.^5 cm) and the 1.37 value previously
calculated, the height of the peak expected from exclusively a natural 
13
abundance C-contribution can be calculated to be ^.71 cm. Yet, 
the measured height of the amide.peak was 8.^0 cm. How can this 
discrepancy of 3.69 cm be accounted for? First, there will be a 
contribution to the total measured height arising from overlap with 
the flanking peaks resulting from "^C-^N coupling. The contribution 
due to this overlap to the total measured height of the central peak 
can be estimated to be 1.30 cm. Second, the administered precursor 
contained a certain amount of species having "^C-labelled carbonyl 
groups not directly bonded to ^N-atom. These arise from several
sources. Importantly, the ’doubly-labelled* precursor was synthesised
15 13from £ N]phenylalanine and [1- C]phenylalanine containing only 96.5%
and $1.0%, respectively, of labelled molecules and, clearly, some
,^ N]cyclodipeptide must be formed in the synthesis. Further,
13account must be taken of the C present at natural abundance both 
in the E^tTJphenylanine used in the synthesis and in the Q^C]cyclo- 
dipeptide added to the precursor mixture to provide an independent 
measure of dilution.
It was therefore necessary to calculate the abundance of each 
species in the cyclo-(L-Fhe-L-Fhe) fed to A. terreus. Table 3 lists 
the ten possible isotopic combinations in the cyclodipeptide mixture 
administered and the percentage abundances calculated (see Appendix) 
for each species. It is necessary,now to consider which of these ten 
species will contribute to the central amide carbonyl peak in the 
spectrum of 1^G,1^N-enriched BDa , that is,those species not
1? 15containing a C atom directly bonded to a N atom.
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TABLE 3
Comparison of the mixture of cyclo-(L-T1-VlPhe-L--[l-:L3c~|Fhe<) 
and cyclo-(L-fU-^ClPhe-L-ihe )»
(a) As fed to Aspergillus terreus
(b) As calculated for random recombination
A
B
C
D
E
F
G
H
I
J
SPECIES
15----
13.----
15----
13----
13-
15- 
13*
13-
13-
15-
15*
13-
13
15
15
13
15
13
15
PERCENTAGE ABUNDANCE
(a) 00
46.87 13.04
4.9 7 25.25
2.69 24.32
0.52 0.19
0.17 0.14
44.66 23.54
0.06 0.36
0.02 6.28
0.02 6.77
0.002 0.001
Notation used: (i) a dash stands for phenylalanine, (ii) two
dashes stand for the cyclodipeptide, (iii)numbers indicate.1^  or 1-*N;
12 14where no numbers are given C or N is implied. Thus,
15-
13-
stands for
Ph
Ph
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Inspection of the Table shows that only species C, D, G, and H fulfil
this requirement. However, the ^C-n.m.r. signal that would be
obtained from species D and G will be split by a two-bond 1^C1^N-
coupling and will not lie on top of the central amide peak, therefore
these two species may be discarded. From the sum of the relative
abundances of species G and H, and with the help of the dilution
value £6.0), obtained independently by means of the '^C-tracer (vide
supra) t the expected height for the amide peak including the 1^C-
contribution due to precursor can be calculated (see Appendix) to
be 5.89 cm. If we add to.this calculated value the correction due
to overlap (1.30 cm) of the satellite peaks, we obtain a height of
7.19 cm, which still leaves a discrepancy of 1.21 cm on comparison
with the peak height, measured directly from the spectrum (8.^0 cm).
This residual discrepancy may lie within the limits of error
of the various measurements. However, dissociation of the doubly-
labelled precursor would also lead to enhancement of the central
peak. This possibility must be considered quantitatively since it
is central to the purpose of the experiment. In the following
calculation it is assumed that the precursor molecules dissociate
1^
and recombine without any dilution by endogenous \_ NJ-species.
That is, we shall calculate the maximum dissociation needed to
account for the additional height of the central amide peak. Any
l^f
additional recombination with, for example, endogenous Q N^phenyl-
13 l^falanine would increase the amount of G, N-labelled product and 
decrease the percentage dissociation needed to explain the discrepancy• 
Dissociation of the precursor, having the composition given in 
Table 3» and recombination of the separate halves at random would
9
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recreate the same ten species initially present, hut this time the 
percentage abundance of each species would be altered. The calculated 
outcome is shown in Table 3» However, a brief inspection of "^C—n.m.r. 
spectrum of the enriched BDA (Figure 3) indicates that there could be 
only partial dissociation of the cyclodipeptide. Had there been 
complete dissociation, the heights of the ^C"^N—satellites would be 
very small relative to the height of the central peak since the 
singly-labelled £ ^G,^N]-precursor would be a major species. It is 
now possible to calculate the maximum extent of dissociation needed 
to account for the extra height of the central amide peak. Using the 
same arguments as before, only species C and H need be considered.
In the cyclodipeptide mixture resulting from complete dissociation 
and random recombination, these two species have increased considerably 
in abundance. The abundances of the species G and H, together with 
dilution value (6.0) and the height of the central peak measured 
from the spectrum (7*10 cm, after correction for satellite overlap), 
can be used to calculate (see Appendix) the maximum extent to which 
the dissociation-recombination process might have occurred. As a 
result, it can be said that the residual discrepancy of 1.21 cm 
in the height of the central amide peak may be accounted for by 5*0% 
dissociation of the initial LL-precursor fed. Therefore, the 
answer to the initial question:- "Is cyclo-(L-Phe-L-Fhe) incorporated 
intact in its biosynthetic transformation into BDA?", is: "Yes, 
a minimum of 95% of the LL-precursor fed is incorporated intact."
The next point to be investigated concerned the fate of the 
methylene protons of cyclo- (L-Fhe-L-Fhe) in its transformation into
Zj, 3
BDA (^2). There was evidence in the literature suggesting that there
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might, he some non-obligatory loss of a methylene deuteron during 
incorporation of DL-£3i3~ f^l- ^G]]phenylalanine into BDA. However, 
it was not clear whether the deuterium atom was lost from the amino- 
acid itself or from some other intermediate along the biosynthetic 
pathway leading to BDA. Since structures such as ( 7^) can be suggested 
for intermediates involved in the introduction of sulphur, it was
W )
desirable to confirm, or disprove, the earlier conclusions using a 
different precursor. Accordingly, we decided to feed cyclo-(L-T3.3- 
Phe-L-£3»3“^H2-I^e) —• ^erreus t0 examine, by mass spectrometry,
the deuterium content in the isolated BDA.
The tetradeuteriated LL-cyclodipeptide may be synthesised, by 
the general method discussed previously, from L-[3*3" ^^phenylalanine. 
However, since it is easier to synthesise racemic £3»3“*TtJPkenyl- 
alanine and since we already knew that the DD- and DL-cyclodipeptides 
were not incorporated efficiently into BDA, it was decided to synthesise 
the desired tetradeuteriated cyclodipeptide as a mixture of the three 
possible stereoisomers. This was achieved by refluxing a solution 
of DL-£3,3-2H2]phenylalanine in ethylene glycol, which gave a 
statistical mixture (1:2:1) of the LL-, LD- and DD-cyclodipeptide 
isomers.
EL-[3,3-2H2]Phenylalanine was synthesised, by slight modifications
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of literature procedures from fformyl-Vlbenzaldehvde. The
synthetic route involved a Gannizzaro reaction of the ^H^Jbenzaldehyde
to give ("methylene- H^tenzyl alcohol, which was then converted into
fmethylene-^H^lbenzyl chloride and thence into the correspondingly
dideuteriated acetamidomalonate derivative. Hydrolysis of the latter
yielded the desired amino-acid. Mass spectrometry analysis of the
dideiiteriated diethyl acetamidomalonate showed that the percentage 
2 2abundances of £ an,d- E H^-species were, respectively, 51 »0
and 3^ .976. The results arise from the fact that the deuterium 
content in the £ H^benzaldehyde was less than 100%, Accordingly, 
mass spectrometry of the tetradeuteriated cyclodipeptide revealed, 
as shown in Table that the most abundant species was that
containing three deuterium atoms. In the ideal experiment, an 
abundance greater than $0% for the [^H^]-species would simplify 
considerably the analysis of the results obtained from feeding 
experiments. Nevertheless, the £ H^-content was adequate for our 
purpose, as will be demonstrated later.
A solution of cyclo-(DL-|~3> 3-^Ho~lFhe-DL-f3,3~ H^^ ~]Phe), mixed
with cyclo-(L-fU-^ClRie-L-Phe) in an amount equivalent to the
deuteriated LL-cyclodipeptide, in dimethyl sulphoxide, was fed
to A. terreus cultures. Radioactivity measurements of the isolated
BDA, after it had been recrystallised to a constant specific activity
14
of 3.00 yCi/mmol, revealed that 18.57& of the C-label had been 
incorporated and that the total LL-cyclodipeptide administered had 
suffered a dilution of 7 A  in its transformation into BDA. Analysis 
of the deuterium composition of the QM --SCH^ ]] fragment ions 
observed in the mass spectra of the isolated BDA, gave the distribution 
shown in Table 5« The fact that [^H^BDA was present, in an amount
11.0
TABLE 4
Composition of synthetic cyclo-(DL-T3.V 2H.]Phe-TlT,-(;, i J v  ]Pha)
SPECIES PERCENTAGE ABUNDANCE
2
Hq 4.68 ± 0.40
\  10.68 ± 0.24
^  28.04- ± 0.20
^  38.45 ± 1.46
\  18.14 ± 1.94
TABLE 5
Composition of [M - SMe]+ fragment ion of BDA:
(a) isolated from feeding experiment
(b) calculated from precursor composition
SPECIES PERCENTAGE ABUNDANCES
(a) 00 (a) - (b)% 91.04 ± 0.29 86.74 ± 2.84 +4.30 ± 2.85
2% 1.55 1 0.23 1.80 ± 0.04 -0.25 ± 0.23
2*
2 1.51 ± 0.16
3.80 ± 0.03 -2.29 ± 0.16
3
4.43 ± 0.18 5.21 ± 0.02 -0.78 ± 0.27
4
1.47 ± 0.11 2 .46 ± 0.26 -0.99 ± 0.28
2
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greater than the calculated (see Appendix) experimental error, 
indicates that deuterium loss is not an obligatory process for the 
biosynthesis of the metabolite. If this had been the case, no
p
C H^]-species would have been detected.
Of course, no direct comparison may be made between the abundance 
of each species in precursor and in metabolite. In its transformation 
into BDA, the cyclodipeptide undergoes a dilution by endogenous 
material present in the organism and thus the relative abundance 
of Q Hq]]BDA is increased. An allowance must also be made for the 
small (0.016^) natural abundance deuterium content in the endogenous 
metabolite and its contribution to the abundance of E^Hj-species 
must be considered. With this in mind, and using the dilution value
/ 1 \ 1^(7.^) obtained from the C-tracer, the percentage abundances of 
the synthetic precursor listed in Table k can be used to calculate 
(see Appendix) the percentage abundances predicted for each species 
in the metabolite, assuming a biosynthetic process in which (a) all 
four deuterium atoms are retained, and (b) no dissociation and 
recombination of the precursor occurs. The calculated values and the 
discrepancies between the observed and calculated values axe listed 
in Table 5»
The discrepancies [(a) - (b) in Table 5] between the observed 
and calculated relative abundances of and [[Si^-EDA are of the
same order as the errors associated with their measurement and, 
therefore, no significant quantitative conclusion may be drawn from 
them. Conversely, the errors associated with the measurements of 
the three other species are considerably smaller than the corresponding 
discrepancies. The total percentage of deuterium (5»9^%) present in
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the BDA isolated from the feeding experiment was calculated (see 
Appendix) from the percentage abundances of the species in Table 5 
[[column (b)] taking account of the number of deuterium atoms present 
in each species. Similarly, the predicted total percentage of 
deuterium ( 7 was calculated using the values in Table 5 [[column
(b)]. Thus, ca. ZCffo of deuterium had been lost during the experiment.
Th£ partial loss of deuterium can be accounted for by an exchange 
process occurring either during the biosynthesis or in the mass 
spectrometer. This latter possibility is considered unlikely. The 
mass spectral data were obtained by repetitive scanning of the mass 
spectrum of the isolated BDA for 6.5 min in an MS 9 mass spectrometer. 
Comparison of the percentage abundance of each species in each scan 
did not reveal any trend indicating an exchange process. Also, 
essentially the same spectrum was obtained with an MS 12 spectrometer. 
Therefore, the loss of deuterium most probably occurs during the 
biosynthetic conversion of the precursor into the metabolite.
However, as pointed out before, the observed presence of [[^H^BDA 
excludes the possibility that this loss of deuterium is an obligatory 
step in BDA biosynthesis. The mechanism that would account for such 
a loss is not evident, but it is clear that this point ought to be 
investigated further.
In conclusion, we have established that cyclo-(L-Phe-L-Phe), 
rather than cyclo-(D-Phe-D-Phe) or cyclo-(D-Rie-L-Phe), is 
incorporated virtually intact and efficiently into bisdethiobis- 
(methylthio)acetylaranotin by A. terreus. Moreover, cyclo-(L-Phe- 
L-Phe) has been identified as a natural metabolite of A. terreus 
and is either an intermediate, or is interconvertible with an 
intermediate, on the biosynthetic pathway from phenylalanine to BDA.
Furthermore, this pathway appears to proceed with partial (i.e. 
non-obligatory) loss of the hydrogen originally in the methylene 
groups of cyclo-(L-Phe-L-Phe).
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CHAPTER 4 
EXPERIMENTAL
4.1 General procedures
Only procedures not mentioned in Part I, Chapter 3# will he 
dicussed here. Optical rotations were measured at 5^9 nm (D line 
of sodium) in a Perkin Elmer l4l polarimeter. The mass spectra of 
BDA (42), discussed in Section 3.3, were obtained in a VG updated 
MS-902S, coupled to a VG data system, with a dynamic resolving power 
of 3,000. Samples were introduced into the probe at 170°C and an
ionization potential of 70 eV was used.
13Proton noise decoupled ^C-nuclear magnetic resonance spectra 
were run at 25.2 MHz in the pulsed Fourier transform mode on a Varian 
XL-100 n.m.r. spectrometer with VFT-100 accessory, at ambient 
temperature (ca. 25°C) and using tetramethylsilane as internal 
standard. Standard conditions for data acquisition were: spectral 
width, 5000 Hz; acquisition time, 0.4 s; pulse width, 10 Ps (pulse 
angle, ca. 20°) and digital resolution, 1.25 Hz/data point.
When measuring enhancements, in order that the peak heights were 
not affected by the digital resolution, a severe exponential 
weighting factor (sensitivity enhancement 0.05 s) was used to 
multiply the free induction decay. This resulted in the line widths 
being about 10 Hz at half height.
After t.l.c., sulphur containing compounds were detected by
47spraying the plates with silver nitrate reagent. This was prepared 
by adding a saturated solution of silver nitrate (l ml) to acetone 
(20 ml) • the precipitated silver nitrate was then redissolved by
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dropwise addition of water (ca, 0,5 nil). Compounds containing S-S
linkages initially gave yellow spots which, in time, first turned
brown and finally black. Compounds containing MeS-groups gave, after
ca. 12 h, white spots on a grey background. Cyclic dipeptides were
48
detected as follows. After development, the t.l.c, plates were 
dried at 100°C for 5 min, cooled to room temperature, and then placed 
for 5 min in a* tank saturated with chlorine gas. Chlorine gas was 
generated by adding concentrated hydrochloric acid to a potassium 
permanganate solution in a small beaker placed at the bottom of the 
tank. Excess chlorine was removed by allowing the plate to stand in 
the fume-cupboard for ca. 5 min. The plate was then sprayed, in the fume-
cupboard, with £-tolidine reagent until the spots became visible. The
reagent was prepared by dissolving o-tolidine (160 mg) in glacial acetic 
acid (30 ml), diluting the solution with water (500 ml) and adding 
potassium iodide (l g). Cyclic dipeptides, depending on their
concentration, gave blue or yellow spots.
4.2 Fermentation conditions
Hyalodendron sp. (FSC-601) was obtained from Dr. A.Taylor of 
the Atlantic Regional Laboratory, National Research Council, Canada.
The fungus was grown for 9 clays on Z% malt—agar slants. Material 
from these slants was used directly to inoculate 500 ml Erlenmeyer 
flasks each containing synthetic medium (100 ml) of the following 
compositions
Glucose 10 g
KHgPO^ 1.5 g
MgS0^.7H20 0.5 g
9
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nh4no3 0.7 g
KC1 1 g
Thiamine.HC1 1 mg
Na^ B^ Or,. lOH^O 0.88 mg
CaCl2.2H20 0.037 mg
FeS0^.7H20 0.25 mg
MnS0^ .*ffl20 0.0^ mg
NagMoO^^O 0.025 mg
ZnS0^ .7H20 0.031 mg
Deionised water 1 litre
The pH of the medium was adjusted to 3<»5 with dilute hydrochloric 
acid and the solution was sterilized hy autoclaving at 121°C and 
15 psi for 15 min. The culture was grown at 25°C on an orbital 
shaker at 160 rpm for 14 days.
Aspergillus terreus (NRRL 3319) was obtained from Lilly Research 
Laboratories, Indiana, USA. Initially, the mould was grown on slants 
having the following composition:
Tomato paste 20 g
Oatmeal flour 20 g
Agar 20 g
Deionised water 1 1
It was found later (see Section 3.3) that better growth was obtained 
with Czapek-Dox slants, which consist of:
Glucose 50 g
NaNO^ 2 g
KG1 1 S.
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MgSO^ 1 g
K2HP04 0,5 S
FeSO^ O.Ol g
Agar 20 g
Deionised water 1 litre
Slants were incubated for one week and washings therefrom were used 
to inoculate 500 ml Erlenmeyer flasks containing the synthetic medium 
(100 ml) described below. These seed flasks were grown at 28°C for 4 
days and aliquots (10 ml) from them were used to inoculate 500 ml 
Erlenmeyer flasks containing synthetic medium (100 or 120 ml) of the 
following composition:
Glucose 15 g
Sucrose 15 g
NaNO^ 2 g
kh2po4 1 g
MgSO^.THgO 0.5 g
KC1 0.5 g
FeS0^ .7H20 0.01 g
Beef extract 0.5 g
Yeast extract 0.125 g
Deionised water 1 litre
The medium was sterilized by autoclaving at 121 C, and 15 psi for 
20 min. The fungus was grown at 28°G for one week on an orbital 
shaker at 160 rpm.
3
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4.3 Feeding experiments
Precursors, dissolved in dimethyl sulphoxide (DMS0),were fed to 
Hyalodendron sp. on the fifth day of growth, at the levels shown 
in Table 6. Cultures were harvested 9 days later. Precursors, 
dissolved in DMSO, were fed to A. terreus 48 h after inoculation, 
at the^levels shown in Table 7» Cultures were harvested 5 days later.
The "intermediate-trapping" experiment was carried out by 
administering cyclo-(L-Phe-L-Phe) (100 mg) in DMSO (10 ml) to two-day- 
old cultures of A. terreus (l l), followed, 2 h later, by the addition 
of L-phenylalanine (25 yCi). After a further 2 h, the culture was 
harvested.
4.4 Metabolite isolation
Hyalodendron sp. cultures were harvested by suction filtration 
through a pad of Celite 545 filter-aid. The mycelium was washed 
with methanol and the mycelial washings and filtrate were combined 
and extracted with chloroform (6 x 1C$ total volume). The combined 
extracts were concentrated to ca. 100 ml, washed with water (3 x 10 ml), 
dried over MgSO^, and evaporated to dryness. The residue was 
chromatographed on silica gel t.l.c. plates developed with benzene- 
ethyl acetate (4:1). The band between Rf ^  0.12 -.0.24, detected 
with ultraviolet light (254 run), was eluted with chloroform (2 x 30 ml) 
and ethyl acetate (2 x 30 ml). The solvents were evaporated, yielding 
crude bisdethiobis(methylthio)hyalodendrin (17) • When the cultures 
had been fed with precursors dissolved in DMSO, this residue was 
dissolved in methylene chloride (10 ml), which was washed with water
3
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( 3 x 5  ml) to remove dimethyl sulphone, dried and evaporated to dryness.
Bi sd e thi obi s (me thy 1 thi o ) hyalodendrin (ca. 20 - 25 mg per litre of mould 
culture) was crystallised from methylene chloride - cyclohexane, m.p.
141.5 - 142.5°G (lit.,16 140 - 140.5°G), 
[a]D31 + 62° (c 1.01. GHG13) [lit.,16 
' M d23 + 6^ ° (£ 1.071, CHC13)], + 48°
(c 0.13, GH^H); 13C-n.m.r. 6 (CDCl^
13.4 (MeN), 14.3 (MeN), 29.4 (MeS),
30.9 (MeS), 42.3 (G-7), 64.3 (C-l4),
71.6 (C-3 or C-6), 73.5 (C-3 or C-6),
127.7 (C-ll), 128.6 (C-10 and C-12),
130.0 (G-9 and G-13), 134.1 (C-8) 
and 165.4 ppm (C-2 and G-5).
A. terreus cultures were harvested by suction filtration and the 
mycelium was washed with methanol. The combined culture broth and 
mycelial washings were acidified to pH 3 with concentrated hydrochloric 
acid and were extracted with GHG13(6 x 10$ total volume). The combined
extracts were concentrated (ca. 100 ml), washed with water (3 .x 10 ml),
dried over MgSO^ and evaporated to dryness. The residue was chromatographed 
on silica gel t.l.c. plates developed with chloroform - ethyl acetate 
(1:1). The band at Rf ^ 0.5 0.7, detected with ultraviolet light 
(254 nm), was eluted with chloroform (3 x JO mi) ethyl acetate 
(3 x 30 ml). The combined eluates were evaporated to dryness, leaving 
a residue which contained BDA (42) and EDAA (43). This mixture was 
re chromatographed on silica gel t.l.c. plates developed with isopropyl 
ether - chloroform - acetic acid (6:3:1). The closely running bands 
at Rf 0.21 - 0.33 and 0.33 - 0.45, detected with ultraviolet light (360 nm), 
were eluted with chloroform (3 x 30 m )^ e"khyl acetate (3 x JO ml).
The material from the faster-running band consisted mostly of BDAA,
11 -SMe
MeN,
Me S' OH
a
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contaminated with varying amounts of BDA, and, generally, could not
be crystallised. The material from the slower-running band gave, after
recrystallisation from methanol, pale yellow crystals of pure BDA
(ca. 10 mg per litre of mould culture) m.p. 201 - 203°G (dec.) [lit., 213-
217° (dec.)32, 215 - 236° (dec.)3^ , 
230° (dec. )33]; ^C-n.m.r. 6 (CDC1.)
14.7 (MeS), 21.0 (C-12), 40.5 (C-4),
60.3 (C-5), 70.5 (C-2), 71.7 (C-9),
105.8 (C-8), 109.5 (C-10), 137.7 
(C-6 or C-7), 139.7 (0-6 or C-7), 
l6 ^ A  (G-3) and 169.9 ppm (C-ll).
lU  ^ l^f
L-[U- C]Phenylalanine, L-[^,-'lf]phenylalanine, DL-[l- C]phenyl-
1^  1alanine and L-[3- CJserine were obtained from The Radiochemical Centre,
13 13Amersham. DL-[3" C^Serine (containing ca. 23^ glycine; 0.90 atom C^),
DL-[l-^c]phenylalanine (0.9I atom "^ C) and L-[^N]phenylalanine
(9»9&5 atom ^N) were obtained from Prochem-B.O.C. Limited.
The commercial DL-[3-1^G]serine was freed from the glycine it
contained by ion-exchange chromatography using a BIO-RAD analytical
grade cation exchange resin, AG 50Wt-X8 (H , 200 - ^00 mesh). The
commercial sample (0.516 g) in deionised water (10 ml), was applied
to the column (l m long, 1 cm inner diameter) which was then washed
with deionised water (^0 ml). The amino-acids were eluted with 1M
hydrochloric acid (flow rate: 0.^  ml/min) and fractions (10 ml) were
collected with an automatic fraction collector. Each fraction was
analysed by t.l.c. on Merck aluminium sheets precoated with Cellulose
SMe
Me CO
ili Labelled amino acids
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( 0 .1 0  mm t h i c k )  d eve lo p ed  w ith  a  m ix tu re  o f  n -b u ta n o l -  a ce to n e  -  
d ie th y la m in e  -  w a te r  (10:10:2:5) The spots  w ere re v e a le d  by  
s p ra y in g  t h e  p la te s  w ith  a  s o lu t io n  o f  n in h y d r in  i n  n -b u ta n o l.  I n  
t h is  s o lv e n t  sys tem , s e r in e  had R^ , = O.^+O, w hereas g ly c in e  had R ,^ =
0.21. Fractions 37 - ^3 were found to contain the desired DL-£3-13C]- 
serine. These were combined and evaporated to dryness under reduced 
pressure. The residue was dissolved in water (5 ml) and taken to pH
6.8 with 1M lithium hydroxide. Ethanol was added until a slight 
cloudiness appeared and the solution was cooled to 0°G. The crystalline 
amino-acid was filtered off, washed with water and dried under vacuum 
over Plates of pure DL-^-^C]serine (0.3^0 g) thus
obtained had m.p. 238°C (dec.) Qlit.,^ 2^6°G (dec.)]. Glycine (0.103 
g) was recovered in a similar manner from fractions 51 “ 57 • Since 
previous chromatographies of mixtures of the two amino-acids had 
shown that the average recovery for serine was ca. 89 ,^ the commercial 
sample contained ca. 23% of glycine.
b .6 Synthetic procedures
C y c lo - ( L -T U - l£ fC ~ lfh e -L -S e r) and c y c lo - (L -T ^ t - ^ H lP h e - L - Q - ^ C jS e r )  
w ere p re p a re d  b y  P a t r ic k ^'^ and c y c lo - ( L -£ U - C ]P h e -L -fh e )  was p re p a re d  
by T a le k a r 2 ^ b y  methods s im i la r  to  th o se  d e s c r ib e d  below  f o r  th e  same 
compounds h a v in g  d i f f e r e n t  is o to p ic  l a b e l l i n g  p a t t e r n s .
Acetate of bisdethiobis(methylthio)hyalodendrin (3 9 ) A solution 
of bi sde thi obi s (me thylthi 0 ) hyalodendrin (12.1 mg), pymdine (2 drops) 
and acetic anhydride (2 drops) was kept at room temperature for 12 h. 
Methanol (0.5 ml) was added and the solution evaporated to dryness.
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The r e s id u e  was r e c r y s t a l l i s e d  from  ace to n e  -  d ie t h y l  e th e r  to  g iv e  
w h ite  n e e d le s  o f  th e  a c e ta te  (39) (10.7 mg, 79.1 #  y i e l d ) ,  m .p . 137 - 
139 G (F o u n d : C, 5^*7; H, 6.2; N, 6.9. ^i8^24^2^2^4 re<lu^res G# 54.6;
H, 6.1; N, 7.1#); <5 (CDCl^) (60 MHz) 7.22 (5H, s, ArH), 4.37 (2H, s, 
-CHg-Hi), 3.30 (2H, ABq, 14 Hz, -CHgO-), 3*28 (3H, s, NMe), 3.05 
(3H, s, Me), 2.33 (3H, s, SMe), 2.23 (3H, s, SMe) and 1.66 (3H, s, SMe).
N-Benzyloxycarbonyl-D-serine.- Benzyl chloroformate (l ml, 96% 
pure) was added, with vigorous stirring, to a solution of D-serine 
(0.53 S» 5 mmol) in aqueous saturated sodium bicarbonate (20 ml). 
Stirring was continued for a further 4 h, and then the reaction mixture 
was extracted with ether (3 x 10 ml) and cooled to 0°G. The cold 
solution was acidified to pH 2 with concentrated hydrochloric acid 
and then extracted with ethyl acetate (5 x 10 ml). The combined ethyl 
acetate extracts were dried over anhydrous Na^SO^ and concentrated 
to a solid. This was triturated with ether (3 x 10 ml) and then dried 
under vacuum to give N-benzyloxycarbonyl-D-serine (1.01 g, 84.5# yield), 
m.p. 117.5 - 118°C (lit.,-51 119.5°C); [a]^2 - 5.2° (c 1.07, HOAc) 
[lit.,52 [a]D20 - 5.6° (c 1, HOAc)].
N-Benzyloxycarbonyl-DL-[3"1^G]serine. - This racemate was 
synthesised from DL-[3-13C]serine (335-8.mg, 3.2 mmol), by the method 
described above for the D-enantiomer, in 82.7# yield, m.p. 125 - 126 C 
(lit.,53 125°G).
L—Serine methyl ester hydrochloride.- Using the method of 
Guttman and Boisonnas,51 L-serine (5*25 Si 50 nmol) was converted, by
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the action of thionyl chloride and methanol, into its methyl ester 
hydrochloride (6.92 g, 89^  yield), m.p. 1 - 166°C (lit.,51 l68°G)
DL-Phenylalanine methyl ester hydrochloride.- A solution of 
DL-phenylalanine (l6^ f.^  mg, 0.99 mmol), 2,2-dimethoxypropane (10 ml) 
and concentrated hydrochloric acid (l ml) was kept in the dark for
CK
18 h, a§ described hy Rachele. Evaporation of the solvents left a 
dark brown residue which was dissolved in anhydrous methanol (1 ml) • 
Cold anhydrous ether was added to this solution until crystals started 
to appear. Crystallisation was complete after cooling to 0°C for 2^ 
h. The crystals were filtered, washed with anhydrous ether and dried 
under vacuum. The white plates of the hydrochloride (193*8 mg, ^1% 
yield) had m.p. 157 - 158*5°C (lit.,55 158°C); m/e 179 (M+, free 
amino ester), 120 (M - CO^e), 103 (M - CyRy + H), 91 (Cr^ H^ ) and 
88 [CHNH^CO^e)].
t/l 1 i^f _
DL-fl- C~]Phenylalanine methyl ester hydrochloride.- DL-j_l- CJ-
Thenylalanine methyl ester hydrochloride was synthesised, as described 
above, from DL-[l-^C];phenylalanine(50 yCi), diluted with DL-phenyl- 
alanine (382.7 mg, 2.3 mmol), in 89^  yield, with a specific activity 
of 21.07 yCi/mmol and m.p. 157 - 158*5°C (li't**-'^  158 G).
DL-f 1~15C~IPhenylalanine methyl ester hydrochloride.- DL-[1- C]- 
Hienylalanine methyl ester hydrochoride was synthesised, as described 
above, from DL-[[l-15C]phenylalanine (255*8 mS# 1*5^ mmol) in 1 %  yield 
and with m.p. 158 - 158*5°C (lit.,55 158 G)*
3
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methyl ester hydrochloride.- L-Fhenylalanine
(33O mg, 2 mmol) was submitted to the reaction conditions described
above for racemic phenylalanine, to give the L—methyl ester hydrochloride
(409.4 mg, 95% yield), m.p. 157 - i59°c (lit.,56 158.5 - 159.5°C);
[a] / 6 + 36° (0 2, EtOH) [lit.,56 [a^ 25 + 40° (c 2. EtOH)].
*
14
L-fU- C]Phenylalanine methyl ester hydrochloride.- The radioactive 
methyl ester hydrochloride was synthesised as described for the 
unlabelled racemate,.from L-[U-1^ G]phenylalanine (50 yCi) diluted 
with L-phenylalanine (188 mg, 1.1 mmol), in 9^$ yield with a specific 
activity of 41.28 yCi/mmol and m.p. 153 - 155°C (lit.,56 158.5 - 159.5°C).
N-Benzyloxycarbonyl-L-phenylalanine. - This compound was obtained
using L-phenylalanine, benzyl chloroformate and aqueous sodium
*57hydroxide, according to the method of Grassman.-^  On re crystallisation 
from methylene chloride - petroleum ether (40 - 60°C), the pure amino- 
acid derivative was obtained (71$ yield), m.p. 85 - 87°G (lit.,57 
88 - 89°C); [a]D22 + 5-7° (c I.96, EtOH) [lit.,57 [a]D20 + 5-1° (c 
2, EtOH)].
N-Benzyloxy carbonyl-L-[ 15N] phenylalanine. - N-Benzyloxycarbonyl- 
L-[^5N]phenylalanine was synthesised, as described above, from L-[ 5N]- 
phenylalanine (303.1 mg, 1*8 mmol) in 84.5$ yield and with m.p. 86 - 
87°G (lit.,57 88 - 89°C).
N—Benzyloxycarbonyl—D—phenylalanine • - N—Benzyloxycarbonyl—D—
phenylalanine was synthesised as described above for the L-enantiomer,
in 80% yield with identical properties except for opposite optical rotation.
3
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N-Benzyloxycarbonyl-NHnethyl-L-phenylalanine. - This compound was
synthesised, according to the method of McDermott and Benoiton,^ from
N-benzyloxycarbonyl-L-phenylalanine and excess methyl iodide and sodium
hydride in tetrahydrofuran0 The derivative, previously reported as 
. 31
an oil, was crystallised from methylene chloride — petrolem ether 
(40-60°C) to give white crystals (66^  yield), m.p. 62 - 64.5°C, [a]D22 
- 74° (c 2.05, MeOH) (Founds G, 69.3; H, 6.2; N, 4.2. C-^H-^NO^
requires C, 69.0; H, 6.1; N, 4.5^); 6 (CDCl^) (90 MHz) 10.79 (1H, bs,
C02H, exchangeable with D20), 7.33 (5H, d - rotamers, ArH), 5.07 (2H, 
d - rotamers, -CH2«0-), 4.92 (1H, m, a-GH), 3.22 (2H, m, p-GH2) and
2.80 (3H, d- rotamers, NMe); m/e 313(M+), 178 (M - G^OGO), 165
(GyHyOGONHMe) and 91 (G^).
13cyclo-(L-Rie-DL-f3- CQSer).- L-Phenylalanine methyl ester 
hydrochloride (435 mg» 2 mmol) was suspended in anhydrous methylene 
chloride (25 ml), cooled to 0°C and anhydrous, freshly distilled 
triethylamine (O.39 ml, 2.8 mmol) was added to give a clear solution. 
N-Benzyloxycarbonyl-DL-£3“^CGserine (478 mg, 2 mmol) was added to 
this solution followed by dicyclohexylcarbodiimide (460 mg, 2.2 mmol).
The solution was kept in the dark at room temperature for 6 h. The 
precipitated dicyclohexylurea was removed by filtration. The filtrate 
was washed with 1M HC1 ( 2 x 5  ml)» water ( 2 x 5  I&1)# saturated 
aqueous sodium bicarbonate (2 x 5 water ( 2 x 5  • The methylene
chloride layer was dried over MgSO^ and evaporated. The residue was 
suspended in anhydrous acetone and filtered to remove more urea, the 
acetone was evaporated and the residue was dissolved in anhydrous 
methanol (20 ml) containing glacial acetic acid (4 drops). This solution
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was hydrogenolysed at. room temperature and atmospheric pressure for
h using 10% palladium - carbon catalyst (70 mg) • The catalyst was
filtered off, the solvents were evaporated, and the residue was dissolved
in anhydrous methanol (l ml). This solution was then treated with
saturated ammoniacal methanol (10 ml) at room temperature for 2^  h*
The product which separated was filtered off, washed with cold anhydrous
methanol (2 x 2 ml) and anhydrous ether (3 x 2 ml) and finally dried
under vacuum. The crystalline cyclodipeptide (9^ ,^ mg) (crop A)
showed two m.p.'s at 2^4 - 255°C and 262 - 26A°C (dec,). Concentration
of the ammoniacal mother liquors, followed by cooling and washing of
the resulting crystals as described above, afforded more cyclodipeptide
(20.1 mg) (crop B), m.p, 235 - A 0 °C . Further concentration of the
mother liquors as above gave crop C (51*1 mg)» m*P. 230 - 235°C,
The 25.2 MHz natural abundance C-n.m.r. spectra of cyclo-(L-
Phe-L-Ser) and cyclo-(L-Phe-D-Ser) were obtained using samples of the
9 27cyclic dipeptides that had been prepared by Patrick. 1 For the LL-
(C-ll), 6 2 A  (C-l^), 56A  (C-3 or C-6), 55»0 (C-3 or C-6) and 38.6 (C-7).
The ^C-n.m.r. spectra of crops A, B and C were obtained and 
compared with those previously obtained for the pure LL- and LD-
isomer: 6 (d^-DMSO) 166.6 (C-2 or C-5),
10___9
OH
165.8 (C-2 or C-5), 136.6 (C-8), 129.9 
(C-9 and C-13), 128.1 (C-10 and C-12), 
126A(C-ll), 63.1 (C-14), 57.1 (C-3 
or C-6), 55.5 (C-3 or C-6) and 39.8
ppm (C-7). For the LD-isomer: 6 (dg- 
DMSO) 167.^ (C-2 or C-5), 166.8 (C-2 
or C-5), 136.2 (C-8), 130.1 (C-9 and 
C-13), 127.9 (C-10 and C-12), 126.5
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isomers. The relative abundances of LL- and LD-isomers present in the 
^C-labelled mixture were calculated from the heights of the signals 
at 6 63*1 and 62.4. Thus the LL:LD ratios were found to be ls3«0 
for crop A, 3»^sl for crop B and 4.2sl for crop G. These results 
were confirmed by "^H-n.m.r. spectroscopy. The NH protons in the T.T.— 
isomer gave signals at 6 7*9^  and 8.06 ppm, whereas the corresponding 
signals'for the LD-isomer appeared at <5 7.85 and 8.16 ppm. However, 
no quantitative information could be obtained from the heights of these 
peaks since, owing to partial overlap, their integration was not very 
accurate. Nevertheless, for crop A, four distinct signals were observed 
in that region, the two inner ones being much weaker (x ■£•) than the 
outer ones, whereas for both crops B and G, the inner peaks were 
higher, the outer ones being barely visible. Therefore, overall 165 mg
1*5 .
of cyclo-(L-Fhe-DL-T3- -'C]Ser) (35% yield from the amino-acid derivatives) 
were obtained, of which ca. 85 mg corresponded to the LD-isomer and 
ca. 80 mg corresonded to the LL-isomer.
c y c l o - ( L - T U -^ C lP h e - D -S e r ) . -  T h is  c y c l ic  d ip e p t id e  was s y n th e s is e d
t£l
by th e  p re c e d in g  m ethod, from  L -£ U - C J p h e n y la la n in e  m e th y l e s t e r
hydrochloride (224 mg, 1.04 mmol, 43.0 yCi), N-benzyloxycarbonyl-D-
serine (248.5 Dig# 1*04 mol), dicyclohexylcarbodiimide (272.3 mg, 1.32
mmol) aofi triethylamine (160 yl) in methylene chloride (10 ml). The
product which separated after treatment with saturated ammoniacal
methanol was filtered off, washed with anhydrous diethyl ether (3 x 2 ml)
14 -1 \
and c r y s t a l l i s e d  fro m  m eth an o l to  g iv e  c y c lo - ( L - f U -  C jH ie -D -S e r )
(92 mg, 38% yield from the amino-acid derivatives), m.p. 258 - 265 C 
( d e c . )  [lit.,9 258 - 268°C (dec.)], with a specific activity of 31.5^ 
UCi/mmol; 0.62 (methanol - ethyl acetate, 1:1); <5 (d^-DMSO) (90 MHz)
0
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8.00 (1H, I d s ,  NH, exchangeable with D£0), 7.70 (1H, bs, NH, exchangeable 
with D20)f 7.2^ (5H, i, ArH), ^.90 (IH, t, J 5-5 Hz, OK, exchangeable 
with DgO), (1H» m, CHCH2Hi) and 3.8O - 2.85 (5H, m, GHGH^OH,
CHgOH and GH^Eh).
cyclo-(L-N-Me-Phe-L-Ser’). - L-Serine methyl ester hydrochloride
(l62.mg, l.O^ f mmol) was suspended in anhydrous methylene chloride
(12 ml), cooled to 0 G and anhydrous, freshly distilled triethylamine
(1^ 0 yl) was added to give a clear solution. N-Benzyloxycarbonyl-N-
methylphenylalanine (333 mg, 1.06 mmol) was added to this solution
followed by dicyclohexylcarbodiimide (223 mg, 1.08 mmol). The reaction
mixture was kept in the dark at room temperature for 4 h, then at 0°G
overnight and finally at room temperature for a further 1 h. The reaction
13mixture was worked up as described for the C-labelled cyclodipeptide, 
namely, by removal of the urea, washing of the filtrate (with 1 M 
hydrochloric acid, water, saturated aqueous sodium bicarbonate and water), 
drying of the organic layer, removal of more urea and finally dissolution 
of the residue in a methanol - acetic acid mixture (85:15, 10 ml).
This was hydrogenolysed for 8 h at room temperature and atmospheric 
pressure using 10$ palladium - carbon catalyst. (71 mg). The catalyst 
was filtered off and the solvents were evaporated. The unprotected 
dipeptide cyclised spontaneously upon complete removal of the acetic 
acid. The crude cyclodipeptide was recrystallised from methanol - 
diethyl ether to give white needles of pure cyclo-(L-N-Me-Phe-L—Ser)
(ca. 35 mg, 13.6$ yield), Rf 0.50 (methanol - ethyl acetate, 1:1), 
m.p. 199 - 201°C, [a]D22 + 2° ± 1° (c 0.165, methanol) (Found: G, 52.5;
H, 7.0; N, 9.1. G13Hl6N203.2|H20 requires G, 53.2; H, 7.2; N, 9.6$)
9
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(m/e 2^9.1235. Calc, for C ^ H - ^ O y  M, 2^.1239); 5 (dg-DMSO) (90 
MHz) 9.13 (1H, d, J 8 Hz, NH, exchangeable with D^O), 7.33 (5H, s,
ArH), 5*26 (1H, t, J 5 Hz, OH, exchangeable with E>20), ^.38 (1H, 
dt, J 8 and ^ Hz, CHCH20H), ^.17 (1H, t, J 7 Hz, CHC^Ih), 3.7^ (2H, 
d, J k Hz, CH20H), 3.6k (3H, s, Me), and 3.15 (2H, d, J 7 Hz, CHgFh). 
Irradiation of the signal at 9.13 ppm caused the signal at 5.26 ppm 
to dis&ppear^ and that at .^38 ppm to collapse to a triplet.
Irradiation of the signal at ^ .38 ppm caused: a) collapse of the 
signal at 9*13 PP® to a singlet, b) collapse of a signal at 5*26 ppm 
to a very broad singlet, and c) collapse of the signal at 3*7^  ppm 
to a broad singlet. Irradiation of the signal at -^.17 ppm caused 
the signal at 3*15 PP® to collapse to a singlet, m/e 2^9 (M+ + H),
221 (M + 1 - CO), I89 (M + 1 - CO - CH^OH), 13^ (C^CH-NHMe), 119 
(CpH^CH-MH) and 91 (C^).
cyclo-(L-N-Me-Phe-L-[3-li|'C]Ser).- Thionyl chloride (160 pi) 
was added to a solution of L-[3-1^ C]serine in anhydrous methanol (2 ml) 
at 0°C. L-Serine (106 mg, 1 mmol) was then added and the solution 
was kept at room temperature for 2 h and then at 0°C overnight.
The solvents were removed under a stream of nitrogen, leaving white 
needles of the methyl ester hydrochloride. These were dissolved in 
anhydrous methylene chloride (6 ml) and anhydrous, frshly distilled 
trie thy lamine (l^ K) pi) was added to free the amino ester. N-Benzyl— 
oxycarbonyl-N-methyl-L-phenylalanine (315 1 mmol) was then added
to the methylene chloride solution followed by dicyclohexylcarbodiimide 
(250 mg, 1.2 mmol). The reaction mixture was kept in the dark at 
room temperature for ^ h, then at 0 C overnight, and then worked up
9
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as described above. The protected dipeptide gave only one spot, R^
0.58 [ethyl acetate - petroleum ether (*+0 - 6o°C) - acetic acid, *+:*+:l]. 
The protecting group was removed by hydrogenolysis for 13 h at room 
temperature and atmospheric pressure using 10% palladium - carbon 
catalyst (80 mg) in methanol (8.5 ml) containing acetic acid (1.5 ml). 
Filtration of the mixture and evaporation of the filtrate afforded a 
mixtureKof three compounds, only one of which had the Rf expected for 
the cyclodipeptide. On the assumption that complete cyclisation had 
not taJcen place, the mixture was dissolved in methanol (2 ml) and treated 
with saturated ammoniacal methanol (10 ml) at room temperature for 
2*+ h. Evaporation of the solvent and inspection by t.l.c. showed a 
mixture of two products, one of which (R^ 0.5*+; methanol - ethyl acetate, 
1:1) was the desired cyclo-(L-N-Me-Fhe-L-L-Ser). The two compounds 
were separated by preparative t.l.c. using chloroform - methanol - 
acetic acid (90:5*5)* The material recovered from the band at R^ 'u 0.11, 
could not be crystallised (see Section 2.3). The crude product (*+6.2 
mg) was dissolved in methanol (-5 ml) • Half of this solution was used 
in a feeding experiment (Table 1, experiment No. 10); the other half 
was used for an isotope dilution analysis. This revealed that the 
specific activity of the cyclo-(L-N-Me-Rie-L-[3“ G^ jSer) was 5*^5 
yCi/mmol, and that it was contaminated with *+0.3$ of radioactive im 
impurities which could not be identified.
cyclo-CD-The-DL-Cl^^Phe)To a solution of DL-Cl-^C]- 
phenylalanine methyl ester hydrochloride (*+33 mg, 2 mmol, *+2.3 bCi) 
in anhydrous methylene chloride (20 ml) was added anhydrous, freshly 
distilled triethylamine (0.3 ml), N-benzyloxycarbonyl-D-phenylalanine 
(598 mg, 2 mmol) and dicyclohexylcarbodiimide (*+13 mg, 2 mmol), in
d
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that order. The reaction mixture was kept in the dark at room 
temperature for ^ h, and then at 0°G overnight. The precipitated 
dicyclohexylurea was removed by filtration. The filtrate was washed 
with 1 M hydrochloric acid ( 2 x 5  ml)» water ( 2 x 5  ml) » saturated 
aqueous bicarbonate (2 x 5 ml) and water ( 2 x 5  ml). The organic 
layer was dried over MgSO^ and evaporated to dryness. The residue 
was suspended in anhydrous acetone (10 ml) and filtered to remove more 
ureai To the acetone solution was added 10$ palladium - carbon catalyst 
(71 mg) and the mixture hydrogenolysed at room temperature and atmospheri 
atmospheric pressure for 3 h. The catalyst was removed by filtration 
and the filtrate was evaporated to dryness. The residue was dissolved 
in anhydrous methanol (2 ml), cooled to 0°C and treated with saturated 
ammoniacal methanol (10 ml). The solution was left at room temperature 
overnight. The solid that separated was filtered, washed with ether 
2 x 5  ml) and recrystallised from methanol (large excess). The mixture 
of cis(DD)- and trans(DL)-cyclodipeptides crystallised as very fine 
white needles (63.3 mg, 11$ yield from amino acid derivative), m.p.
295 - 297°C, specific activity 20.73 yCi/mmol, Rf 0.25 (DD-isomer) 
and 0.51 (DL-isomer) (isopropyl ether - chloroform - acetic acid,
6s3:l) * 6 (CF^G02H) (90 MHz) 8.11 (bs, NH), 7.8^ (bs, NH), 7.# and 
7.12 (m, ArH), ^.58 (bm, ct-CH), 3-9^ (m, ct-CH), 3-H (*. 0-CH), and 
2.27 (m, p-GH)• The signals at 6 8.11 and ^.58 ppm corresponded to 
the DD-isomer, whereas those at 6 7*84 and 3*9^ PPm corresponded to 
the DL-isomer (by comparison with the ^H-n.m.r. spectra of the two 
separate isomeric cyclodipeptides). Integration of these signals showed 
that the DL:DD ratio was k i6 .
3
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cyclq-(L-[ N]]Phe-DL-^l- C^]]Phe).- Using the procedure described 
13
above, DL-[1- C]phenylalanine methyl ester hydrochloride (240 mg, 1.1 
mmol) and N-benzyloxycarbonyl-L-[^^phenylalanine (330 mg, 1.1 mmol)
were coupled to give the protected dipeptide. This compound was
deprotected by hydrogenolysis and cyclised, as before, to give cyclo— 
15 13
(L"C N^]Fhe-DL-£l- C]Ehe) in two crops: the first (^0.8 mg) had m.p.
295 - 297°C and the second (54.8 mg) had m.p. 281 - 291°G (overall
29% yield from the amino-acid derivative). In the first crop the
LLsLD ratio was 52*7:47.3» whereas in the second it was 59*41, a-s
calculated from integration of the ^H-n.m.r. spectrum. "^C-n.m.r.
6 (GF^CO^H) (25.2 MHz) 173.3 (carbonyl group of LD-isomer) and 172.6
ppm (carbonyl group of LL-isomer), 18 Hz (assignments m^de on
59 \comparison with published data ).
Morpholine perchlorate.-- A solution of morpholine (50 g, 0.6 
mol) in methanol (200 ml) was cooled to 0°G and perchloric acid (50 
ml of 72% aqueous solution, d 1.67 g/ml, 0.6 mol) was added dropwise 
and with stirring, to keep the exothermic reaction under control.
The resulting pale yellow solution was allowed to cool to room 
temperature, whereupon the perchlorate crystallised as small white 
needles. These were filtered off, washed with cold methanol (2 x 25 
ml), and dried first by suction and then under vacuum, over 
for 24 h. No attempts were made to characterise the product (72.6 g, 
64.7%) due to its potentially explosive character.
q-Ihenyl-a-morpholinoacetonitrile.- • a-Fhenyl-a-morpholinoaceto- 
nitile was synthesised by the method of Bennett et al. The crude
d
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product was re crystallised from petroleum ether (60 - 80°C) to give 
white needles (87% yield), m.p. 69.5 - 70°C (lit.,60 69 - 70°C)
(Founds G, 71.2; H, 7.2; N, 14.0. Gale, for C ^ H - ^ O :G, 71.3; H, 6.9;
N, 13-90); vmax# (KBr) 2 980, 2 9^ 5, 2 910, 2 825, 2 230 and 1 ^ 55 cm"1;
6 (CGl^) (90 MHz) 7 M  (5H, m, ArH), ^.7^ (1H, s, ct-H), 3.67 (^ H, t, -GH20-) 
and 2.53 (4H, t, “CH^-N-); m/e 202 (M+), 171 (M - CH^O) and 116 (M - 
C^ HgNO)'.
q-Phenyl-q-fa-^H~]morpholinoacetonitrile. - ot-Bhenyl-a-mcrpholino- 
acetonitrile (50.5 St 0.2 5 mol) in anhydrous NN-dime thy If ormamid e (200 
ml), under dry, oxygen-free nitrogen, was treated with sodium hydride 
(mineral oil suspension; O.76 mol) at room temperature for 1 h to 
generate the green benzylic anion. Addition of D^O (26 ml) was 
followed by acidification of the solution at 0°G to pH ^  2 with a 
slight excess of thionyl chloride. The brown mixture was diluted 
with water (ca. 20 ml) and extracted with chloroform (^  x 30 ml).
The combined chloroform extracts were washed with water (3 x 10 ml), 
dried over MgSO^ and evaporated to give a syrupy residue. This was 
crystallised from petroleum ether (60 - 80°C) giving white needles 
(4-5.6 g, 90% yield, 0.9^ atom deuterium), m.p. 68 - 70°G (lit.,60 
69 - 70°G for nondeuteriated compound) (Founds C, 71.1; H, 7*6; N, 13.8. 
Gale, for G ^ H ^ N ^ O  C, 70.9; H, 7>; N# 13.0% ); vmax# (KBr) 2 980,
2 9^0, 2 910, 2 820, 2 255 and 1 455; <$ (CCl^ ) (90 MHz) 7.^0 (5H, 
m, ArH), ^.68 (0.06H, s, residual a-GH), 3.62 (^ H» t.-CHgO-) and 
2.^9 (4H, t, -CH2N-); m/e 203 (M+), 172 (M - GH^O) and 117 (M - G
C^HgNO).
2
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[f9Hgi-2H]Benzaldehyde> - a-Phenyl^.[a-2H>orpholinoacetonitrile 
(^•5 g» °*23 mol) was heated for 1 h in refluxing 2 M hydrochloric 
acid (250 ml). The solution was cooled to room temperature and extracted 
with methylene chloride (8 x 30 ml), The combined methylene chloride 
extracts were dried over MgSO^ and the solvent was distilled off-through 
a short fractionating column at atmospheric pressure, fformyl-2H~j- 
Benzaldehyde (21.7 g» 88% yield, 0.95 atom deuterium) was obtained 
by distillation of the residue, b.p. 170 - 178°C (lit.,^° 178°G for 
nondeuteriated compound); Vj^ (film) 3 060, 2 100, 2 060, 2 C&0 and 
1 685 cm”1; 6 (CCl^) (90 MHz) 9.97 (0.05H, s, residual GHO) and 7.86 
and 7*57 (5H, m, ArH); m/e 107 (M+) and 79 (M - GO).
2 2fmethylene- ^^Benzyl alcohol.- fformyl- H]Benzaldehyde (30 g)
was heated for 2.5 h in refluxing 25% aqueous potassium hydroxide 
solution (80 ml) and then left at room temperature overnight. Water 
was added, to dissolve the precipitated potassium benzoate, and the 
solution was extracted with diethyl ether x 20 ml). The combined 
ether extracts were concentrated (to ca. 30 ml) and washed with saturated 
aqueous sodium .metabisulphite,*(2 x 5 ml), 10% aqueous sodium carbonate 
( 2 x 5  ml) and water ( 2 x 5  ml). The organic layer was dried over 
MgSO^ and evaporated under reduced pressure. Upon distillation, the 
yellow residue afforded the pure alcohol (11.8 g, 7&»5f° yield, ca. 1.60 
atom deuterium), b.p. 65 - 75°G/30 Torr (lit.,-^ 205 G, for nondeuteriated 
compound); 6 (CCl^) (60 MHz) 7*00 (5H, s, ArH), ^.33 (O.^ t-H, bs, 
residual CH^) and 3*53 (IB# Bs, OH, exchangeable with B^O).
2
[methylene_- H^Benzyl chloride.- To a solution of fmethylene-^H2~|- 
benzyl alcohol (6.5 g, 60 mmol) and pyridine (0.7 ml) in anhydrous 
diethyl ether (50 ml) was added, dropwise and with stirring, a solution 
of thionyl chloride (9*8 g, 82 mmol) in anhydrous diethyl ether (35 ml). 
The mixture was stirred overnight and was the washed with water (2 x 10 
ml) and dried over MgSO^. The ether was evaporated and bulb-to-hulb 
distillation of the residue afforded the pure chloride (5.9 g, 78^  
yield, 1.72 atom deuterium), b.p. 110 - 115°C/30 Torr (lit.,-*0 179°C 
for nondeuteriated compound); 6 (CCl^ ) (60 MHz) 7.33 (5H, s, ArH) 
and 4.53 (O.29H, bs, residual GH^ ).
2
Ethyl 2-acetamido-2-ethoxycarbonyl-3-phenyl-r3.3- H^~|propionate.- 
2("methylene- H ^ B e n z y l  chloride was used to prepare this compound a 
according to the procedure described by Snyder et al.^ for the 
nondeuteriated analogue. The crude solid was recrystallised from 
water to give white crystals ( 62% yield, 1.42 atom deuterium), m.p.
105 - 106°C (lit.,^ 1 106°C for nondeuteriated compound) (Found 1 G, 62.0; 
H, 7.5? N, 4.3. Calc, for C-^H-^O^N: C, 62.1; H, 7.4; N, 4.#); vmax. 
(KBr) 3 280, 3 010, 2 995, 1 755 and 1 650 cm-1; 6 (CCl^) (90 MHz)
7.16 (5H, m, ArH), 6.57 (IH, bs, NH), 4.28 (4h, q, -OGHg-), 3-60 
(0.60H, bs, residual GH^Eh), 1.97 (3H, s, COGH^) and 1.30 (6H, t, 
CH2CH3); m/e 309 (M). 279, 174 and 119.
DL-f 3.3-2H2lPhenvlalanine. - The [2H2]-acetamidomalonate 
derivative (5.3 g, 17 mmol) was heated in refluxing concentrated 
hydrochloric acid for 18 h. The solution was evaporated to dryness 
under reduced pressure, the residue dissolved in water and the solution
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was taken to pH 6.5 with 5 M sodium hydroxide. Cooling of this solution
afforded a white solid which was crystallised first from ethanol -
water (2:l) to give a mixture (2.2 g), positive to ninhydrin, consisting
of the amino-acid and sodium chloride. This mixture was recrystallised
three times from water to give the pure amino-acid (1.6 g, 56% yield)
as white plates, m.p. 215 - 217°C (dec.) [lit.,-50 284 - 288°C (dec.),
for th& nondeuteriated compound] (Found: C, 64.9; H, 7.6; N, 8.4.
Calc, for CqH D2N02;C, 64.7; H, 7.8; N, 8.^); (KBr) 3 450, 3 200 -7 / max•
2 500, 1 630, 1 595 and 1 500 cm"1; 6 (CF^CO^) (90 MHz) 7.36 (5H, m,
ArH) and 4.62 (1H, bs, a-CH).
C£Olo-(DL-C3,3-2H2]Phe-DL-T3,3-2H2]Hie).- DL-[3,3-2H2]Phenyl-
alanine (O.563 g# 3*4 mmol) was heated, under a nitrogen atmosphere, 
in refluxing ethylene glycol for 4 h, according to the method of
62Sannie. On cooling to room temperature the solution deposited 
white crystals. They were filtered off, washed with cold methanol 
(2 x 5 ml) and diethyl ether (2 x 5 ml)» and dried under vacuum.
The cyclic dipeptide (319*5 mg» 63*1$ yleld) bad m.p. 293 “ 295 C 
(dec.); 5 (CF C0?H) (90 MHz) 8.07 (2H, bs, 2 x NH of cis-isomers),
j  ^
7.78 (2H,.bs, 2 x NH of trans-isomer), 7*33 and 7.11 (10H, m, ArH),
4.56 (2H, bs, a-CH of cis-isomers), 3*93 (2H, bs, a-CH of trans­
isomer), 3.11 (1.6H, bm, residual p-CH) and 2.29 (0.3H, bm, residual 
P-CH); m/e 298 (M+), 205 (M - 0/ ^ ) ,  177 (M - C^CD^HNH), 122 
(H2N=CH-GD2C6H^) and 93 (C^^Dg).
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APPENDIX
A. Studies involving radioactive isotopes
1/j. \
In the G- and "rl-biosynthetic studies described in this work, 
the incorporation I) of the radiolabelled precursor is given by the
Ni
equations
M
% I  SL.x — 2L x 100 (l)
S M 
P P
where,
Sm: molar specific activity of metabolite
Spj molar specific activity of precursor
M s number of moles of isolated metabolite m
M s number of moles of administered precursor 
P
The dilution (D) of the radiolabel in the biosynthetic transformation 
of precursor into metabolite is given by the equation:
(2)
Sm
B. Studies involving ^C-labelled precursors
(i) Terminology
In "^C-biosynthetic experiments, information on the incorporation 
and dilution of the precursor is obtained from the enhancement (P) of
140
the 15C-n.m.r. signals corresponding to the labelled sites. In single­
site labelling experiments, the enhancement (P) of the site is given 
by the ratios
P =   (3)
nat, abund.
where the i's denote peak heights, with i ^  standing for the height
of the signal of the labelled centre in the spectrum of the enriched
metabolite and i ^ ^  abund ^or height of the same signal in the
natural abundance spectrum. The value of i . , , used in this
nat. abund.
calculation is obtained as follows. Excluding the signal of the 
labelled site, the intensity of each peak in the spectrum of the 
enriched metabolite is divided by the intensity of the corresponding 
peak in the natural abundance spectrum. The average of these ratios 
is then calculated and used to estimate what the peak intensity of the 
labelled site would have been, had it not been enriched above natural 
abundance. The value thus obtained is ; i-^ is then
measured directly from the spectrum of the enriched metabolite.
13
Results are commonly expressed as percentage C-enrichments,
13that is, P.r, where r represents the natural abundance G-content 
(1.1#). The dilution may, in turn, be obtained from the formulas
e - r 
D = --------
Pr - r
w
where e is the percentage ^C-enrichment of the precursor at the 
specific site of labelling. The value of e is usually obtained either 
from the supplier of the labelled precursor or by independent calculation
1 M
from n .m .r .  o r  mass s p e c t r a l  d a ta .
The v a l i d i t y  o f  eq.uat io n  (^f) can "be dem onstrated  by e x a m in a tio n
o f w hat goes on d u r in g  a  b io s y n th e t ic  e x p e rim e n t. L e t  us assume t h a t
we a d m in is te r  A m oles o f  a  la b e l le d  p re c u rs o r , h a v in g  a  p e rc e n ta g e
■ ^ c -e n ric h m e n t v a lu e  o f  e a t  a  s p e c i f ic  s i t e ,  to  an o rg an ism . I n
response to  t h i s ,  B m oles o f  la b e l le d  m e ta b o lite ,  a ls o  h a v in g  a  
13p ercen tag e  C -e n r ic h m e n t v a lu e  o f  e, w i l l  be produced by th e  o rg an ism , 
b u t th e y  w i l l  be d i lu t e d  w ith  E m oles o f  u n la b e l le d ,  endogenous 
m e ta b o li te .  The d i l u t i o n  ( d )  o f  th e  p re c u rs o r  i s  th e  r a t i o  o f  th e  
t o t a l  m oles o f  m e ta b o l i t e  produced o v e r th e  m oles o f  m e ta b o lite  
d e r iv e d  e x c lu s iv e ly  fro m  p re c u rs o r , t h a t  i s ,
B +  E
D =   --------------  ( 5 )
B
The p e rc e n ta g e  ^ C -e n r ic h m e n t  o f  th e  m e ta b o lite  ( P . r )  w i l l  have  
c o n t r ib u t io n s  fro m  th e  f r a c t i o n  o f  m oles o f  m e ta b o lite  p o ssess in g  
th e  same p e rc e n ta g e  "^ C -e n ric h m e n t as th e  p re c u rs o r  and th e  f r a c t i o n  
o f m oles o f  m e ta b o l i t e  o n ly  h a v in g  th e  ^ C - is o t o p ic  n a t u r a l  abundance. 
Hence,
B E
P . r  =  -----------------  e +    r
B +  E B +  E
Be +  E r  
B +  E
I f  we s u b t r a c t  r  fro m  b o th  s id e s  o f  t h is  i d e n t i t y ,  we o b ta in s
Be +  E r
P . r  -  r  = — ------------------ "  r
B +  E
B (e  -  r )
B +  E
s
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Rearrangement of this last equation leads to equation (4).
1*
(ii) ^-Experiment on Hvalodendron sp.
I n  th e  fe e d in g  o f  2 ^ - ( L - a e - D I ^ > 13C ]S e r )  to  H va lo d en d ro n  s p . ,
13the percentage C-enrichment for this precursor at C-3 was determined 
to be *90#, from mass spectral data. The percentage enrichment 
of the isolated metabolite was found, upon measurement of P as 
described before, to be 3.0 x 1.1%. Thus, the dilution value for 
this experiment can be calculated by substituting the numerical 
values in equation (4).
90f% - 1.1#
D = ------------  = 40.4
3 x 1.1# - 1.1#
( i i i )  ~ ^ C ^ N -E x p e r im e n t on A. te r r e u s
The composition of the precursor fed, listed in Table 3 [column 
(a)] was calculated as follows:
ic
1. The isotopic compositions of the commercial [ ifjphenylalanine
and [l--^C]phenylalanine listed below were calculated based on the
1^N- and “^ e-enrichments of 96.5 and 91#, respectively, quoted by
15the suppliers. We shall designate n as the N-enmchment and r
as the ^c-enrichment. Thus, for the commercial [“^l-phenylalanine,
13
n = 0.965 and r = 0.011, and for commercial [1- C]phenylalanine, 
n = 0.0037 and r = 0.9I. By the same token, for unlabelled 
phenylalanine, n = 0.0037 and r = 0.011.
SPECIES FORMULA
RELATIVE ABUNDANCE 
in [15N]Fhe in [l-13C]Ph in Fhe
15 — n(l - r) 0.95£j4 0.0003 0.0037
(1 - n)(l - r) 0.0346 O.O897 0.9853
15 — —  13 nr 0.0106 0.0034 0.00004
> —  13 r(l - n) 0.0004 0.9066 0.0110
2. The composition of a dioxopiperazine synthesised by coupling 
two amino acids can be obtained by construction of a 4 x 4 matrix
using the sets of values listed above. Because the matrix will be
symmetrical about its main diagonal, 12 of the 16 combinations
15—
obtained will really be 6 sets of mirror images. Pictorially, 13---
 15represents the same dioxopiperazine as. _____ • Thus, to obtain
13
the composition of the C^, N-labelled dioxopiperazine, we use the
1*5 13values calculated for [_ N]phenylalanine and [1- C]phenylalanine,
whereas for cyclo-(L-fU-^CHFhe-L-Rie) we use the set of values obtained
for unlabelled phenylalanine. However, the two dioxopiperazines were
present in different amounts in the total mixture fed, 6.5 mg
corresponding to the doubly labelled LL-dioxopiperazine and 5*5
corresponding to the ^C-labelled dioxopiperazine. Therefore, the
13 13 14
percentage abundance of each species in the C N- and C-labelled 
dioxopiperazines must, be multiplied by 6.5/12 and 5• 5/12, respectively, 
before they are added to give the final composition of the LL-cyclo-
dipeptide administered.
As discussed in Section 3.3, only species C and H will contribute 
to the central amide peak in the 13C-n.m.r. spectrum of BDA, when the
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13 15 14- ADMINISTERED
C, N-LABELLED C-LABELLED
DIOXOPIPERAZINE
DIOXOPIPERAZINE DIOXOPIPERAZINE
MIXTURE
A
1 11 —1 1—1 86.52 0.008 4 6 .8 7
B
15—
8.56 0.73 4 .9 7
G 13— 3 .1 ^ 2.17 2.69
D
15.
13—
13
0.96 a 0 .5 2
E
15
13 15 0.32
_a
0 .1 7
F 0.31 9 7 .0 8 4 4 .6 6
G 13— — 15 0.11 0 .0 0 8 0 .0  6
H 13
13
0 .0 4 0 .0 0 1 0 .0 2
I
15—
15 0 .0 3 0 .0 0 4 0 .0 2
J
15—  
13—
TT
0 .0 0 4
a
0 .0 0 2
a  le s s  th a n  0 .0 0 0 1
l a t t e r  i s  o b ta in e d  a f t e r  a  6 .0  d i l u t i o n  o f  th e  a d m in is te re d  p r e c u r s o r .
M o re o v e r, s p e c ie s  H w i l l  c o n t r ib u te  tw ic e ,  s in c e  i t  possesses two
13 1 4  / j \  .C - N u n i t s .  R earrangem ent o f  e q u a tio n  ( 4 ) ,  g ivess
e -  r
P =   -V I
rD
T h e r e fo r e , s in c e :
e =  2 . 69#  +  2 (0 .0 0 2 % ) =  2 .73%
D = 6 .0
P = 1.25
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U s in g  e q u a t io n  ( 3) and th e  h e ig h t  o f  amide peak ( 4 . 7 1  cm) exp ec ted  
fro m  e x c lu s iv e ly  a  n a t u r a l  abundance " ^ C -c o n t r ib u t io n ,  we o b ta in :
i^  -t = P x  i  , 
l a b .  n a t .  abund. 1
= 5*89 cm
I f  we now assume t h a t  th e re  has been com plete  d is s o c ia t io n  to  
g iv e  p h e h y la la n in e , we d is c o v e r  t h a t  th e  r e l a t i v e  abundances o f  each  
a m in o -a c id  s p e c ie s  have become:
SPECIES
1 5 '
1 5 ---------  13
 ---- 13
RELATIVE ABUNDANCE
0.2603
0.4852
0.0038
0.2506
C o m b in a tio n  o f  th e s e  v a lu e s , as p r e v io u s ly  e x p la in e d , i n  a  4  x  4  m a t r ix ,  
y ie ld s  a  new s e t  o f  p e rc e n ta g e  abundances f o r  th e  d io x o p ip e r a z in e  t h a t  
w ould  r e s u l t  fro m  random re c o m b in a tio n  as d is cu s se d  i n  S e c t io n  3 * 3 *  anl  
l i s t e d  i n  T a b le  3 Ccolumn ( b ) ] .
PERCENTAGE 
ABUNDANCE
SPECIES
1 5 -
1 3 -
1 5 -
1>
15-
13-
15-
13-
■13
15
SPECIES
13.04
25.25
24.32
0.19
0.14
13 '
13-
15*
15'
13'
■15
•13
•15
■13
15
PERCENTAGE
ABUNDANCE
23.54*
0.36
6.28
6.77
0.001
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Again, only species G and H will contribute to the central
amide peak, this time with e = 36.88^ . However, dissociation has
only occurred to a certain fractional extent, x. The value of x may
be calculated as follows.
e = 2.73(1 - x) + 36.88x
= 2.73 + 34.15x
and D = 6.0
.\ P = 1.25 + 5.17x .
And, consequently,
ilat)# = 4.71(1.25 + 5.17x)
= 5.89 + 24.35x
Recalling that the value for measured directly from the ^C-n.m.r.
spectrum (Figure 3) is, after correction for overlap, 7.10 cm, the 
identity:
i la b . = 7 ,1 °  = 5'89 +  2 /f,35x
can be solved for x,
x = 4.9756
Hence., as discussed in Section 3*3# at least 95% of the LL-cyclo- 
dipeptide is incorporated intact.
2
C. Studies involving H-labelled precursors
The percentage abundances and errors for the various deuteriated 
species listed in Table 4 were calculated as follows. Three scans
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of the spectrum of cyclo-(DL-T3.V 2H_1:Fhe-DL-[?r ]Fhfl) were
obtained in an MS-12 mass spectrometer. In each scan, the heights
of the peaks (for M+*) at m/e = 294, 295, 296, 297 and 298 (corresponding
to the 2Hq-, ^ 1-, ZKz - ,  j -  and ^H^-dioxopiperazines) were measured
(with a ruler) and the heights obtained were normalized to a total
height of unity. The mean (x) of the three values obtained for each
species^was calculated, along with the standard error (standard
deviation from the mean), according to the equations:
X.. + x0 + ... + x1 2  nMEAN = x
n
STANDARD ERROR =
,2x - x
(n - 1)
The spectrum of a sample of unlabelled cyclo-(DL-Fhe-DL-Rie) was 
obtained under the same conditions and, from the heights measured, 
the M + l/M and M + 2/fy corrections were calculated to be 0.22 and
0.04 respectively. These values agreed with those reported in mass 
spectral tables. The mean and standard error for each species in 
the deuteriated cyclodipeptide were adjusted, taking account of 
these corrections, and then renormalized to give the percentage 
abundances and standard errors listed in Table 4.
The values listed in Table 5 [column (a)] were obtained in a 
similar way, with the following modifications: (i) thirty scans of 
the MS-9 spectrum of the isolated deuteriated BDA were used to 
calculate the mean intensity and standard error for the fragments 
of m/e = 487, 488 , 489, ^ 0  and 491, corresponding to the five
to 2Hy.) species of the [M - SMe]+# fragment ion; (ii) thirty
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scans of the MS-9 spectrum of unlahelled BDA were used to calculate 
the P + l/P and P + 2/P corrections, which were 0.27 and 0.10, 
respectively. No tabulated values were available for comparison.
material. Thus, 6.36 ± 0.21 and 0.027 ± 0.0009 were added, respectively,
abundances of all the species and their errors were normalized to a 
total of 100.
The total percentages of deuterium in the isolated and predicted 
BDA were calculated by adding the products of multiplying the 
percentage abundance of each species by the number of deuterium atoms 
it contains, and normalizing the sum to a percentage. Thus,
The values in Table 5 [[column (b)] were calculated using Table 4 
and the dilution value of 7.4 ± 0.21 obtained by means of the^C-tracer.
p
Since deuterium has a natural abundance of 0.016%, both the HQ- and 
2H^-spesies suffer the influence of the dilution by endogenous
2 2to the percentage abundances of the Hq- and H^-species and then the
PREDICTED BDA ISOLATED BDA
1.80 ± 0.04 
7.60 ± 0.06 
10.42 ± 0.04 
9.84 ± 1.04 
29.66 ± 1.04 
7.42 ± 0.26
0
3.02 ± 0.32 
13.29 ± 0.54 
5.88 ± 0.44 
23.74 ± 0.80 
5.94 ± 0.20
1.55 ± 0.23
0
2Total H atoms 
Total fo 2H
The loss of deuterium can he calculated from these values:
7A2 - 5.9^
Loss of deuterium x 100 19.95 ± 0.23^
7.42
1^9
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